Rezza Giovanni DocenteMedicinaMED/42 - Straordinario

Biografia

Pubblicazioni

Biografia

Data di nascita: Roma, 6 maggio 1954

Nazionalità: Italiana

 

TITOLI FORMATIVI

Titoli di studio

10 aprile 1979   Laurea in Medicina e Chirurgia, Sapienza Università di Roma.

1982   Specializzazione in Igiene e Medicina Preventiva (indirizzo Laboratorio), Sapienza Università di Roma.

1986   Specializzazione in Malattie Infettive, Sapienza Università di Roma.

Altre esperienze formative

1979   Tirocinio pratico ospedaliero in Medicina Interna presso l’Ospedale San Camillo, Roma.

1980-1982   Formazione clinica in Malattie Infettive presso l’Ospedale Lazzaro Spallanzani, Roma.

1986   Borsa di studio dell’Organizzazione Mondiale della Sanità (OMS) per l’Epidemiologia delle malattie trasmissibili, Centro di Collaborazione OMS sull’AIDS - Istituto Leon Mba, Ospedale Claude Bernard, Parigi.

1989   Visiting Research Fellow presso il “Centre for Research on Drug and Health Behaviour”, Charing Cross and Westminster Medical School, Università di Londra.

 

CONOSCENZA DELLE LINGUE

Utente avanzato in riferimento a comprensione, parlato e produzione scritta in lingua inglese.

Utente intermedio in riferimento a comprensione, parlato e produzione scritta in lingua francese.

 

IDONEITA’ ACCADEMICHE

2018   Professore Prima Fascia, Settore concorsuale: 06/M1 (Igiene e Medicina Preventiva).

 

ATTIVITÁ PROFESSIONALE

Posizioni di ruolo

Durante la propria carriera professionale ha ricoperto molteplici ruoli e assunto la direzione di strutture complesse, con diversi livelli di responsabilità, gestendone personale e budget:

1980-1981   Medico a contratto (Servizio di Guardia Medica).

1982-1991   Medico funzionario, Ministero della Salute.

1989   Short Term Consultant, Organizzazione Mondiale della Sanità di Ginevra, Global Program on AIDS, (6 marzo – 1 settembre ).

1991- Maggio 2020   Dirigente di Ricerca, Istituto Superiore di Sanità (ISS).

Maggio 2020-2023   Direttore Generale della Prevenzione Sanitaria, Ministero della Salute.

2021-2023   Chief Medical Officer per l’Italia

Dicembre 2023-Oggi   Professore straordinario di Igiene, Università Vita-Salute San Raffaele, Milano

Incarichi di responsabilità nella gestione di strutture

1990   Responsabile del servizio di Epidemiologia del Servizio centrale dipendenza da alcool e sostanze stupefacenti (SECEDAS), Ministero della Sanità.

1993-2004   Direttore del Centro Operativo AIDS (COA), Istituto Superiore di Sanità.

1999-2004   Direttore del Reparto AIDS e Malattie Sessualmente Trasmesse, Laboratorio di Epidemiologia e Biostatistica, Istituto Superiore di Sanità.

2004-2009   Direttore del Reparto Epidemiologia, Dipartimento Malattie Infettive, Parassitarie e Immunomediate, Istituto Superiore di Sanità.

2009-2016   Direttore del Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Istituto Superiore di Sanità.

2017- Maggio 2020   Direttore del Dipartimento Malattie Infettive, Istituto Superiore di Sanità. Budget di funzionamento di circa € 8/900.000 per anno cui si sommano i fondi ricerca (stimabili in circa € 4/500.000). Il personale afferente è di oltre 250 unità, di cui 7 direttori di reparto).

Maggio 2020-2023   Direttore Generale della Prevenzione Sanitaria, Ministero della Salute.
Durante il suo mandato sono stati elaborati e/o adottati il Piano Nazionale Prevenzione 2020-25, il Piano Pandemico 2021-23, il Piano Nazionale per il Contrasto all'Antibiotico-resistenza 2022-25, ed è stato messo a punto il Piano Nazionale Prevenzione Vaccinale 2023-25.

 

INCARICHI, COMMISSIONI E CONSULENZE A LIVELLO NAZIONALE E INTERNAZIONALE

1986-2020   Esperto del Consiglio Superiore di Sanità su temi relativi ad infezione da HIV/AIDS e altre malattie infettive, Ministero della Salute, Roma.

1987-1991   Temporary Advisor, Organizzazione Mondiale della Sanità, Ginevra (Svizzera), Cracovia (Polonia), Dakar (Senegal), Copenhagen (Danimarca), Albania, e short-term consultant dell’OMS per un programma sul fondo esperti italiani per l’Albania.

1993-2014   Membro della Commissione Nazionale AIDS e Malattie Infettive Emergenti e Riemergenti, Ministero della Salute, Roma.

1993-2014   Membro di Commissioni Nazionali di Sorveglianza delle Tossicodipendenze del Ministero della Sanità; membro di comitati tecnici e di valutazione di progetti del Ministero della Salute e del Ministero Affari Sociali.

1997-2010   Componente del Comitato Etico dell’Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani IRCCS, Roma.

2001-2004   Membro del WHO-UNAIDS HIV Vaccine Advisory Committee (VAC), Organizzazione Mondiale della Sanità, Ginevra (Svizzera).

2003   Membro della Commissione SARS ed altre emergenze infettive, Ministero della Salute, Roma.

2005   Esperto del Ministero della Salute per la stesura del “Rapporto Globale sullo Stato di Salute dell’Unione Europea”.

2010-2017   Membro della Commissione per l’Etica della Ricerca e la Bioetica del Consiglio Nazionale delle Ricerche, Roma.

2010   Membro del Comitato Tecnico per la Campagna Antinfluenzale, Ministero della Salute, Roma.

2010   Membro del Comitato Scientifico sulla formazione per l’educazione continua in Medicina, Istituto Superiore di Sanità, Roma.

2010   Membro del Comitato Tecnico-Scientifico a supporto del Ministero della Salute, nelle trattative con l’azienda Novartis per la definizione di un accordo di transazione conseguente all’acquisto del vaccino A/H1N1v.

2010   Membro del Comitato Tecnico-Scientifico della Fondazione Internazionale Fatebenefratelli, Roma.

2010   Membro del Comitato Scientifico della Fondazione Ivo de Carneri, Milano, Ces (TN), Zanzibar (Tanzania).

2011-2013   Esperto della Commissione per la valutazione dell’ammissibilità alla sperimentazione clinica Fase I (D.M. del 22/11/2011) dell’Istituto Superiore di Sanità per gli anni 2011-2013 (Decreti Legislativi 211/2003 e 200/2007 e DPR n. 439).

2012   Componente del Comitato Tecnico Scientifico dell’Istituto Dermatologico San Gallicano, Roma.

2012   Esperto nel gruppo di lavoro del Ministero della Salute per la predisposizione di un rapporto contente raccomandazioni in merito alle vaccinazioni indicate nei soggetti a rischio, Roma.

2013   Membro del Comitato Scientifico del Master in Protection against CBRNe events, Università degli Studi di Roma Tor Vergata.

2013- in corso   Membro del Comitato di Redazione del sito www.uniticontrolaids.it - www.zerohiv.it del Ministero della Salute, Roma.

2014 –2020   Componente del Comitato Etico dell’Istituto Superiore di Sanità, Roma.

2014   Contact person della Direzione generale della salute e dei consumatori (DG SANCO) e della Agenzia esecutiva per i consumatori, la salute, l’agricoltura e la sicurezza alimentare (CHAFEA) della Commissione europea per l’azione congiunta “Risposta efficiente ai patogeni emergenti altamente pericolosi in Europa”, Bruxelles (Belgio).

2014- in corso   Membro del Comitato Scientifico VaccinarSì (http://www.vaccinarsi.org/), Società Italiana di Igiene, Roma.

2014-2016   Responsabile del “Microbiology National Focal Point” presso il Centro europeo per la prevenzione e il controllo delle malattie dell’Unione europea (ECDC), Stoccolma (Svezia).

2015   Membro del Comitato Scientifico per la vaccinazione contro il meningococco B del Centro Studi Investimenti Sociali (CENSIS), Roma.

2015   Membro del Comitato Scientifico per la riorganizzazione del sistema sanitario in ambito penitenziario (Delibera n. 228 del 15.06.2015), Ministero della Salute, Roma.

2015   Membro del Comitato di Certificazione (Organismo Notificato 0373 sezione TESA) (Decreto del Direttore Generale ISS n. 243/15), Istituto Superiore di Sanità, Roma.

2015-2018   Membro del Comitato Tecnico-Sanitario del Ministero della Salute Sezione per la lotta contro l’AIDS.

2015- in corso   Membro del Comitato Scientifico della rivista The Future of Science and Ethics (ISSN 2421-3039), edita dalla Fondazione Umberto Veronesi, Milano.

2016   Membro della Commissione Immunologia-Oncologia dell’Ordine dei Medici Chirurghi e degli Odontoiatri della Provincia di Roma (OMCeO).

2016   Rappresentante del CNCCS nel Comitato Scientifico della Italian Advanced Translational Research Infrastructure (A-IATRIS), promossa dal Ministero della Salute, Roma.

2016   Componente del Comitato Scientifico del Portale della Conoscenza dell’Istituto Superiore di Sanità, Roma. 

2016   Esperto, su nomina del Ministero della Salute e per conto della Commissione Europea, del gruppo di lavoro costituitosi sull’emergenza dell’epidemia da virus Zika.

2017-2018   Membro NITAG (Commissione Nazionale Vaccini) del Ministero della Salute.

2017-2018   STE Expert del Progetto: Twinning Light Project: “Improving microbiology system quality in the function of surveillance on communicable diseases in the Republic of Serbia” TWLCONTRACT:  48-00-00002/2017-28.

2017- in corso   Membro del Gruppo di Lavoro Polio presso il Ministero della Salute, Roma.

2018   Componente del GdL, Comitato Tecnico Sanitario (CTS), Sezione L e M per la lotta   all’AIDS, Ministero della Salute, Roma.

2018-2019   Componente del Gruppo di Lavoro per il coordinamento della strategia nazionale di contrasto dell’antimicrobico-resistenza presso il Ministero della Salute.

2018-2019   Membro del nucleo tecnico del NITAG (Commissione Nazionale Vaccini) del Ministero della Salute.

2020   Ha partecipato sin dall’inizio ai lavori del Comitato-Tecnico Scientifico sul COVID-19.

2020   Coordinatore della sorveglianza epidemiologica e microbiologica del SARS-CoV-2 istituita presso l’Istituto Superiore di Sanità.  

2017- 2020   Member of the Board EU-Joint Action on Vaccination.

Maggio 2020-2023   Competent body, ECDC, Stoccolma.

Maggio 2020-2023   Senior official, GHSI (Global Health Security Initiative); coordinator GHSA (Global Health Security Agenda).

2020   Coordinatore, Gruppo di Lavoro intersettoriale su vaccini e vaccinazione anti-  COVID-19.

2020-2023   Cabina di Regia per il monitoraggio del rischio sanitario da SARS-CoV-2 di cui all’all.10 del DPCM26/4/2020 e al DM Salute 30 aprile 2020.

2021-2023   Rappresentante italiano nell’High Level Group of Experts e poi del Board di HERA (Authority Europea di preparedness su contromisure mediche nei confronti di pandemie).

Aprile 2021-2023   Membro dello Steering Board della Commissione Europea sui Vaccini.

2023-oggi   Membro del Comitato Scientifico del CNCCS (IRBM, CNR e ISS)

È stato inoltre membro del Comitato Scientifico di numerose conferenze scientifiche internazionali, tra le quali l’International AIDS Conference di Firenze nel 1991 e quella di Barcellona nel 2002, e ha contribuito alla organizzazione del G20 tenutosi in Italia nel 2021, intervenendo in plenaria sul tema Mental Health..

 

ATTIVITÀ GESTIONALE NEL SETTORE PUBBLICO/PRIVATO

2010-2012   Presidente del Consiglio di Amministrazione della società consortile a responsabilità limitata “Collezione Nazionale di Composti Chimici e Centro Screening” (CNCCS) costituita tra CNR, ISS e IRBM Science Park Srl, Roma. Il bilancio complessivo della Scarl nel periodo in cui ha rivestito l’incarico di Presidente è stato di circa € 26.000.000,00.

2016- maggio 2020   Membro del Consiglio di Amministrazione della Fondazione ICONA, Milano.

2017- maggio 2020   Membro del Consiglio di Amministrazione della Fondazione “The Brigge – ScIenza tra Clinica e Società”, Milano.

2024-oggi   Membro dell’Organismo di Valutazione di IRBM

2024-oggi   Membro dell’Organismo di Valutazione di Advaxia

 

INCARICHI E RESPONSABILITA’ DI PROGETTI DI RICERCA

È stato responsabile scientifico di innumerevoli progetti di ricerca, twinning finanziati dall’UE e progetti di cooperazione internazionale, nonché coordinatore di programmi di ricerca nazionali che hanno previsto la gestione di bandi per l’assegnazione di fondi, il coordinamento e la valutazione delle singole unità operative, la programmazione ed esecuzione di azioni concertate e il raccordo con istituzioni e agenzie di finanziamento nazionali e internazionali.

1989-1992   Responsabile dell’azione su HIV prevention strategies in injection drug users, EC Concerted Action su “Assessing AIDS Prevention”, coordinato dall’Università di Losanna (Svizzera).

2000-2002   Responsabile Scientifico del progetto “Epidemiologia e modelli di ricerca assistenziale” nell’ambito del Programma Nazionale di Ricerca sull’AIDS 2000.

2000-2010   Partner e Membro dello Steering Committee del Progetto Europeo Concerted Action on Seroconversion to AIDS and Death in Europe coordinato dal Medical Research Council e finanziato dalla Commissione europea.

2001-2003   Responsabile Scientifico del Progetto “Epidemiologia dell’HIV ed altre infezioni trasmesse per via sessuale”, nell’ambito del Programma Nazionale di Ricerca sull’AIDS 2000.

2001-2007   Componente del Comitato Scientifico del “Progetto per lo sviluppo di vaccini HIV/AIDS” (ICAV) del Programma Nazionale di Ricerche sull’AIDS.

2002   Responsabile Scientifico del Progetto finanziato dalla Commissione Europea “Creazione di una rete tra i National Focal Point dei Paesi dell’area mediterranea”.

2002   Responsabile Scientifico del Progetto “Un sistema integrato di sorveglianza HIV e AIDS per il miglioramento continuo degli interventi di prevenzione”, Regione Veneto.

2002-2003   Responsabile Scientifico del Progetto Sperimentale multiregionale per la sorveglianza dell’infezione da HIV, finanziato dal ministero della Salute.

2002-2003   Responsabile Scientifico “Centro Operativo AIDS” (comprendente Telefono Verde e il Centro Operativo AIDS presso il Ministero) nell’ambito del Programma Nazionale di Ricerca sull’AIDS.

2002-2003   Responsabile Scientifico del Programma Italia-USA “Epidemiologia” nell’ambito del Programma Nazionale di Ricerca sull’AIDS.

2002-2004   Responsabile Scientifico del Progetto “Miglioramento del sistema di sorveglianza delle infezioni da hiv/aids e del monitoraggio degli interventi di prevenzione e controllo dell’infezione da HIV”, Regione Veneto.

2002-2004   Responsabile Scientifico del Progetto “Cascade Virology”, finzianziato dalla Commissione europea.

2002-2005   Responsabile Scientifico del Progetto “Epidemiologia molecolare nelle malattie da infezione”, INMI Lazzaro Spallanzani IRCCS.

2003-2004   Responsabile Scientifico della Ricerca finalizzata 2002 “Strategie di immunoterpaia contro genotipi di HPV oncogeni e non oncogeni”, IFO San Gallicano, Roma.

2003-2004   Responsabile Scientifico del Progetto “Sars: modelli matematici per scenari epidemiologici”, Ministero della Salute, Roma.

2004   Co-Responsabile Scientifico del Progetto “Epidemiologia dell’HIV/AIDS” nell’ambito del V Programma Nazionale della Ricerca sull’AIDS.

2004   Co-Responsabile Scientifico del Progetto “Aspetti psicosociali” nell’ambito del V Programma Nazionale della Ricerca sull’AIDS.

2004-2005   Coordinatore dell’Azione Concertata “Assistenza domiciliare e case alloggio” nell’ambito del V Programma Nazionale della Ricerca sull’AIDS.

2004-2005   Responsabile Scientifico del Progetto “Sorveglianza delle nuove diagnosi di infezione da HIV in Italia”, finanziato dal Ministero della Salute, Roma.

2004-2006   Responsabile Scientifico del Progetto “Studio di coorte multicentrico sulla storia naturale dell’infezione da HIV in tossicodipendenti per via endovenosa, omosessuali maschi e contatti eterosessuali” nell’ambito del V Programma Nazionale della Ricerca sull’AIDS.

2004-2006   Ricerca finalizzata 2003: Responsabile Scientifico del Progetto “Sars-cov: epidemiologia e modelli matematici”.

2004-2006   Responsabile Scientifico del Progetto “Preparatory studies (laboratory and clinical setting) for preventive and therapeutic clinical trials in adults. Epidemiological, virological and cross-clade immunological (feasibility) field studies for cohort preparation to phase vaccine”, finanziato dal Ministero della Salute, Roma.

2004-2007   Componente del Comitato Scientifico del Progetto “Azione Concertata Italiana per lo sviluppo di un vaccino contro HIV/AIDS (ICAV)” nell’ambito del Programma Nazionale di Ricerca sull’AIDS.

2004-2010   Responsabile Scientifico del Progetto “Controllo delle infezioni nei soggetti deboli ed immunocompressi – agenti opportunistici e nuove opportunità di controllo delle infezioni”, finanziato dal Ministero della Salute, Roma.

2004-2010   Responsabile Scientifico del Progetto Italia-USA “Antrace”, finanziato dal Ministero della Salute, Roma.

2004-2011   Responsabile Scientifico del Progetto Italia-USA - Ministero della Salute “Infections and cancer: epidemiological and molecular aspects of kaposi’s sarcoma”.

2005-2007   Responsabile Scientifico del Progetto della Fondazione Salvatore Maugeri “Indicatori di risultato di un intervento riabilitativo intensivo in pazienti affetti da patologie polmonari”, Milano.

2005-2008   Responsabile Scientifico Ricerca Finalizzata 2004. Responsabile Scientifico del Progetto “Disegno epidemiologico degli studi sulla broncopneumopatia cronica ostruttiva”, Ministero della Salute, Roma.

2005-2009   Responsabile Scientifico di un progetto della Cooperazione Italiana allo Sviluppo del Ministero Affari Esteri a Yaoundé (Camerun) dal titolo “Assistenza al Centro Internazionale Chantal Biya per la ricerca sulla Prevenzione e Presa in Carico dei Pazienti HIV/AIDS”.

2006   Responsabile Scientifico del Progetto “Epidemiologia dell’HIV/AIDS” nell’ambito del VI Programma Nazionale della Ricerca sull’AIDS extra ed intramurale.

2006   Responsabile Scientifico del Progetto “Aspetti Assistenziali e Psicosociali” nell’ambito del VI Programma Nazionale della Ricerca sull’AIDS extra ed intramurale.

2006   Coordinatore dell’Azione Concertata “Raccolta dati di epidemiologia molecolare” nell’ambito del VI Programma Nazionale della Ricerca sull’AIDS extramurale.

2006-2009   Responsabile Scientifico del Progetto “The contribution of epidemiological methods to the conductione of preparatory studies for candidate vaccine trials in african countries with high genetic diversity of hiv-1”, finanziato dal Ministero della Salute, Roma.

2006-2010   Responsabile Scientifico del Progetto finanziato dalla Commissione europea “Concerted action on seroconversion to AIDS and death in Europe – Cascade”.

2006-2008   Responsabile Scientifico di un Twinning dell’Unione europea con la Bulgaria dal titolo “Strengthening of the Surveillance System for Communicable Diseases”.

2006-2009   Responsabile Scientifico di “Progetti di ricerca con coinvolgimento del volontariato ex art. 56 legge 289/2002”, Ministero della Salute, Roma. NON SI CAPISCE BENE.

2007-2010   Responsabile Scientifico del Progetto congiunto con Sapienza Università di Roma dal titolo “Utilizzazione del potenziale didattico nell’ambito della scuola di specializzazione in malattie infettive”.

2008-2010   Responsabile Scientifico del Progetto “Migrazione: sistema di accoglienza verso la popolazione immigrata dei servizi sanitari e verifica dell’osservanza del diritto alla salute di queste popolazioni”, finanziato dal Ministero della Salute.

2009-2010   Responsabile Scientifico del Progetto “Supporto epidemiologico nelle aree di interesse strategico ENI”, finanziato da Eniricerche S.p.A., Roma.

2009-2011   Responsabile Scientifico del Progetto “Zoonosi e infezioni virali esotiche: fronteggiare le emergenze attraverso un approccio integrato fra medicina umana e veterinaria”, finanziato dal Ministero della Salute.

2009-2011   Responsabile Scientifico del Progetto “Studio e sviluppo di nuovi farmaci antivirali contro infezioni da A-H1N1”, finanziato dal Ministero della Salute, Roma.

2009-2012   Responsabile Scientifico del Progetto CCM “Svilupo di un sistema di sorveglianza mirata (risck based surveillance) e delle capacità diagnostiche per le malattie da vettori in Italia”, finanziato dall’ Istituto Zooprofilattico Sperimentale delle Venezie (IZS).

2009-2012   Responsabile Scientifico del Progetto “Genetic and Epidemiology” nell’ambito del programma “Patogenesi, diagnosi, terapia della sclerosi multipla alla luce di ipotesi emergenti sul ruolo di alternate interazioni tra geni e ambiente nello sviluppo della malattia”, finanziato dal Ministero della Salute, Roma.

2010-2011   Responsabile Scientifico del Progetto “Progettazione, programmazione ed esecuzione di una campagna di comunicazione sull’uso razionale degli antibiotici”, finanziato dall’Agenzia italiana del farmaco (AIFA), Roma.

2010-2012   Responsabile Scientifico del Progetto “Prevenzione e Cura della Cecità ed Ipovisione nella Regione di Gao-Mali”, finanziato dal dipartimento per la Cooperazione Italiana allo Sviluppo del Ministero degli Affari Esteri, Roma.

2010-2012   Responsabile Scientifico del Progetto CCM “Sorveglianza di laboratorio di infezioni batteriche da patogeni sottoposti a sorveglianza europea o da agenti di bioterrorismo”, finanziato dal Ministero della Salute, Roma.

2010-2012   Responsabile Scientifico del Progetto “Unifluvac – vaccino influenzale universale”, finanziato dal Ministero della Salute, Roma.

2011-2013   Responsabile Scientifico del Progetto “New peptidonimetic inhibitors of aspartyl proteinase for therapy of opportunistic agents”, finanziato dal Ministero della Salute, Roma.

2012-2013   Responsabile Scientifico del Progetto “Malattie Infettive emergenti e riemergenti (incluse le emergenze causate da atti bioterroristici): diagnostica microbiologica e sorveglianza eziologica”, finanziato dal Ministero della Salute.

2012-2013   Responsabile Scientifico del Progetto “Identificazione, sorveglianza e controllo di agenti infettivi emergenti e riemergenti”, finanziato da ISS/Ministero della Salute.

2013-2014   Responsabile Scientifico del Progetto finanziato dal consorzio CNCCS “Malattie rare e trascurate”.

2015- 2020   Responsabile Scientifico del Progetto “EUROMED - Resistenza antimicrobica”, finanziato dal Ministero della Salute, Roma.

2015- 2020   Responsabile Scientifico del Progetto finanziato dalla Regione Lazio “Sviluppo e test di piattaforme biotecnologiche per high throughtput screening di molecole farmacologicamente attive contro malattie infettive emergenti e della povertà”.

2016   Responsabile Scientifico del Progetto finanziato dalla European Defense Agency (EDA) “Bioforensics for Biodefence – B2 FORENSICS”.

2016   Responsabile Scientifico del Progetto CCM “Attività di interesse comune finalizzate alla continuazione e alla sistemazione delle sorveglianze sanitarie”, finanziato dal Ministero della Salute, Roma.

2016   Responsabile Scientifico del Progetto “Preparedness per rilevamento di patogeni emergenti e bioterrorismo”, finanziato dal Ministero della Salute, Roma.

2016   Co-coordinatore del Progetto “Efficient response to highly dangerous and emerging pathogens at EU level – EMERGE”, finanziato da 3rd EU Health Programme.

2018- 2020   Medicina di precisione: implementazione di una rete di laboratori finalizzata al miglioramento della diagnostica delle malattie trasmissibili e delle cure delle malattie da infezioni. Progetto finanziato dal Ministero della Salute.

 

ESPERIENZA DI COORDINAMENTO E GESTIONE DI PROGRAMMI NAZIONALI DI RICERCA

L’esperienza manageriale è stata esplicata sia nella gestione di strutture complesse come quelle dipartimentali, sia a livello di consigli di amministrazione, sia nella gestione di fondi di ricerca intramurali ed extramurali consistenti in bandi nazionali e azioni concertate.

- 2000   Programma Nazionale di Ricerca sull’AIDS 2000

Responsabile Scientifico del progetto “Epidemiologia e modelli di ricerca assistenziale” (decreto approvato in data 29.12.2000 ed integrato in data 11.07.2001) con un finanziamento di € 929.622,42 da destinare per € 516.456,90 a proposte di ricercatori italiani operanti in enti ed istituzioni scientifiche e per € 413.165,52 ad azioni concertate per ricerca e sorveglianza epidemiologica.

- 2002   Programma Nazionale di Ricerca sull’AIDS – ripartizione residuo 2001:

Responsabile Scientifico del Progetto “Epidemiologia e modelli di ricerca Assistenziale” (€ 103.291,38).

Responsabile Scientifico “Centro Operativo AIDS” (comprendente Telefono Verde e Centro Operativo AIDS presso il Ministero) (€ 671.393,97).

Responsabile Scientifico del Programma Italia-USA Epidemiologia (€ 51.645,69).

- 2004   V Programma Nazionale della Ricerca sull’AIDS

Co-Responsabile Scientifico del Progetto “Epidemiologia dell’HIV/AIDS” (approvato con decreto 10.12.2003) con un finanziamento di € 949.000,00.

Responsabile Scientifico del Progetto “Studio di coorte multicentrico sulla storia naturale dell’infezione da HIV in tossicodipendenti per via endovenosa, omosessuali maschi e contatti eterosessuali”   (€ 80.000,00).

Co-Responsabile Scientifico del Progetto “Aspetti psicosociali” (approvato con decreto 10.12.2003) nell’ambito del V Programma Nazionale della Ricerca sull’AIDS con un finanziamento di € 647.000,00.

Coordinatore dell’Azione Concertata “Assistenza domiciliare e case alloggio” (€ 40.000,00).

- 2005-2009   Responsabile Scientifico di un progetto della Cooperazione Italiana allo Sviluppo del Ministero Affari Esteri a Yaoundé (Camerun) dal titolo “Assistenza al Centro Internazionale Chantal Biya per la ricerca sulla Prevenzione e Presa in Carico dei Pazienti HIV/AIDS” (oltre 1.500.000 €).

- 2006   VI Programma Nazionale di Ricerca sull’AIDS Extramurale:

Responsabile Scientifico del Progetto “Epidemiologia dell’HIV/AIDS” con un finanziamento di € 616.000,00 (decreto 24.03.2006).

Responsabile Scientifico del Progetto “Aspetti Assistenziali e Psicosociali” con un finanziamento di € 470.000,00.

Coordinatore dell’Azione Concertata “Raccolta dati di epidemiologia molecolare” per un importo di € 60.000,00 (approvata con Decreto del 03.08.2006).

VI Programma Nazionale di Ricerca sull’AIDS Intramurale:

Responsabile Scientifico dell’Azione concertata Progetto “Epidemiologia dell’HIV/AIDS e aspetti psicosociali” con un finanziamento di € 294.000,00 (decreto 24.03.2006).

- 2011- 2020   Vice-Direttore del Progetto Bandiera “Interomics” del Consiglio Nazionale delle Ricerche.

 

INCARICHI ACCADEMICI E DOCENZE

Ha svolto costante attività di formazione e accademica presso l’Istituto Superiore di Sanità e presso numerose università italiane e straniere.

Incarichi accademici:

2001/02 e 2008/09   Professore a contratto presso la scuola di Specializzazione in Malattie Infettive dell’Università degli Studi di Sassari (per 5 anni accademici).

2002/03 e 2009/10   Professore a contratto presso la Scuola di Specializzazione in Ostetricia e Ginecologia dell’Università degli Studi di Roma Tor Vergata (corso di Metodologia della Ricerca Clinica).

2006-2014   Docente della Scuola di Specializzazione in Malattie Infettive presso Sapienza Università di Roma.

2007 ad oggi   Membro della Faculty e della commissione per l’esame finale di dottorato di ricerca in Microbiologia Medica e Immunologia, Dipartimento di Medicina Sperimentale, Università degli Studi di Roma Tor Vergata.

2008-2011   Docente nel Dottorato di ricerca in Scienze infettivologiche e nelle terapie infettivologiche presso Sapienza Università di Roma.     

2011-2014   Docente nel Dottorato di Ricerca in Scienze Infettivologiche presso Sapienza Università di Roma.

2019-a oggi   Professore a contratto presso la Scuola di Specializzazione in Igiene dell’Università Cattolica di Roma.

Altre docenze: attività di formazione

- Membro della Faculty e docente presso la Mediterranean School of Epidemiology del CNR (Siracusa) (1999-2003).

- Direttore di corsi di formazione presso l’Istituto Superiore di Sanità, fra i quali: “Modelli dell’Epidemia di Infezioni HIV e di AIDS”, “Metodi Epidemiologici e Statistici per lo Studio della Storia Naturale dell’Infezione da HIV”, “Introduzione alle Tecniche di Bioinformatica per l’Analisi Epidemiologico-Molecolari, con particolare riferimento alla Virologia dell’HIV”, “Epidemiologia delle Malattie Infettive” (1991-ad oggi).

- Docente alla “Summer School on Addiction”, Charing Cross and Westminster Medical School,  Londra (1990).

- Relatore a seminari internazionali (Johns Hopkins, Baltimora e IARC, Lyon) sull’epidemiologia delle infezioni da HIV (1990-2009).

- Supervisore di studenti presso l’ ”International Course for Primary Health care for manager at district level in developing countries”, Istituto Superiore di Sanità (1989).

- Supervisore di studenti della Scuola di Specializzazione di Igiene e Medicina Preventiva dell’Università Cattolica del Sacro Cuore di Roma e dell’Università degli Studi di Roma Tor Vergata (1990-ad oggi).

 

ONOREFICENZE E PREMI

Onorificenze:

27/12/1999   Cavaliere Ufficiale dell’Ordine al Merito della Repubblica Italiana.

2022   Commendatore della Repubblica Italiana.

2019   Socio Onorario dell’Accademia di Storia dell’Arte Sanitaria.

2020   Socio onorario Aspen Institute Italia.    

2021   Consulente onorario dell'Ospedale Militare del Celio.

Premi:

2018   Vincitore del Premio Levi-Montalcini per l’impegno nella diffusione della cultura scientifica.

2021   Premio Internazionale Ora et Labora, Cassino.

2022   Premio Eccellenze in Sanità, Categoria “Management -Governo clinico”, Fondazione San Camillo, Roma.

2022   Premio Edela, Prima Edizione, Roma.

2022   Premio per l'Infanzia e l'Adolescenza, Telefono Azzurro.

2022   Premio Rocco Mazzarone per le Scienze, Matera.

2022   Premio SITI (Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica), Padova.

 

APPARTENENZA A SOCIETÀ SCIENTIFICHE

È membro della SITI (Società Italiana di Igiene).

Nel 2017 è stato nominato Socio Ordinario dell’Accademia Medica Romana.

È stato membro della International AIDS Society e della SIMIT (Società Italiana Malattie Infettive e Tropicali), nonché Fondatore del Gruppo Italiano per lo studio di AIDS e Tumori (GICAT).

 

ATTIVITÀ DI REFERAGGIO/EDITOR PER RIVISTE, VALUTATORE PER ENTI/ISTITUZIONI INTERNAZIONALI, MEMBRO DI GIURIE PER LASSEGNAZIONE DI PREMI IN AMBITO SCIENTIFICO

- Editor di AIDS-A Year in Review (2000-2001).

- Section Editor per BMC Public Health, sezione “Infectious Diseases Epidemiology” (2010 ad oggi).

- Academic Editor per la rivista International Journal of Tropical Disease and Health (2015 ad oggi).

- Academic Editor di Plos One (2015 ad oggi).

- Membro dell’Editorial Board di “AIDS” (due trienni), Frontiers in Public Health, Vaccines.

- Membro del Comitato di Redazione degli Annali dell’Istituto Superiore di Sanità (2008 ad oggi).

- Referee per diverse riviste scientifiche internazionali, tra le quali: British Medical Journal, AIDS, Journal of AIDS, Journal of Infectious Diseases, European Journal of Epidemiology, American Journal of Epidemiology, Lancet, Lancet Infectious Diseases, Journal of Epidemiology and Community Health, Cancer Research, Emerging Infectious Diseases, Scandinavian Journal of Infectious Diseases, International of Infectious Diseases, Vaccine.

- Revisore e selezionatore di progetti dell’area di “Epidemiologia” per l’Unione Europea e per diverse istituzioni di altri Paesi europei (ad esempio MRC-Regno Unito, RIVM-Olanda, Ministero della Ricerca Scientifica-Germania).

- Referee esterno per lo European Research Council (ERC Advanced / Starting Grant - 2010).

- Referee per la valutazione di richieste di finanziamento per il Progetto Mattone Internazionale (2012).

- 2017-2019 Componente “Cabina di Regia” di cui all’art. 4 del protocollo d’intesa tra la Regione Lazio ed il Consiglio Nazionale delle Ricerche sottoscritto in data 11 ottobre 2016 (Reg. Cron. N. 19790 del 13 gennaio 2017) per l’attuazione di progetti, programmi di ricerca, sviluppo e innovaazione finalizzati ai bisogni economici e sociali dell’Amministrazione Regionale.

- Esperto Nucleo di Valutazione per gli adempimenti di chiusura relativi all’Avviso Pubblico “Infrastrutture Aperte per la Ricerca”, Regione Lazio, 2018.

- Membro del Commissioning Panel-Epidemiology for Vaccinology-UK NIHR Policy Research Programme, Londra, UK (Contribution to the ODA: Epidemiology for Vaccinology call), 2017/2018.

- Membro della giuria del Premio Aspen Istitute Italia del 2019.

 

BREVETTI

  1. Test sierologico per SV40 (condiviso con l’Università degli Studi di Ferrara) – anno 2007-2010.
  2. HERV-H per l’uso come marcatore molecolare del Disturbo dello Spettro Autistico e relativo metodo diagnostico in vitro, kit diagnostico e usi medici (2012).

 

ATTIVITÀ DI DIVULGAZIONE SCIENTIFICA

Da anni svolge intensa attività di divulgazione scientifica, collaborando con riviste del settore e con una presenza costante sui media.

Collabora/ha collaborato, in qualità di editorialista, con quotidiani nazionali quali “Il Messaggero” e il Corriere della Sera, e collabora con la rubrica “Corriere Salute” de “Il Corriere della Sera”.

Pubblicazioni

Autore di oltre 550 articoli pubblicati come autore principale (esclusa la autorship all’interno di study/working groups) su riviste scientifiche accreditate (indicizzate in PubMed), fra le quali numerose ad elevato impact factor (es.: AIDS, Br Med J, JAMA, J Infect Dis, J Natl Cancer Inst, Lancet, Nature, Nature Med), libri e capitoli di libri pubblicati a livello nazionale o internazionale.

H-Index (2023): 67 (calcolato con Scopus).

Capitoli di libri internazionali

  1. Rezza G. AIDS Situation in Italy. In: AIDS, Diagnosis and Control: Current Situation. NMV Medizin Verlag, Munchen, 1988.
  2. Rezza G. Evaluation of prevention strategies for HIV among injecting drug users. In: Aspects of HIV management in injecting drug users. Colwood Hause Medical Publications, 1990.
  3. Dorrucci M, Rezza G, Pezzotti P, Lazzarin A, Angarano G, Sinicco A, Zerboni R, Aiuti F, Pristerà R, Gafà S, Castelli F, Salassa B, Barbanera M., Canessa A, Ortona L, Ricchi E, Viale P. Tirelli U, Zaccarelli M. Alliegro B. The seroconversion study on the natural history oh HIV infection. In: HIV Epidemiology: Models and Methods, Elsevier, Milano, 2000.
  4. Carballo M, Rezza G. AIDS, Drug Misuse and the Global Crisis. In: AIDS and Drug Misuse: the challenge for policy and practice in 1990s. Routledge, London, 2009.
  5. Serraino D, Piselli P for the Immunosuppression Study Group. Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups. In: Methods in Molecular Biology, Cancer Epidemiology (vol. 471:409-419). Springer, 2009.
  6. Rezza G. Chikungunya. In: Emerging infectious Diseases: clinical case studies. Academic Press, 2014.

Libri

  1. Ippolito G, Rezza G, Albertoni F, Perucci CA. AIDS e Infezioni da HTLV-III/LAV: linee guida di Sanità Pubblica. Progetto Salute, Regione Lazio, 1986.
  2. Ippolito G, Rezza G. AIDS. Un manuale per i medici italiani. Masson, Milano 1987.
  3. Serpelloni G, Rezza G, Gomma M.  Infezione da HIV e Patologie Correlate 1995.
  4. Rezza G, Epidemie – Origini ed Evoluzione. Carocci, Roma 2010. II Edizione: Epidemie. I perché di una minaccia globale. Carocci, Roma, 2010.
  5. Rezza G, Ippolito G. Emerging and re-emerging viral infections. Advances in Microbiology, Infectious Diseases and Public Health, Volume 6. Springer International Publishing, Switzerland 2017.
  6. Forni G, Mantovani A, Moretta L, Rezza G. I vaccini fanno bene, La Nave di Teseo, 2020 (tratto dal rapporto “I vaccini” edito dall’Accademia dei Lincei).
  7. Rezza G. Epidemie. Una minaccia globale (riedizione). Carocci Editore, Roma, 2020.
  8. Rezza G. Epidemie. Una minaccia globale, 3° edizione. Carocci Editore, Roma, 2024.

Articoli publicati su riviste internazionali (riportati in PubMed), esclusi “Study/working groups”, al 31/7/2023.

  1. Guzzetta G, Marziano V, Mammone A, Siddu A, Ferraro F, Caraglia A, Maraglino F, Rezza G, Vespignani A, Longini I, Ajelli M, Merler S. The decline of the 2022 Italian mpox epidemic: role of behavior changes and control strategies. Nat Commun 2024 Mar 13:15(1)2283. Doi: 10.1038/s41467-024-46590-4.
  2. Rezza G. Climate change and the spread of Aedes mosquito-borne viruses in Europe.Patog Glob Health. 2024 Feb 29:1-2. doi: 10.1080/20477724.2024.2323842.
  3. Merakou C, Amendola A, Fortuna C, Marsili G, Fiorentini C, Argentini C, Benedetti E, Rezza G, Maraglino F, Del Manso M, Bella A, Pezzotti P, Riccaro F, Palamara AT, Ventiuri G. Diagnosis of imported dengue and Zika virus infections in Italy from November 2015 to November 2022: laboratory surveillance data from a National Reference Laboratory. Viruses 2023 Dec 28; 16(1):50. Doi: 10.3390/v16010050.
  4. Silenzi A, Vitiello A, Rezza G. From mass vaccination to personalized vaccinilogy? The COVID-1 case.Ann Ist Super Sanita 2023; 59: 247-250.
  5. Vitiello A, Sabbatucci M, Silenzi A,Capuano A, Rossi F, Zovi A, Biasi F, Rezza G. The impact of SARS-CoV-2 infection in patients with cystic ffibrosis unfergoing CFTR channel mudulators treatment: a literature review. Respir Res. 202 Nov 13;24(1)278. Doi: 10.1186/s12931-023-02592-1.
  6. Sagaro GG, Angeloni U, Battineni G, Chintalapudi N, Dicanio M, Kebede MM, Marotta C, Rezza G, Silenzi A, Amenta F. Risk prediction model of self-reported hypertension for telemedicine based on the sociodemographic, occupational and lealth-related characteristics of seafarers: a cross-sectional epidemiological study. BMJ Open. 2023 Oct 4;13(10):e070146. Doi: 10.1136/bmjopen-2022-070146.
  7. Mateo-Urdiales A, Sacco , Petrone D, Bella A, Riccardo F, Del Manso M, Bressi M, Siddu A, Brusaferro S, Palamara AT, Rezza G, Pezzotti P, Fabiani M. Estimated effectiveness of a primary cycle of protein-recombinant vaccine NVX—CoV2373 against COVID-19. JAMA Netw Open 2023 Oct 2;6(10):e2336854. Doi: 10.1001/jamanetworkopen.2023.36854.
  8. Subissi L, Stefanelli P, Rezza G. Human mpox global trends, molecular epidemiology and options for vaccination. Pathog Glob Health 2024; 118: 25-32.
  9. COVID-19 severity and fatality. Influenza Other Respir Viruses; 2023 Aud 16;(17(8):e13181. Doi:10.1111/irv.13181.Trentini F, Stefanelli P, Rezza G, Palamara AT, Brusaferro S, Ajelli M, Pezzotti P, Merler S. Estimating SARS-CoV-2 infections and associated changes in
  10. Fabiani M, Mateo-Urdiales A, Sacco C, Rota C, Fotakis EA, Petrone D, Del Manso M, Siddu A, Stefanelloi P, Bella A, Riccardo F, Rezza G, Palamara AT, Brusaferro S, Pezzotti P. Relative effectiveness of bivalent original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to Jne 2023. Euro Surveill 2023 Aud;28(32):2300397. Doi: 10.2807/1560-7917.ES.2023.28.32.2300397.
  11. Marotta C, Silenzi A, Farina U, Strabello GM, Angeloni U, Rezza G. Dieci anni di esperienza degli Ufici di Sanità Marittima, aerea e di frontiera del Ministero della Salute nella sorvegianza sanitaria dei flussi migratoriirregolari lungo le rotte del Mediterraneo. Recenti Progr Med 2023; 114: 543-544.
  12. Mateo-Urdiales A, Sacco C, Fotakis EA, Del Manso M, Bella A, Riccardo F, Bressi M, Rota MC, Petrone D, Siddu A, Fedele G, Stefanelli P, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Fabiani M. Relative effectiveness of monovalent and bivalent boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study. Lancet Infect Dis 2023 Jul 18:S1473-3099(23)00374-2. doi: 10.1016/S1473-3099(23)00374-2.
  13. Silenzi A, Marotta C, Caredda E, Sa Machado R, Severoni S, Rezza G. Climate change, human migration and health nexus: what do we know about public health implications on a global scale? Epidemiol Prev 202; 47: 39-43.
  14. Vitiello A, Zovi A, Rezza G. New emerging SARS-CoV-2 variants and antiviral agents. Drug Resist Updat. 2023 Jun 26; 70:100986. doi:10.1016/j.drup.2023.100986.
  15. Sagaro GG, Angeloni U, Marotta C, Nittari G, Rezza G, Silenzi A, Battineni G, Amenta F. The magnitude of cardiovascular disease risk factors in seafarers from 1994 to 2021: a systematic review and meta-analysis. Pers Med 2023 May 20; 13(5)861. doi: 10.3390/jpm13050861.
  16. Sabbatucci M, Vitiello A, Clemente S, Zovi A, Boccellino M, Ferrara F, Cimmino C, Langella R, Ponzo A, Stefanelli P, Rezza G. Omicron variant evolution in vaccines and monoclonal antibodies. Inflammopharmacology 2023 May 19: 1-10. doi: 10.1007/s10787-023-01253-6.
  17. Guzzetta G, Ajelli M, Miglietta A, Fazio C, Neri A, Merler S, Rezza G, Stefanelli P. Evaluating the effect of targeted strategies as control tools for hypervirulent meningococcal C outbreaks: a case stydy from Tuscany, Italy, 2015 to 2016. Euro Surveill 2023May;28(19):2200650. Doi: 10.2807/1560-7917.ES.2023.28.19.2200650.
  18. Silenzi A, Siddu A, D’Amelio AC, Cataldi S, Fasano C, Maraglino F, Rezza G, Signorelli C. The new Italian National Immunization Technical Advisory Group (NITAG) and its commitment to endorse a new efficient National Immunization Plan in COVID-19 times. Ann Ist Super Sanita 2023; 59: 26-30.
  19. Faggioni G, De Santis R, Moramarco F, Di Donato M, Domenico A, Molinaro F, Petralito G, Fortuna C, Venturi G, Rezza G, Lista F. Pan-yellow fever virus detection and lineage assignment by real-time RT-PCR and amplicon sequencing. Virol Methods 2023 Jun; 316:114717. doi:10.1016/j.viromet.2023.114717.Epub 2023 Mar  25.
  20. De Santis R, Faggioni G, Amoroso A, Ciammaruconi A, Pomponi A, Stella Lia M, Amatore D, Molinari F, Petralito G, Stefanelli P, Rezza G, Lista F. Durability of neutralizing antibodies against yellow fever after vaccination in healthy adults. Vaccine 2023; 4:2761-2763.
  21. Vairo F, Leone S, Mazzotta V, Piselli P, De Carli G, Lanini S, Maggi F, Nicastri E, Gagliardini R, Vita S, Siddu A, Rezza G, Barca A, Vaia F, Antinori A, Girardi E.The possible effect of socio-behavioral factors and public health actions on the mpox epidemic slowdown. Int J Infect Dis. 2023 Mar 9:S1201-9712(23)00081-4. doi: 10.1016/j.ijid.2023.03.005. Online ahead of print.
  22. Sticchi C, Raso R, Ferrara L, Vecchi E, Ferrero L, Filippi D, Finotto G, Frassinelli E, Silvestre C, Zozzoli S, Ambretti S, Diegoli G, Gagliotti C, Moro ML, Ricchizzi E, Tumietto F, Russo F, Tonon M, Maraglino F, Rezza G, Sabbatucci M. Increasing Number of Cases Due to Candida auris in North Italy, July 2019-December 2022. J Clin Med. 2023 Feb 28;12(5):1912. doi: 10.3390/jcm12051912.
  23. Fabiani M, Mateo-Urdiales A, Sacco C, Fotakis EA, Rota MC, Petrone D, Bressi M, Del Manso M, Siddu A, Fedele G, Stefanelli P, Bella A, Riccardo F, Palamara AT, Rezza G, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022. Euro Surveill. 2023 Feb;28(8):2300105. doi: 10.2807/1560-7917.ES.2023.28.8.2300105.
  24. Fabiani M, Mateo-Urdiales A, Sacco C, Rota MC, Petrone D, Bressi M, Del Manso M, Siddu A, Proietti V, Battilomo S, Menniti-Ippolito F, Popoli P, Bella A, Riccardo F, Palamara AT, Rezza G, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group, of the Italian COVID-19 Vaccines Registry group. Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study. Vaccine. 2023 Jan 4;41(1):76-84. doi: 10.1016/j.vaccine.2022.11.013. Epub 2022 Nov 14.
  25. Stefanelli P, Trentini F, Petrone D, Mammone A, Ambrosio L, Manica M, Guzzetta G, d'Andrea V, Marziano V, Zardini A, Molina Grane' C, Ajelli M, Di Martino A, Riccardo F, Bella A, Sane Schepisi M, Maraglino F, Poletti P, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Merler S. Genomic SARS–CoV–2 National Surveillance Working Group; Italian Integrated Surveillance of COVID–19 Study Group; Italian Integrated Surveillance of COVID-19 Study Group; Genomic SARS-CoV-2 National Surveillance Working Group.Euro Surveill. 2022 Nov;27(45):2200125. doi: 10.2807/1560-7917.ES.2022.27.45.2200125.
  26. Mipatrini D, Montaldo C, Bartolini B, Rezza G, Iavicoli S, Ippolito G, Zumla A, Petersen E. 'Disease X'-time to act now and prepare for the next pandemic threat. Eur J Public Health. 2022 Nov 29;32(6):841-842. doi: 10.1093/eurpub/ckac151.
  27. Meggiolaro A, Sane Schepisi M, Farina S, Castagna C, Mammone A, Siddu A, Stefanelli P, Boccia S, Rezza G. Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis. Expert Rev Vaccines. 2022 Dec;21(12):1831-1841. doi: 10.1080/14760584.2022.2130773. Epub 2022 Oct 14.
  28. Riccardo F, Bella A, Monaco F, Ferraro F, Petrone D, Mateo-Urdiales A, Andrianou XD, Del Manso M, Venturi G, Fortuna C, Di Luca M, Severini F, Caporali MG, Morelli D, Iapaolo F, Pati I, Lombardini L, Bakonyi T, Alexandra O, Pezzotti P, Perrotta MG, Maraglino F, Rezza G, Palamara AT; Italian Arbovirus Surveillance network. Rapid increase in neuroinvasive West Nile virus infections in humans, Italy, July 2022. Euro Surveill. 2022 Sep;27(36):2200653. doi: 10.2807/1560-7917.ES.2022.27.36.2200653.
  29. Guzzetta G, Mammone A,Ferraro F, Caraglia A, Rapiti A, Marziano V, Poletti P, Cereda D, Vairo F, Mattei G, Maraglino F, Rezza G, Merler S. Early estimates of Monkeypox incubation period, generation time, and reproduction number, Italy, May-June 2022. Emerg Infect Dis 2022; 20: 2078-2081.
  30. Mennini FS, Silenzi A, Marcellusi A, Conversano M, Siddu A, Rezza G. HPV vaccination during the COVID-19 pandemic in Italy: opportunity loss or incremental cost. Vaccines  2022; doi: 10.3390/vaccines10071133.
  31. Djeunang Dongho GB, Venturi G, Fortuna C, Paganotti GM, Severini C, L’Episcopia M, Tsapi AT. Benedetti E, Marsili G, Amendola A, Rezza G, Sobze MS, Russo G. Dengue and chikungunya virus circulation in Cameroon and Gabon: molecular evidence among symptomatic individuals. Access Microbiol 2022. Doi:10.1099/acmi.0.000340.e.Collection 2022.
  32. Sacco C, Del Manso M, Mateo-Urdiales A, Rota MC, Petrone D, Riccardo F, Bella A, Siddu A, Battilomo S, Proietti V, Popoli P, Menniti Ippolito F, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Fabiani M. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022. Lancet 2022; 400: 97-103.
  33. Stefanelli P, Rezza G. COVID-19 vaccination strategies and their adaptation to the emergence of SARS-CoV-2 variants. Vaccines 2022; doi:10.3390/vaccines10060905.
  34. Ferraro F, Caraglia A, Rapiti A, Cereda D, Vairo F, Mattei G, Maraglino F, Rezza G. Multiple introductions of MPX in Italy from different geographic areas. Euro Surveill 2022 Jun;27(23). Doi:10.2807/1560-7917.ES.2022.27.23.2200456.
  35. Fazio C, Daprai L, Neri A, Tirani M, Vacca P, Arghitti M, Ambrosio L, Cereda D, Gramegma N, Palmieri A, Carannante A, Bertoli MR, Crottogini L, Gennati G, Quinz E, Trezzi L, Ciammaruconi A, Fillo S, Fortunato A, Rezza G, Lista F, Stefanelli p. Reactive vaccination as control strategy for an outbreak of invasive meningococcal vaccine caused by Neisseria meningitidis C:1.5-1,10:F3-6:ST-11(cc11), Bergamo province, Italy, December 2019 to January 2020. Euro Surveill 2022 June(27)24. Doi:10.2807/1560-7917.ES.2022.27.24.2100919.
  36. Fabiani M, Puopolo M, Filia A,, Sacco C, Spila Alegiani S, Del Manso S, D’Ancona F, Vescio F, Bressi M, Petrone D, Spuri M, Rota MC, Da Cas R, Morciano C, Stefanelli P, Bella A, Tallon M, Proietti V, Siddu A, Battilomo S, Palamara AT, Popoli P, Brusaferro S, Rezza G, Riccardo F, Menniti Ippolito F, Pezzotti P.  Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021 https://doi.org/10.1080/14760584.2022.2064280.
  37. Soraci L, Lattanzio F, Soraci G, Gambuzza ME, Pulvirenti C, Cozza A, Corsonello A, Luciani F, Rezza G. COVID-19 vaccines: current and future perspectives. Vaccines 2022 Apr 13; 10(4):608. Doi:10.3390/vaccines10040608.
  38. Stefanelli P, Trentini F, Guzzetta G, Marziano V, Mammone A, Sanè Schepisi M, Poletti P, Molina Grané C, Manica M, Del Manso M, Andrianou X, Ajelli M, Rezza G, Brusaferro S, Merler S. Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, Februaary and March 2021. Euro Surveill 2022 Feb 27(5):2100429. Doi:10.2807/1560-7017.ES.2022.27.5.2100429.
  39. Lo Presti A, Di Martino A, Faggioni G, Giordani F, Fillo S, Anselmo A, Fain VV, Fortunato A, Petralito G, Molinari F, Palomba S, De Santis R, Fiore S, Fabiani C, Di Mario G, Facchini M, Calzoletti L, Lista F, Rezza G, Stefanelli P. Analysis of genomic characteristics of SARS-CoV-2 in Italy, 29 January to 27 March 2020. Viruses 2022; 14(3): 472. Doi:10.3390/v14030472.
  40. Ripabelli G, Sammarco ML, Rezza G, D'Amico A, De Dona R, Iafigliola M, Parente A, Samprati N, Santagata A, Adesso C, Natale A, Di Palma MA, Cannizzaro F, Dentizzi C, Stefanelli P, Tamburro M. A SARS-CoV-2 Outbreak Among Nursing Home Residents Vaccinated with a Booster Dose of mRNA COVID-19 Vaccine.J Community Health. 2022 Mar 25:1-6. doi: 10.1007/s10900-022-01082-8.
  41. Chintalapudi N, Angeloni U, Battineni G, di Canio M, Marotta C, Rezza G, Sagaro GG, Silenzi A, Amenta F.LASSO Regression Modeling on Prediction of Medical Terms among Seafarers' Health Documents Using Tidy Text Mining. Bioengineering (Basel). 2022 Mar 17;9(3):124. doi: 10.3390/bioengineering9030124.PMID: 35324813 Free PMC article.
  42. Lo Presti A, Coghe F, Di Martino A, Fais S, Cappai R, Marra M, Carollo M, Crescenzi M, Orrù G, Rezza G, Stefanelli P. First detection of SARS-CoV-2 lineage A.27 in Sardinia, Italy. Ann Ist Super Sanita. 2022 Jan-Mar;58(1):1-5. doi: 10.4415/ANN_22_01_01.PMID: 35324468 Free article.
  43. Meggiolaro A, Sane Schepisi M, Nikolaidis GF, Mipatrini D, Siddu A, Rezza G.Effectiveness of Vaccination against SARS-CoV-2 Infection in the Pre-Delta Era: A Systematic Review and Meta-Analysis. Vaccines (Basel). 2022 Jan 21;10(2):157. doi: 10.3390/vaccines10020157.PMID: 35214615 Free PMC article. Review. 
  44. Lazzerini M, Benvenuto S, Mariani I, Fedele G, Leone P, Stefanelli P, Vittori G, Schreiber S, Tommasini A, Rezza G, Barbi E, Comar M. Evolution of SARS-CoV-2 IgG Seroprevalence in Children and Factors Associated with Seroconversion: Results from a Multiple Time-Points Study in Friuli-Venezia Giulia Region, Italy. Children (Basel). 2022 Feb 12;9(2):246. doi: 10.3390/children9020246.PMID: 35204966. 
  45. Filia A, Rota MC, Grossi A, Martinelli D, Prato R, Rezza G. Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination. Vaccine. 2022 Mar 18;40(13):1987-1995. doi: 10.1016/j.vaccine.2022.02.041. Epub 2022 Feb 19.PMID: 35190211.
  46. Fabiani M, Puopolo M, Morciano C, Spuri M, Spila Alegiani S, Filia A, D'Ancona F, Del Manso M, Riccardo F, Tallon M, Proietti V, Sacco C, Massari M, Da Cas R, Mateo-Urdiales A, Siddu A, Battilomo S, Bella A, Palamara AT, Popoli P, Brusaferro S, Rezza G, Menniti Ippolito F, Pezzotti P. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study. Italian Integrated Surveillance of covid-19 study group and Italian covid-19 Vaccines Registry group.BMJ. 2022 Feb 10;376:e069052. doi: 10.1136/bmj-2021-069052.PMID: 35144968.
  47. Riccardo F, Guzzetta G, Urdiales AM, Del Manso M, Andrianou XD, Bella A, Pezzotti P, Carbone S, De Vito T, Maraglino F, Demicheli V, Dario C, Coscioni E, Rezza G, Urbani A, Merler S, Brusaferro S; Italian COVID-19 monitoring group. COVID-19 response: effectiveness of weekly rapid risk assessments, Italy. Bull World Health Organ. 2022 Feb 1;100(2):161-167. doi: 10.2471/BLT.21.286317. Epub 2021 Nov 25.PMID: 35125541.
  48.  Stefanelli P, Trentini F, Guzzetta G, Marziano V, Mammone A, Sane Schepisi M, Poletti P, Molina Grané C, Manica M, Del Manso M, Andrianou X, Ajelli M, Rezza G, Brusaferro S, Merler S; COVID-19 National Microbiology Surveillance Study Group.Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021. Euro Surveill. 2022 Feb;27(5):2100429. doi: 10.2807/1560-917.ES.2022.27.5.2100429.PMID: 35115077.
  49. Fedele G, Stefanelli P, Bella A, Fiore S, Pancheri S, Benedetti E, Fabiani C, Leone P, Vacca P, Schiavoni I, Neri A, Carannante A, Simmaco M, Santino I, Zuccali MG, Bizzarri G, Magnoni R, Benetollo PP, Brusaferro S, Rezza G, Ferro A. Anti-SARS-CoV-2 antibodies persistence after natural infection: a repeated serosurvey in Northern Italy.Ann Ist Super Sanita. 2021 Oct-Dec;57(4):265-271. doi: 10.4415/ANN_21_04_01.PMID: 35076416.
  50. Sabbatucci M, Odone A, Signorelli C, Siddu A, Silenzi A, Maraglino FP, Rezza G. Childhood Immunisation Coverage during the COVID-19 Epidemic in Italy. Vaccines (Basel). 2022 Jan 14;10(1):120. doi: 10.3390/vaccines10010120.PMID: 35062781.
  51. Marziano V, Guzzetta G, Mammone A, Riccardo F, Poletti P, Trentini F, Manica M, Siddu A, Bella A, Stefanelli P, Pezzotti P, Ajelli M, Brusaferro S, Rezza G, Merler S.The effect of COVID-19 vaccination in Italy and perspectives for living with the virus. Nat Commun. 2021 Dec 14;12(1):7272. doi: 10.1038/s41467-021-27532-w.PMID: 34907206.
  52. Stefanelli P, Fazio C, Vacca P, Neri A, Ambrosio L, Rezza G. Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease? Pathog Glob Health. 2021 Nov 30:1-3. doi: 10.1080/20477724.2021.1995657. Online ahead of print.PMID: 34844520.
  53. De Santis R, Luca V, Näslund J, Ehmann RK, De Angelis M, Lundmark E, Nencioni L, Faggioni G, Fillo S, Amatore D, Regalbuto E, Molinari F, Petralito G, Wölfel R, Stefanelli P, Rezza G, Palamara AT, Antwerpen M, Forsman M, Lista F.Rapid inactivation of SARS-CoV-2 with LED irradiation of visible spectrum wavelengths. J Photochem Photobiol. 2021 Dec;8:100082. doi: 10.1016/j.jpap.2021.100082. Epub 2021 Oct 28.PMID: 34729540.
  54. Faggioni G, Stefanelli P, Giordani F, Fillo S, Anselmo A, Vera Fain V, Fortunato A, Petralito G, Molinari F, Lo Presti A, Di Martino A, Palomba S, De Santis R, Rezza G, Lista F.Identification and characterization of SARS-CoV-2 clusters in the EU/EEA in the first pandemic wave: additional elements to trace the route of the virus. Infect Genet Evol. 2021 Dec;96:105108. doi: 10.1016/j.meegid.2021.105108. Epub 2021 Oct 9.PMID: 34637920.
  55. Marotta C, Stefanelli P, Tramuto F, Angleloni U, Maida CM, Cermigliaro A, Barone T, Vitale F, Rezza G, Mazzucco W, The dual global value of SARS-CoV-2 genome surveillance on migrantsvia the Mediterranean routes. Ann Glob Health 2021 Jul 21;87(1)71.doi 10.5334/aogh.3425.e Collection 2021.
  56. Maida CM, Tramuto F, Di Naro D, Randazzo G, Stefanelli P, Marotta C, Reale S, Cernigliaro A, Barone T, Cesari C, Pulvirenti C, Angeloni U, Di Martino A, Rezza G, Vitale F, Mazzucco W; SAMI-Surv Collaboration, Alba D, Amodio E, Asciutto R, Candura R, Cascio F, Casuccio A, Costantino C, D'Agostino N, D'Amato S, Di Quarto L, Fruscione S, Graziano G, La Milia D, Lucchese M, Mangano G, Messina M, Migliorisi C, Mistretta G, Palmeri G, Pecoraro L, Restivo V, Rizzo AP, Savatteri A, Scibetta S, Scondotto S, Sparaco A, Spoto V, Stabile D, Tagliavia AM, Vitale F, Zappia M, Zichichi S.First detection of SARS-CoV-2 A.23.1 sub-lineage in migrants arriving to Italy via the Mediterranean Sea and public health implications. Travel Med Infect Dis. 2021 Sep-Oct;43:102142. doi: 10.1016/j.tmaid.2021.102142.
  57. Sabbatucci M, Odone A, Signorelli C, Siddu A, Maraglino F, Rezza G.Improved Temporal Trends of Vaccination Coverage Rates in Childhood after the Mandatory Vaccination Act, Italy 2014-2019. J Clin Med. 2021 Jun 8;10(12):2540. doi: 10.3390/jcm10122540.
  58. de Paula Silveira-Lacerda E, Laschuk Herlinger A, Tanuri A, Rezza G, Anunciação CE, Ribeiro JP, Tannous IP, Abrantes GR, da Silva EG, Arruda KF, de Sousa ARV, Romero Rebello Moreira F, Santana Aguiar R, Corrêa JF, Dos Santos MM, Silva HD, Garcia-Zapata MTA, do Nascimento NS, Talon de Menezes M, Araujo Maia R, Ferreira C O, Barbosa R, Brindeiro R, Cardoso C, Brunini SM.Molecular epidemiological investigation of Mayaro virus in febrile patients from Goiania City, 2017-2018. Infect Genet Evol. 2021 Jun 29;95:104981. doi: 10.1016/j.meegid.2021.104981.
  59. Scaturro M, Rota MC, Caporali MG, Girolamo A, Magoni M, Barberis D, Romano C, Cereda D, Gramegna M, Piro A, Corbellini S, Giagulli C, Rezza G, Caruso A, Ricci ML.A community-acquired Legionnaires' disease outbreak caused by Legionella pneumophila serogroup 2an uncommon event, Italy, August to October 2018.Euro Surveill. 2021 Jun;26(25):2001961. doi: 10.2807/1560-7917.ES.2021.26.25.2001961.
  60. Comar M, Benvenuto S, Lazzerini M, Fedele G, Barbi E, Amaddeo A, Risso FM, Strajn T, Di Rocco P, Stefanelli P, Rezza G. Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study. Ital J Pediatr. 2021 Jun 5;47(1):131. doi: 10.1186/s13052-021-01074-9.PMID: 34090486.
  61. Tramuto F, Reale S, Lo Presti A, Vitale F, Pulvirenti C, Rezza G, Vitale F, Purpari G, Maida CM, Zichichi S, Scibetta S, Mazzucco W, Stefanelli P.Genomic Analysis and Lineage Identification of SARS-CoV-2 Strains in Migrants Accessing Europe Through the Libyan Route. Front Public Health. 2021 Apr 15;9:632645. doi: 0.3389/fpubh.2021.632645. eCollection 2021.PMID: 33937168. 
  62. Signorelli C, Odone A, Stirparo G, Cereda D, Gramegna M, Trivelli M, Rezza G. SARS-CoV-2 transmission in the Lombardy Region: the increase of household contagion and its implication for containment measures. Acta Biomed. 2020 Nov 20;91(4):e2020195. doi: 10.23750/abm.v91i4.10994.PMID: 33525234. 
  63. Fortuna C, Montarsi F, Severini F, Marsili G, Toma L, Amendola A, Bertola M, Michelutti A, Ravagnan S, Capelli G, Rezza G, Di Luca M; the Working Group.The common European mosquitoes Culex pipiens and Aedes albopictus are unable to transmit SARS-CoV-2 after a natural-mimicking challenge with infected blood. Parasit Vectors. 2021 Jan 22;14(1):76. doi: 10.1186/s13071-021-04578-9.PMID: 33482887.
  64. Sorgentone S, Busani L, Calistri P, Robuffo G, Bellino S, Acciari V, Ferri M, Graziani C, Antoci S, Lodi F, Alfonsi V, Cammà C, Fazii P, Andrianou X, Cito F, Lombardi G, Centorotola G, D'Amario M, D'Alterio N, Savini V, De Massis F, Pelatti A, Di Domenico M, Di Donato G, Di Giannatale E, Di Marcantonio L, Di Marzio V, Di Serafino G, Janowicz A, Marfoglia C, Marotta F, Morelli D, Migliorati G, Neri D, Pomilio F, Scattolini S, Rezza G, Caponetti A, Pezzotti P, Garofolo G.A large food-borne outbreak of campylobacteriosis in kindergartens and primary schools in Pescara, Italy, May-June 2018.J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001262. Epub 2021 Jan 20.PMID: 33475480.
  65. Fabiani M, Mateo-Urdiales A, Andrianou X, Bella A, Del Manso M, Bellino S, Rota MC, Boros S, Vescio MF, D'Ancona FP, Siddu A, Punzo O, Filia A, Brusaferro S, Rezza G, Dente MG, Declich S, Pezzotti P, Riccardo F; COVID-19 Working GroupEpidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system..Eur J Public Health. 2021 Feb 1;31(1):37-44. doi: 10.1093/eurpub/ckaa249.PMID: 33416859.
  66. Marziano V, Guzzetta G, Rondinone BM, Boccuni F, Riccardo F, Bella A, Poletti P, Trentini F, Pezzotti P, Brusaferro S, Rezza G, Iavicoli S, Ajelli M, Merler S. Retrospective analysis of the Italian exit strategy from COVID-19 lockdown. Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):e2019617118.doi:10.1073/pnas.2019617118.
  67. Fabiani M, Mateo-Urdiales A, Andrianou X, Bella A, Del Manso M, Bellino S, Rota MC, Boros S, Vescio MF, D'Ancona FP, Siddu A, Punzo O, Filia A, Brusaferro S, Rezza G, Dente MG, Declich S, Pezzotti P, Riccardo F; COVID-19 working group. Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system. Eur J Public Health. 2021 Jan 8:ckaa249. doi: 10.1093/eurpub/ckaa249.
  68. Michelozzi P, De' Donato F, De Sario M, Stortichini M, Stafoggia M, Niccioli F, Andrianou X, Boros S, Del Manso M, Fabiani M, Urdiales AM, Pezzotti P, Rossi P, Rezza G, Costa G, Davoli M. [Temporal variations in excess mortality during phase 1 and phase 2 of the COVID-19 epidemic in Italy].Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):236-243. doi: 10.19191/EP20.5-6.S2.123.
  69. Lo Presti A, Rezza G, Neri A, Fazio C, Ambrosio L, Palmieri A, Vacca P, Stefanelli P.Ann Ist Super Sanita. Gene flow and Bayesian phylogeography of serogroup C meningococci circulating in Italy. 2020 Oct-Dec;56(4):430-436. doi: 10.4415/ANN_20_04_04.
  70. Riccardo F, Ajelli M, Andrianou XD, Bella A, Del Manso M, Fabiani M, Bellino S, Boros S, Urdiales AM, Marziano V, Rota MC, Filia A, D'Ancona F, Siddu A, Punzo O, Trentini F, Guzzetta G, Poletti P, Stefanelli P, Castrucci MR, Ciervo A, Di Benedetto C, Tallon M, Piccioli A, Brusaferro S, Rezza G, Merler S, Pezzotti P; COVID-19 working group. Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020. Euro Surveill. 2020 Dec;25(49):2000790. doi: 10.2807/1560-7917.ES.2020.25.49.2000790.
  71. Stefanelli P, Bella A, Fedele G, Pancheri S, Leone P, Vacca P, Neri A, Carannante A, Fazio C, Benedetti E, Fiore S, Fabiani C, Simmaco M, Santino I, Zuccali MG, Bizzarri G, Magnoni R, Benetollo PP, Merler S, Brusaferro S, Rezza G, Ferro A. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.Clin Microbiol Infect. 2020 Nov 28:S1198-743X(20)30709-6.doi:10.1016/j.cmi.2020.11.013.
  72. Magurano F, Baggieri M, Marchi A, Rezza G, Nicoletti L; COVID-19 Study Group. SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature. Clin Microbiol Infect. 2020 Nov 5:S1198-743X(20)30688-1. doi: 10.1016/j.cmi.2020.10.034. Online ahead of print.
  73. Guzzetta G, Riccardo F, Marziano V, Poletti P, Trentini F, Bella A, Andrianou X, Del Manso M, Fabiani M, Bellino S, Boros S, Urdiales AM, Vescio MF, Piccioli A, Brusaferro S, Rezza G, Pezzotti P, Ajelli M, Merler S. Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy. Emerg Infect Dis. 2021 Jan;27(1):267-70. doi: 10.3201/eid2701.202114.
  74. Mancini F, Barbanti F, Scaturro M, Fontana S, Di Martino A, Marsili G, Puzelli S, Calzoletti L, Facchini M, Di Mario G, Fabiani C, Dstat AB, Riccardo F, Dstat PP, Stefanelli P, Rezza G, Ciervo A.J Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting. Infect Dis. 2020 Oct 20:jiaa658. doi: 10.1093/infdis/jiaa658.
  75. Lo Presti A, Rezza G, Stefanelli P. Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction. Heliyon. 2020 Sep;6(9):e05001. doi: 10.1016/j. heliyon.2020.e05001. Epub 2020 Sep 21.
  76. Michelozzi P, de'Donato F, Scortichini M, Pezzotti P, Stafoggia M, De Sario M, Costa G, Noccioli F, Riccardo F, Bella A, Demaria M, Rossi P, Brusaferro S, Rezza G, Davoli M. Temporal dynamics in total excess mortality and COVID-19 deaths in Italian cities. BMC Public Health. 2020 Aug 14;20(1):1238. doi: 10.1186/s12889-020-09335-8.
  77. Bellino S, Punzo O, Rota MC, Del Manso M, Urdiales AM, Andrianou X, Fabiani M, Boros S, Vescio F, Riccardo F, Bella A, Filia A, Rezza G, Villani A, Pezzotti P; COVID-19 WORKING GROUP. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy. Pediatrics. 2020 Oct;146(4):e2020009399. doi: 10.1542/peds.2020-009399.
  78. Rezza G, Ricciardi W. No jab, no pay and vaccine mandates: Do compulsory policies increase vaccination coverage? The Italian experience. Vaccine. 2020 Jul 14;38(33):5089. doi: 10.1016/j.vaccine.2020.05.043.
  79. Mancini F, Barbanti F, Scaturro M, Errico G, Iacobino A, Bella A, Riccardo F, Marsili G, Stefanelli P, Pezzotti P, Rezza G, Ciervo A. Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing. Emerg Microbes Infect. 2020 Dec;9(1):1393-1396. doi: 10.1080/22221751.2020.1775500. 
  80. Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, Raparelli V, Pezzotti P, Riccardo F, Bella A, Fabiani M, D'Ancona FP, Vaianella L, Tiple D, Colaizzo E, Palmer K, Rezza G, Piccioli A, Brusaferro S, Onder G. Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1796-1800. doi: 10.1093/gerona/glaa146.
  81. Boccolini D, Menegon M, Di Luca M, Toma L, Severini F, Marucci G, D'Amato S, Caraglia A, Maraglino FP, Rezza G, Romi R, Gradoni L, Severini C; Italian Malaria Surveillance Group. Non-imported malaria in Italy: paradigmatic approaches and public health implications following an unusual cluster of cases in 2017. BMC Public Health. 2020 Jun 5;20(1):857. doi: 10.1186/s12889-020-08748-9.
  82. Riccardo F, Bolici F, Fafangel M, Jovanovic V, Socan M, Klepac P, Plavsa D, Vasic M, Bella A, Diana G, Rosi L, Pezzotti P, Andrianou XD, Di Luca M, Venturi G, Maraglino F, Pervanidou D, Cenciarelli O, Baka A, Young J, Bakonyi T, Rezza G, Suk JE. West Nile virus in Europe: after action reviews of preparedness and response to the 2018 transmission season in Italy, Slovenia, Serbia and Greece. Global Health. 2020 May 18;16(1):47. doi: 10.1186/s12992-020-00568-1.
  83. Lo Presti A, Vacca P, Neri A, Fazio C, Ambrosio L, Rezza G, Stefanelli P. Estimates of the reproductive numbers and demographic reconstruction of outbreak associated with C:P1.5-1,10-8:F3-6:ST-11(cc11) Neisseria meningitidis strains. Infect Genet Evol. 2020 Oct;84:104360. doi: 10.1016/j.meegid.2020.104360.
  84. Russo G, Subissi L, Rezza G. Chikungunya fever in Africa: a systematic review. Pathog Glob Health. 2020 Apr 18:1-9. doi: 10.1080/20477724.2020.1748965. [Epub ahead of print].
  85. Stefanelli P, Faggioni G, Lo Presti A, Fiore S, Marchi A, Benedetti E, Fabiani C, Anselmo A, Ciammaruconi A, Fortunato A, De Santis R, Fillo S, Capobianchi MR, Gismondo MR, Ciervo A, Rezza G, Castrucci MR, Lista F, On Behalf Of Iss Covid-Study Group. Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe. Euro Surveill. 2020 Apr;25(13). doi: 10.2807/1560-7917.ES.2020.25.13.2000305.
  86. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020 Mar 23. doi: 10.1001/jama.2020.4683. [Epub ahead of print] No abstract available.
  87. Ticconi C, Rezza G. Defining Zika virus infection in pregnant women. Pathog Glob Health. 2019 Oct;113(7):290. doi: 10.1080/20477724.2019.1706712. Epub 2020 Jan 6. No abstract available.
  88. Rezza G. Mandatory vaccination for infants and children: the Italian experience. Pathog Glob Health. 2019 Oct;113(7):291-296. doi: 10.1080/20477724.2019.1705021. Epub 2019 Dec 23. Review.
  89. Ricciardi W, Marcheggiani S, Puccinelli C, Carere M, Sofia T, Giuliano F, Dogliotti E, Mancini L, Agrimi U, Alleva E, Busani L, De Castro P, Gaudi S, Michelozzi P, Rezza G, Testai E, Vella S. Health and Climate Change: science calls for global action. Ann Ist Super Sanita. 2019 Oct-Dec;55(4):323-329. doi: 10.4415/ANN_19_04_04.
  90. Lo Presti A, Neri A, Fazio C, Vacca P, Ambrosio L, Grazian C, Liseo B, Rezza G, Maiden MCJ, Stefanelli P. Reconstruction of Dispersal Patterns of Hypervirulent Meningococcal Strains of Serogroup C:cc11 by Phylogenomic Time Trees. J Clin Microbiol. 2019 Dec 23;58(1). pii: e01351-19. doi: 10.1128/JCM.01351-19. Print 2019 Dec 23.
  91. Riccardo F, Venturi G, Di Luca M, Del Manso M, Severini F, Andrianou X, Fortuna C, Remoli ME, Benedetti E, Caporali MG, Fratto F, Mignuoli AD, Rizzo L, De Vito G, De Giorgio V, Surace L, Vairo F, Angelini P, Re MC, Amendola A, Fiorentini C, Marsili G, Toma L, Boccolini D, Romi R, Pezzotti P, Rezza G, Rizzo C. Secondary Autochthonous Outbreak of Chikungunya, Southern Italy, 2017. Emerg Infect Dis. 2019 Nov;25(11):2093-2095. doi: 10.3201/eid2511.180949.
  92. Rezza G. Emergence of human monkeypox in west Africa. Lancet Infect Dis. 2019 Aug;19(8):797-799. doi: 10.1016/S1473-3099(19)30281-6. Epub 2019 Jul 5. No abstract available.
  93. Valdarchi C, Dorrucci M, Mancini F, Farchi F, Pimentel de Araujo F, Corongiu M, Ciervo A, Rezza G, Pantosti A, Camilli R; FIMMG Group. Pneumococcal carriage among adults aged 50 years and older with co-morbidities attending medical practices in Rome, Italy. Vaccine. 2019 Aug 14;37(35):5096-5103. doi: 10.1016/j.vaccine.2019.06.052. Epub 2019 Jul 5.
  94. D'Ancona F, D'Amario C, Maraglino F, Rezza G, Iannazzo S. The law on compulsory vaccination in Italy: an update 2 years after the introduction. Euro Surveill. 2019 Jun;24(26). doi: 10.2807/1560-7917.ES.2019.24.26.1900371.
  95. Cinquetti S, Dalmanzio M, Ros E, Gentili D, Ramigni M, Grossi A, Andrianou XD, La Torre LE, Rigoli R, Scotton PG, Taraschi A, Baldo V, Napoletano G, Russo F, Pezzotti P, Rezza G, Filia A. High rate of transmission in a pulmonary tuberculosis outbreak in a primary school, north-eastern Italy, 2019. Euro Surveill. 2019 Jun;24(24). doi: 10.2807/1560-7917.ES.2019.24.24.1900332.
  96. Venturi G, Fortuna C, Alves RM, Passos do Prado Paschoal AG, da Silva Júnior PJ, Remoli ME, Benedetti E, Amendola A, da Silva Batista E, Gama DVN, Barros DH, Fiorentini C, Rezza G, Leite Primo Chagas JR. Epidemiological and clinical suspicion of congenital Zika virus infection: Serological findings in mothers and children from Brazil. J Med Virol. 2019 Sep;91(9):1577-1583. doi: 10.1002/jmv.25504. Epub 2019 May 29.
  97. Guimarães LCDC, Brunini S, Guimarães RA, Galdino-Júnior H, Minamisava R, da Cunha VE, Santos JRS, Silveira-Lacerda EP, Souza CM, de Oliveira VLB, Albernaz GC, de Menezes TG, Rezza G. Epidemiology of hepatitis B virus infection in people living in poverty in the central-west region of Brazil. BMC Public Health. 2019 Apr 29;19(1):443. doi: 10.1186/s12889-019-6828-8.
  98. Miglietta A, Solimini A, Djeunang Dongho GB, Montesano C, Rezza G, Vullo V, Colizzi V, Russo G. The Ebola virus disease outbreak in Tonkolili district, Sierra Leone: a retrospective analysis of the Viral Haemorrhagic Fever surveillance system, July 2014-June 2015. Epidemiol Infect. 2019 Jan;147:e103. doi: 10.1017/S0950268819000177.
  99. Donà MG, Chiantore MV, Gheit T, Fiorucci G, Vescio MF, La Rosa G, Accardi L, Costanzo G, Giuliani M, Romeo G, Rezza G, Tommasino M, Luzi F, Di Bonito P. Comprehensive analysis of β- and γ-human papillomaviruses in actinic keratosis and apparently healthy skin of elderly patients. Br J Dermatol. 2019 Sep;181(3):620-622. doi: 10.1111/bjd.17836. Epub 2019 Jun 26.
  100. Ecarnot F, Bernabei R, Gabutti G, Giuffrida S, Michel JP, Rezza G, Maggi S. Adult vaccination as the cornerstone of successful ageing: the case of herpes zoster vaccination. A European Interdisciplinary Council on Ageing (EICA) expert focus group. Aging Clin Exp Res. 2019 Mar;31(3):301-307. doi: 10.1007/s40520-019-01154-1. Epub 2019 Feb 25.
  101. Lindh E, Argentini C, Remoli ME, Fortuna C, Faggioni G, Benedetti E, Amendola A, Marsili G, Lista F, Rezza G, Venturi G. The Italian 2017 Outbreak Chikungunya Virus Belongs to an Emerging Aedes albopictus-Adapted Virus Cluster Introduced From the Indian Subcontinent. Open Forum Infect Dis. 2018 Dec 12;6(1):ofy321. doi: 10.1093/ofid/ofy321. eCollection 2019 Jan.
  102. Ecarnot F, Bernabei R, Gabutti G, Giuffrida S, Michel JP, Rezza G, Maggi S. Adult vaccination as the cornerstone of successful ageing: the case of herpes zoster vaccination. A European Interdisciplinary Council on Ageing (EICA) expert focus group. Aging Clin Exp Res. 2019 Mar;31(3):301-307. doi: 10.1007/s40520-019-01154-1. Epub 2019 Feb 25.
  103. Lindh E, Argentini C, Remoli ME, Fortuna C, Faggioni G, Benedetti E, Amendola A, Marsili G, Lista F, Rezza G, Venturi G. The Italian 2017 Outbreak Chikungunya Virus Belongs to an Emerging Aedes albopictus-Adapted Virus Cluster Introduced From the Indian Subcontinent. Open Forum Infect Dis. 2018 Dec 12;6(1):ofy321. doi: 10.1093/ofid/ofy321. eCollection 2019 Jan.
  104. Rezza G, Weaver SC. Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development. PLoS Negl Trop Dis. 2019 Jan 17;13(1):e0006919. doi: 10.1371/journal.pntd.0006919. eCollection 2019 Jan. Review.
  105. Miglietta A, Innocenti F, Pezzotti P, Riccobono E, Moriondo M, Pecile P, Nieddu F, Rossolini GM, Azzari C; Meningococcal Carriage Study Group, Balocchini E, Rezza G, Voller F, Stefanelli P. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study. BMC Infect Dis. 2019 Jan 8;19(1):29. doi: 10.1186/s12879-018-3598-3.
  106. Riccardo F, Bella A, Ivanovic D, Kelic I, Ciccaglione AR, Simic D, Rossi P, Pantosti A, Grisetti T, Pozio E, Pezzotti P, Rosi L, Ivanovic I, Vrga S, Sovic N, Rezza G, Jovanovic V, Stefanelli P. Methodological approach towards a Gap Assessment of the Serbian microbiology system in the function of surveillance in line with EU standards and acquis. Ann Ist Super Sanita. 2018 Oct-Dec;54(4):324-331. doi: 10.4415/ANN_18_04_09.
  107. Pezzotti P, Bellino S, Riccardo F, Lucaroni F, Cerquetti M, Pantosti A, Rezza G, Stefanelli P. Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016. Vaccine. 2019 Jan 3;37(1):41-48. doi: 10.1016/j.vaccine.2018.11.047. Epub 2018 Nov 23.
  108. Giuliani M, Latini A, Colafigli M, Benevolo M, Rollo F, Zaccarelli M, Giuliani E, Moretto D, Giglio A, Rezza G, Cristaudo A, Donà MG. Vaccine-preventable anal infections by human papillomavirus among HIV-infected men who have sex with men. Future Microbiol. 2018 Oct;13:1463-1472. doi: 10.2217/fmb-2018-0149. Epub 2018 Oct 12.
  109. Gomez-Barroso D, Vescio MF, Bella A, Ciervo A, Busani L, Rizzo C, Rezza G, Pezzotti P. Mediterranean spotted fever rickettsiosis in Italy, 2001-2015: Spatio-temporal distribution based on hospitalization records. Ticks Tick Borne Dis. 2019 Jan;10(1):43-50. doi: 10.1016/j.ttbdis.2018.09.001. Epub 2018 Sep 3.
  110. Pezzotti P, Bellino S, Prestinaci F, Iacchini S, Stefanelli P, Rezza G. Reply to letters to the Editor: Bellavite P. Factors that influenced the historical trends of tetanus and diphtheria. Donzelli A, Duca P. More than 70,000 deaths prevented by vaccination against three diseases in about 75 years? The estimation seems exaggerated. Vaccine. 2018; 5;36(37):5508-5509.
  111. Miglietta A, Fazio C, Neri A, Pezzotti P, Innocenti F, Azzari C, Rossolini GM, Moriondo M, Nieddu F, Iannazzo S, D'Ancona F, Maraglino FP, Guerra R, Rezza G, Voller F, Stefanelli P. Interconnected clusters of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11), involving bisexuals and men who have sex with men, with discos and gay-venues hotspots of transmission, Tuscany, Italy, 2015 to 2016. Euro Surveill. 2018 Aug;23(34). doi: 10.2807/1560-7917.ES.2018.23.34.1700636.
  112. Esposito S, Principi N, Rezza G, Bonanni P, Gavazzi G, Beyer I, Sulzner M, Celentano LP, Prymula R, Rappagliosi A, Sevilla J, Poland G; WAidid-EVASG Panel on vaccination of 50+. Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward. Vaccine. 2018 Sep 18;36(39):5819-5824. doi: 10.1016/j.vaccine.2018.08.041. Epub 2018 Aug 22.
  113. Bartoloni A, Remoli ME, Farchi F, Zammarchi L, Fortuna C, Benedetti E, Ciufolini MG, Macchioni F, Rojas P, Lara Y, Padilla C, Roselli M, Mantengoli E, Mantella A, Tolari F, Paredes GA, Monasterio J, Valdarchi C, Venturi G, Rezza G. Seroprevalence of West Nile and dengue virus in the human population of the Bolivian Chaco. J Med Virol. 2019 Jan;91(1):146-150. doi: 10.1002/jmv.25283. Epub 2018 Sep 7.
  114. Riccardo F, Monaco F, Bella A, Savini G, Russo F, Cagarelli R, Dottori M, Rizzo C, Venturi G, Di Luca M, Pupella S, Lombardini L, Pezzotti P, Parodi P, Maraglino F, Costa AN, Liumbruno GM, Rezza G, The Working Group. An early start of West Nile virus seasonal transmission: the added value of One Heath surveillance in detecting early circulation and triggering timely response in Italy, June to July 2018. Euro Surveill. 2018 Aug;23(32). doi: 10.2807/1560-7917.ES.2018.23.32.1800427.
  115. Tini ML, Rezza G. Morbilliform skin rash with prominent involvement of the palms in Chikungunya fever. IDCases. 2018 Jul 4;13:e00421. doi: 10.1016/j.idcr.2018.e00421. eCollection 2018.
  116. Stefanelli P, Fazio C, Vacca P, Palmieri A, Ambrosio L, Neri A, Piana A, Castiglia P, Argiolas F, Santus S, Masala L, Steri G, Riccardo F, Iannazzo S, Maraglino FP, D'Amario C, Rezza G. An outbreak of severe invasive meningococcal disease due to a capsular switched Neisseria meningitidis hypervirulent strain B:cc11. Clin Microbiol Infect. 2019 Jan;25(1):111.e1-111.e4. doi: 10.1016/j.cmi.2018.07.014. Epub 2018 Jul 21.
  117. Dettori M, Arru B, Azara A, Piana A, Mariotti G, Camerada MV, Stefanelli P, Rezza G, Castiglia P. In the Digital Era, Is Community Outrage a Feasible Proxy Indicator of Emotional Epidemiology? The Case of Meningococcal Disease in Sardinia, Italy. Int J Environ Res Public Health. 2018 Jul 18;15(7). pii: E1512. doi: 10.3390/ijerph15071512.
  118. Barros CVL, Galdino Júnior H, Rezza G, Guimarães RA, Ferreira PM, Souza CM, Guimarães LCDC, Barros DAC, Brunini SM. Bio-behavioral survey of syphilis in homeless men in Central Brazil: a cross-sectional study. Cad Saude Publica. 2018 Jun 25;34(6):e00033317. doi: 10.1590/0102-311X00033317.
  119. Subissi L, Keita M, Mesfin S, Rezza G, Diallo B, Van Gucht S, Musa EO, Yoti Z, Keita S, Djingarey MH, Diallo AB, Fall IS. Ebola Virus Transmission Caused by Persistently Infected Survivors of the 2014-2016 Outbreak in West Africa.  J Infect Dis. 2018 Nov 22;218(suppl_5):S287-S291. doi: 10.1093/infdis/jiy280.
  120. Pezzotti P, Miglietta A, Neri A, Fazio C, Vacca P, Voller F, Rezza G, Stefanelli P. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy. Vaccine. 2018 Jul 5;36(29):4222-4227. doi: 10.1016/j.vaccine.2018.06.002. Epub 2018 Jun 9.
  121. Fortuna C, Toma L, Remoli ME, Amendola A, Severini F, Boccolini D, Romi R, Venturi G, Rezza G, Di Luca M. Vector competence of Aedes albopictus for the Indian Ocean lineage (IOL) chikungunya viruses of the 2007 and 2017 outbreaks in Italy: a comparison between strains with and without the E1:A226V mutation. Euro Surveill. 2018 May;23(22). doi: 10.2807/1560-7917.ES.2018.23.22.1800246.
  122. D'Ancona F, D'Amario C, Maraglino F, Rezza G, Ricciardi W, Iannazzo S. Introduction of new and reinforcement of existing compulsory vaccinations in Italy: first evaluation of the impact on vaccination coverage in 2017. Euro Surveill. 2018 May;23(22). doi: 10.2807/1560-7917.ES.2018.23.22.1800238.
  123. Brunini SM, Barros CVL, Guimarães RA, Galdino Júnior H, Rezza G, Santos JR, da Cunha VE, Sousa JM, Ferreira PM, Barros DAC. HIV infection, high-risk behaviors and substance use in homeless men sheltered in therapeutic communities in Central Brazil.Int J STD AIDS. 2018 Nov;29(11):1084-1088. doi: 10.1177/0956462418767188. Epub 2018 Jun 3.
  124. Faggioni G, De Santis R, Pomponi A, Grottola A, Serpini GF, Meacci M, Gennari W, Tagliazucchi S, Pecorari M, Monaco F, Savini G, Benedetti E, Remoli ME, Fortuna C, Venturi G, Rezza G, Lista F. Prevalence of Usutu and West Nile virus antibodies in human sera, Modena, Italy, 2012. J Med Virol. 2018 Oct;90(10):1666-1668. doi: 10.1002/jmv.25230. Epub 2018 Jun 6.
  125. Fillo S, Mancini F, Anselmo A, Fortunato A, Rezza G, Lista F, Ciervo A. Draft Genome Sequence of Streptococcus suis Strain SsRC-1, a Human Isolate from a Fatal Case of Toxic Shock Syndrome. Genome Announc. 2018 May 17;6(20). pii: e00447-18. doi: 10.1128/genomeA.00447-18.
  126. Severini F, Boccolini D, Fortuna C, Di Luca M, Toma L, Amendola A, BenedettiE, Minelli G, Romi R, Venturi G, Rezza G, Remoli ME. Vector competence of Italian Aedes albopictus populations for the chikungunya virus (E1-226V). PLoS Negl Trop Dis 2018 Apr 19;12(4).
  127. Rezza G. Chikungunya is back in Italy: 2007-2017. J Travel Med 2018 Jan 1;25(1).
  128. Rezza G. Routine vaccination strategies, reactive vaccination, and pandemicpreparedness and response. Ig Sanita Pubbl 2017 Sep-Oct;73(5):419-428. Italian.
  129. Pezzotti P, Bellino S, Prestinaci F, Iacchini S, Lucaroni F, Camoni L, Barbieri MM, Ricciardi W, Stefanelli P, Rezza G. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015.Vaccine 2018 Mar 7;36(11):1435-1443.
  130. Tchidjou HK, Vescio MF, Serafinelli J, Giampaolo R, Jenkner A, Tadonkeng MC,Avellis L, Fiocchi A, Pezzotti P, Rezza G, Rossi P. Susceptibility to allergy in adoptive children: a cross-sectional study at "Bambino Gesù Children's Hospital".Ital J Pediatr. 2018 Jan 4;44(1):3
  131. Fiore V, Mancini F, Ciervo A, Bagella P, Peruzzu F, Nunnari G, Deiana GA, Rezza G, Babudieri S, Madeddu G. Tache Noire in a Patient with Acute Q Fever. MedPrinc Pract. 2018;27(1):92-94.
  132. Taruscio D, Baldi F, Carbone P, Neville AJ, Rezza G, Rizzo C, Mantovani A. Primary Prevention of Congenital Anomalies: Special Focus on EnvironmentalChemicals and other Toxicants, Maternal Health and Health Services and Infectious Diseases. Adv Exp Med Biol. 2017;1031:301-322.
  133. Spada E, Rezza G, Garbuglia AR, Lombardo FL, Zuccaro O, Menniti Ippolito F, Cupellaro E, Capone S, Capobianchi MR, Nicosia A, Cortese R, Folgori A, Mele A. Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.;Collaborative Study Group. J Urban Health. 2018; 95(1):99-110.
  134. Vratnica Z, Busani L, Zekovic Ž, Rakocevic B, Medenica S, Urciuoli R, Rezza G, Mugoša B. Haemorrhagic fever with renal syndrome in Montenegro, 2004-14. Eur JPublic Health. 2017 Dec 1;27(6):1108-1110.
  135. Lanini S, Minosse C, Vairo F, Garbuglia A, Di Bari V, Agresta A, Rezza G,Puro V, Pendenza A, Loffredo MR, Scognamiglio P, Zumla A, Panella V, Ippolito G, Capobianchi MR; Gruppo Laziale Sorveglianza Epatiti Virali (GLaSEV). A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio,Italy; August 2016 - March 2017. PLoS One. 2017 Nov 10;12(11):e0185428.
  136. Ramos de Souza M, do Amaral WN, Alves Guimarães R, Rezza G, Brunini SM. Reproductive desire among women living with HIV/AIDS in Central Brazil:Prevalence and associated factors. PLoS One. 2017 Oct 20;12(10):e0186267.
  137. Venturi G, Di Luca M, Fortuna C, Remoli ME, Riccardo F, Severini F, Toma L,Del Manso M, Benedetti E, Caporali MG, Amendola A, Fiorentini C, De Liberato C,Giammattei R, Romi R, Pezzotti P, Rezza G, Rizzo C. Detection of a chikungunya outbreak in Central Italy, August to September 2017. Euro Surveill. 2017 Sep;22(39).
  138. Rizzo C, Rezza G, Ricciardi W. Strategies in recommending influenza vaccination in Europe and US. Hum Vaccin Immunother. 2018 Mar 4;14(3):693-698.
  139. Rezza G, Chen R, Weaver SC. O'nyong-nyong fever: a neglected mosquito-borne viral disease. Pathog Glob Health. 2017 Sep;111(6):271-275.
  140. Magurano F, Baggieri M, Marchi A, Bucci P, Rezza G, Nicoletti L. Mumps clinical diagnostic uncertainty. Eur J Public Health. 2018 Feb 1;28(1):119-123.
  141. Brunini S, França DDS, Silva JB, Silva LN, Silva FPA, Spadoni M, Rezza G. High Frequency of Mayaro Virus IgM among Febrile Patients, Central Brazil. Emerg Infect Dis. 2017 Jun;23(6):1025-1026. doi: 10.3201/eid2306.160929.
  142. Signorelli C, Odone A, Ciorba V, Cella P, Audisio RA, Lombardi A, Mariani L, Mennini FS, Pecorelli S, Rezza G, Zuccotti GV, Peracino A. Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence. Epidemiol Infect. 2017 Jul;145(10):1962-1982.
  143. Fontana S, Buttinelli G, Fiore S, Mulaomerovic M, Aćimović J, Amato C, Delogu R, Rezza G, Stefanelli P. Acute flaccid paralysis surveillance in bosnia and herzegovina: Recent isolation of two sabin like type 2 poliovirus. J Med Virol 2017 Sep;89(9):1678-1681. doi: 10.1002/jmv.24827.
  144. Ippolito G, Rezza G. Preface - Emerging Viruses: From Early Detection to Intervention. Adv Exp Med Biol. 2017;972:1-5.
  145. Fortuna C, Remoli ME, Rizzo C, Benedetti E, Fiorentini C, Bella A, Argentini  C, Farchi F, Castilletti C, Capobianchi MR, Zammarchi L, Bartoloni A, Zanchetta N, Gismondo MR, Nelli LC, Vitale G, Baldelli F, D'Agaro P, Sodano G, Rezza G, Venturi G. Imported arboviral infections in Italy, July 2014-October 2015: a National Reference Laboratory report. BMC Infect Dis 2017: 16;17(1):216. doi: 10.1186/s12879-017-2320-1.
  146. Busani L, Platonov AE, Ergonul O, Rezza G. How to Tackle Natural Focal Infections: From Risk Assessment to Vaccination Strategies. Adv Exp Med Biol. 2017;972:7-16. doi: 10.1007/5584_2016_199.
  147. Russo G, Faggioni G, Paganotti GM, Djeunang Dongho GB, Pomponi A, De Santis R, Tebano G, Mbida M, Sanou Sobze M, Vullo V, Rezza G, Lista FR. Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals  from Dschang, West Cameroon. Malar J. 2017 14;16(1):74.
  148. Mipatrini D, Stefanelli P, Severoni S, Rezza G. Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence. Pathog Glob Health. 2017 Mar;111(2):59-68.
  149. Uccella I, Petrelli A, Vescio MF, De Carolis S, Fazioli C, Pezzotti P, Rezza  G. HIV rapid testing in the framework of an STI prevention project on a cohort of vulnerable Italians and immigrants. AIDS Care. 2017 Aug;29(8):996-1002.
  150. Ferreira PM, Guimarães RA, Souza CM, Guimarães LC, Barros CV, Caetano KA, Rezza G, Spadoni L, Brunini SM. Exposure to hepatitis C virus in homeless men in Central Brazil: a cross-sectional study. BMC Public Health. 2017 Jan 18;17(1):90.
  151. Scagnolari C, Caputo B, Rezza G, Antonelli G. Antiviral Activity of the Combination of Interferon and Ribavirin Against Chikungunya Virus: Are the Results Conclusive? J Infect Dis. 2017 Feb 1;215(3):492-493.  Stefanelli P, Buttinelli G, Rezza G. Poliomyelitis: residual hurdles to global eradication. Commentary. Ann Ist Super Sanita. 2016 Oct-Dec;52(4):469-471.
  152. Zammarchi L, Fortuna C, Venturi G, Rinaldi F, Capobianco T, Remoli ME, Rossolini GM, Rezza G, Bartoloni A. Recent Chikungunya Virus Infection in 2 Travelers Returning from Mogadishu, Somalia, to Italy, 2016. Emerg Infect Dis 2016 Nov; 22(11):2025-2027.
  153. Ticconi C, Pietropolli A, Rezza G. Zika virus infection and pregnancy: what we do and do not know. Pathog Glob Health. 2016 Oct - Dec;110(7-8):262-268. Epub 2016 Sep 30. Review. PubMed PMID: 27690200; PubMed Central PMCID: PMC5189862.
  154. Boccolini D, Toma L, Di Luca M, Severini F, Romi R, Remoli ME, Sabbatucci M,  Venturi G, Rezza G, Fortuna C. Experimental investigation of the susceptibility of Italian Culex pipiens mosquitoes to Zika virus infection. Euro Surveill. 2016  Sep 1;21(35).
  155. Tumolskaya NI, Pozio E, Rakova VM, Supriaga VG, Sergiev VP, Morozov EN, Morozova LF, Rezza G, Litvinov SK. Dirofilaria immitis in a child from the Russian Federation. Parasite. 2016;23:37. doi: 10.1051/parasite/2016037. Epub 2016 Sep 7. PubMed PMID: 27600944; PubMed Central PMCID: PMC5018928.
  156. Puzelli S, Rizzo C, Fabiani C, Facchini M, Gaibani P, Landini MP, Gagliotti C, Moro ML, Rangoni R, Piccolomini LL, Finarelli AC, Tamba M, Rezza G, Declich S, Donatelli I, Castrucci MR. Influenza A(H7N7) Virus among Poultry Workers, Italy,  2013. Emerg Infect Dis. 2016 Aug;22(8):1512-3.
  157.  Tosoni A, Mirijello A, Ciervo A, Mancini F, Rezza G, Damiano F, Cauda R, Gasbarrini A, Addolorato G; Internal Medicine Sepsis Study Group. Human Rickettsia aeschlimannii infection: first case with acute hepatitis and review of the literature. Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2630-3.
  158.  Madeddu G, Fiore V, Mancini F, Caddeo A, Ciervo A, Babudieri S, Masala G, Bagella P, Nunnari G, Rezza G, Mura MS. Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study. Infection. 2016 Dec;44(6):733-738.
  159.  Dezsényi B, Strausz T, Makrai Z, Csomor J, Danka J, Kern P, Rezza G, Barth TF, Casulli A. Autochthonous human alveolar echinococcosis in a Hungarian patient. Infection. 2017 Feb;45(1):107-110. doi: 10.1007/s15010-016-0918-7.
  160. Rezza G. Dengue and other Aedes-borne viruses: a threat to Europe? Euro Surveill. 2016; May 26;21(21).
  161. Di Luca M, Severini F, Toma L, Boccolini D, Romi R, Remoli ME, Sabbatucci M, Rizzo C, Venturi G, Rezza G, Fortuna C. Experimental studies of susceptibility of Italian Aedes albopictus to Zika Virus. Euro Surveill. 2016 May 5;21(18).
  162. Stefanelli P, Miglietta A, Pezzotti P, Fazio C, Neri A, Vacca P, Voller F, D'Ancona FP, Guerra R, Iannazzo S, Pompa MG, Rezza G. Increased incidence of invasive meningococcal disease of serogroup C / clonal complex 11, Tuscany, Italy, 2015 to 2016. Euro Surveill. 2016;21(12).
  163. Venturi G, Zammarchi L, Fortuna C, Remoli ME, Benedetti E, Fiorentini C, Trotta M, Rizzo C, Mantella A, Rezza G, Bartoloni A. Authors' reply: diagnostic challenges to be considered regarding Zika virus in the context of the presence of the vector Aedes albopictus in Europe. Euro Surveill. 2016;21(10).
  164. Amegah AK, Rezza G, Jaakkola JJ. Temperature-related morbidity and mortality in Sub-Saharan Africa: A systematic review of the empirical evidence. Environ Int. 2016 May;91:133-49.
  165. Venturi G, Zammarchi L, Fortuna C, Remoli ME, Benedetti E, Fiorentini C, Trotta M, Rizzo C, Mantella A, Rezza G, Bartoloni A. An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014. Euro Surveill. 2016;21(8).
  166. Ingrosso L, Schmidt T, Sherally J, Dembech M, Barragan Montes S, Sa Machado R, Annunziata G, Rezza G, Severoni S. A desk review on institutional and non-institutional organizations active in the field of migrant's health in the WHO European Region. Ann Ist Super Sanita. 2015 Oct-Dec;51(4):313-20.
  167. Mancini F, Ciccozzi M, Lo Presti A, Cella E, Giovanetti M, Di Luca M, Toma L, Bianchi R, Khoury C, Rezza G, Ciervo A. Characterization of spotted fever group Rickettsiae in ticks from a city park of Rome, Italy. Ann Ist Super Sanita. 2015 Oct-Dec;51(4):284-90.
  168. Giuliani M, Vescio MF, Donà MG, Latini A, Frasca M, Colafigli M, Farinella M, Rezza G, Cristaudo A. Perceptions of Human Papillomavirus (HPV) infection and acceptability of HPV vaccine among men attending a sexual health clinic differ according to sexual orientation. Hum Vaccin Immunother. 2016 Jan 11:1-9.
  169. Ganushkina LA, Patraman IV, Rezza G, Migliorini L, Litvinov SK, Sergiev VP. Detection of Aedes aegypti, Aedes albopictus, and Aedes koreicus in the Area of Sochi, Russia. Vector Borne Zoonotic Dis. 2016 Jan;16(1):58-60.
  170. Ciervo A, Mancini F, di Bernardo F, Giammanco A, Vitale G, Dones P, Fasciana T, Quartaro P, Mazzola G, Rezza G. Louseborne Relapsing Fever in Young Migrants, Sicily, Italy, July-September 2015. Emerg Infect Dis. 2016 Jan;22(1):152-3.
  171. Stefanelli P, Fazio C, Neri A, Rezza G, Severoni S, Vacca P, Fasciana T, Bisbano A, Di Bernardo F, Giammanco A. Imported and Indigenous cases of Invasive Meningocococcal Disease W:P1.5,2:F1-1: ST-11 in migrants' reception centers. Italy, June-November 2014.Adv Exp Med Biol. 2016;897:81-3.
  172. Rezza G, Farchi F, Pezzotti P, Ruscio M, Lo Presti A, Ciccozzi M, Mondardini V, Paternoster C, Bassetti M, Merelli M, Scotton PG, Luzzati R, Simeoni J, Mian P, Mel R, Carraro V, Zanin A, Ferretto R, Francavilla E; TBE Virology Group. Tick-borne encephalitis in north-east Italy: a 14-year retrospective study, January 2000 to December 2013. Euro Surveill. 2015;20(40). doi: 10.2807/1560-7917.ES.2015.20.40.30034.
  173. Stefanelli P, Rezza G. Impact of vaccination on meningococcal epidemiology. Hum Vaccin Immunother. 2015 Oct 29:1-5.
  174. Audisio RA, Icardi G, Isidori AM, Liverani CA, Lombardi A, Mariani L, Mennini FS, Mitchell DA, Peracino A, Pecorelli S, Rezza G, Signorelli C, Rosati GV, Zuccotti GV.Public health value of universal HPV vaccination. Crit Rev Oncol Hematol. 2016 Jan;97:157-67.
  175. Delle Rose D, Sordillo P, Gini S, Cerva C, Boros S, Rezza G, Meledandri M, Gallo MT, Prignano G, Caccese R, D'Ambrosio M, Citterio G, Rocco M, Leonardis F, Natoli S, Fontana C, Favaro M, Celeste MG, Franci T, Testore GP, Andreoni M, Sarmati L. Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals. Am J Infect Control. 2015 Nov 1;43(11):1178-83.
  176. Tchidjou HK, Vescio MF, Sanou Sobze M, Souleyman A, Stefanelli P, Mbabia A, Moussa I, Gentile B, Colizzi V, Rezza G. Low vaccine coverage among children born to HIV infected women in Niamey, Niger. Hum Vaccin Immunother. 2016 Feb;12(2):540-4.
  177. Russo G, Miglietta A, Pezzotti P, Biguioh RM, Bouting Mayaka G, Sobze MS, Stefanelli P, Vullo V, Rezza G. Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak. BMC Public Health. 2015 Jul 10;15:630.
  178. Rezza G. Do we need a vaccine against chikungunya? Pathog Glob Health. 2015 Jun;109(4):170-3.
  179. Rezza G. A vaccine against Ebola: Problems and opportunities. Hum Vaccin Immunother. 2015;11(5):1258-60.
  180. Magurano F, Zammarchi L, Baggieri M, Fortuna C, Farese A, Benedetti E, Fiorentini C, Rezza G, Nicoletti L, Bartoloni A. Chikungunya from the Caribbean: the importance of appropriate laboratory tests to confirm the diagnosis. Vector Borne Zoonotic Dis. 2015 Apr;15(4):258-60.
  181. Marinaro M, Greco G, Tarsitano E, Ventrella G, Camero M, Corrente M, Rezza G, Buonavoglia D. Changes in peripheral blood leucocytes of sheep experimentally infected with Mycoplasma agalactiae. Vet Microbiol. 2015 Feb 25;175(2-4):257-64.
  182. Rezza G. Dengue and chikungunya: long-distance spread and outbreaks in naïve areas. Pathog Glob Health. 2014 Dec;108(8):349-55.
  183. Giuliani M, Vescio MF, Latini A, Palamara G, Pimpinelli F, Dona MG, Stivali F, Carduccelli F, Ensoli F, Di Carlo A, Rezza G. Continuous increase in HIV-1 incidence after the year 2000 among men who have sex with men in Rome: insights from a 25-year retrospective cohort study. Euro Surveill. 2014 Nov 27;19(47):20969.
  184. Vescio F, Busani L, Mughini Gras L, Fazio C, Neri A, Avellis L, Rezza G, Stefanelli P. Climate, demographic factors and geographical variations in the incidence of invasive meningococcal disease in Italy. Epidemiol Infect. 2014 Oct 13:1-9. [Epub ahead of print]
  185. Puzelli S, Rossini G, Facchini M, Vaccari G, Di Trani L, Di Martino A, Gaibani P, Vocale C, Cattoli G, Bennett M, McCauley JW, Rezza G, Moro ML, Rangoni R, Finarelli AC, Landini MP, Castrucci MR, Donatelli I; Influenza Task Force. Human Infection with Highly Pathogenic A(H7N7) Avian Influenza Virus, Italy, 2013. Emerg Infect Dis. 2014 Oct;20(10):1741-5.
  186. Ciccozzi M, Lo Presti A, Cella E, Giovanetti M, Lai A, El-Sawaf G, Faggioni G, Vescio F, Al Ameri R, De Santis R, Helaly G, Pomponi A, Metwally D, Fantini M, Qadi H, Zehender G, Lista F, Rezza G. Phylogeny of Dengue and Chikungunya viruses in Al Hudayda governorate, Yemen. Infect Genet Evol. 2014 Oct;27:395-401.
  187. Ciancio BC, Rezza G. Costs and benefits of influenza vaccination: more evidence, same challenges. BMC Public Health. 2014 Aug 8;14:818.
  188. Rezza G, El-Sawaf G, Faggioni G, Vescio F, Al Ameri R, De Santis R, Helaly G, Pomponi A, Metwally D, Fantini M, Qadi H, Ciccozzi M, Lista F. Co-circulation of Dengue and Chikungunya Viruses, Al Hudaydah, Yemen, 2012. Emerg Infect Dis. 2014 Aug;20(8):1351-4.
  189. Ingrosso L, Vescio F, Giuliani M, Migliori GB, Fattorini L, Severoni S, Rezza G. Risk factors for tuberculosis in foreign-born people (FBP) in Italy: a systematic review and meta-analysis. PLoS One. 2014 Apr 14;9(4):e94728.
  190. Stefanelli P., Rezza G. Contrasting the anti-vaccine prejudice: a public health perspective. Commentary. Ann Ist Super Sanita. 2014;50(1):6-9.
  191. Grassi T, Mancini F, Ciervo A, Vescio MF, Ghazal A, Ashour H, Saleh E, El Zalabani M, Donatelli I, El Sawaf G, Rezza G. Chlamydophila pneumoniae, Mycoplasma pneumoniae, and influenza in children with respiratory infections in Alexandria, Egypt. J Infect Dev Ctries. 2014 Mar 13;8(3):379-83.
  192. Toma L, Mancini F, Di Luca M, Cecere JG, Bianchi R, Khoury C, Quarchioni E, Manzia F, Rezza G, Ciervo A. Detection of microbial agents in ticks collected from migratory birds in central Italy. Vector Borne Zoonotic Dis. 2014 Mar;14(3):199-205.
  193. Platonov AE, Tolpin VA, Gridneva KA, Titkov AV, Platonova OV, Kolyasnikova NM, Busani L, Rezza G. The incidence of West Nile disease in Russia in relation to climatic and environmental factors. Int J Environ Res Public Health. 2014 Jan 23;11(2):1211-32.
  194. Mazzoni E, Gerosa M, Lupidi F, Corallini A, Taronna AP, D'Agostino A, Bovenzi M, Ruggeri G, Casali F, Rotondo JC, Rezza G, Barbanti-Brodano G, Tognon M, Martini F. Significant prevalence of antibodies reacting with simian virus 40 mimotopes in sera from patients affected by glioblastoma multiforme. Neuro Oncol. 2014 Apr;16(4):513-9.
  195. Barzon L, Pacenti M, Franchin E, Pagni S, Lavezzo E, Squarzon L, Martello T, Russo F, Nicoletti L, Rezza G, Castilletti C, Capobianchi MR, Salcuni P, Cattai M, Cusinato R, Palù G. Large human outbreak of West Nile virus infection in north-eastern Italy in 2012. Viruses. 2013 Nov 22;5(11):2825-39.
  196. Karan LS, Ciccozzi M, Yakimenko VV, Lo Presti A, Cella E, Zehender G, Rezza G, Platonov AE. The deduced evolution history of Omsk hemorrhagic fever virus. J Med Virol. 2014 Jul;86(7):1181-7.
  197. Zehender G, Ebranati E, Shkjezi R, Papa A, Luzzago C, Gabanelli E, Lo Presti A, Lai A, Rezza G, Galli M, Bino S, Ciccozzi M. Bayesian phylogeography of Crimean-Congo hemorrhagic fever virus in Europe. PLoS One. 2013 Nov 4;8(11):e79663.
  198. Mughini-Gras L, Mulatti P, Severini F, Boccolini D, Romi R, Bongiorno G, Khoury C, Bianchi R, Montarsi F, Patregnani T, Bonfanti L, Rezza G, Capelli G, Busani L. Ecological Niche Modelling of Potential West Nile Virus Vector Mosquito Species and Their Geographical Association with Equine Epizootics in Italy. Ecohealth. 2013 Oct 12. [Epub ahead of print].
  199. de Souza SM, Teles SA, Rezza G, Pezzotti P, Gir E. Epidemiology of HIV Infection in Central Brazil: Data From Voluntary Counseling and Testing Centers. J Assoc Nurses AIDS Care. 2013 Feb 25. [Epub ahead of print].
  200. Mazzoni E, Tognon M, Martini F, Taronna A, Corallini A, Barbanti-Brodano G, Guerra G, Carandina G, Casali F, Rezza G, Pizzo G, Valdarchi C. Simian virus 40 (SV40) antibodies in elderly subjects. J Infect. 2013;67(4):356-8.
  201. Puzelli S, Azzi A, Santini M, Di Martino A, Facchini M, Castrucci M, Meola M, Arvia R, Corcioli F, Pierucci F, Baretti S, Bartoloni A, Bartolozzi D, de Martino M, Galli L, Pompa M, Rezza G, Balocchini E, Donatelli I. Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. Euro Surveill. 2013;18(34).
  202. Ciccozzi M, Peletto S, Cella E, Giovanetti M, Lai A, Gabanelli E, Acutis PL, Modesto P, Rezza G, Platonov AE, Lo Presti A, Zehender G. Epidemiological history and phylogeography of West Nile virus lineage 2. Infect Genet Evol. 2013;17:46-50.
  203. Martini F, Mazzoni E, Corallini A, Taronna A, Querzoli P, Magri E, Marci R, Dolcetti R, Rezza G, Barbanti-Brodano G, Tognon M. Breast cancer and simian virus 40 infection. Epidemiology. 2013;24(3):464-5.
  204. Taronna A, Mazzoni E, Corallini A, Bononi I, Pietrobon S, Guerra G, Palmonari C, Borgna-Pignatti C, Comar M, Bovenzi M, Casali F, Marci R, Rezza G, Barbanti-Brodano G, Tognon M, Martini F. Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents. PLoS One. 2013;8(4):e61182.
  205. Ippolito G, Rezza G. HIV treatment as prevention: population effect vs. individual protection? Ann Ig. 2013;25(2):93-7.
  206. Vescio FM, Busani L, Mughini-Gras L, Khoury C, Avellis L, Taseva E, Rezza G, Christova I. Environmental correlates of Crimean-Congo haemorrhagic fever incidence in Bulgaria. BMC Public Health. 2012;12:1116.
  207. Magurano F, Remoli ME, Baggieri M, Fortuna C, Marchi A, Fiorentini C, Bucci P, Benedetti E, Ciufolini MG, Rizzo C, Piga S, Salcuni P, Rezza G, Nicoletti L. Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy. Clin Microbiol Infect. 2012;18(12):E545-7.
  208. Rezza G, Boccolini D, Menegon M, Romi R. Reply: Probable imported rather than autochthonous Plasmodium vivax cases in Italy. Eurosurveillance. 2012;17 (50):6.
  209. Romi R, Boccolini D, Menegon M, Rezza G. Probable autochthonous introduced malaria cases in Italy in 2009-2011 and the risk of local vector-borne transmission. Euro Surveill. 2012;17(48):4.
  210. Faggioni G, Pomponi A, De Santis R, Masuelli L, Ciammaruconi A, Monaco F, Di Gennaro A, Marzocchella L, Sambri V, Lelli R, Rezza G, Bei R, Lista F. West Nile alternative open reading frame (N-NS4B/WARF4) is produced in infected West Nile Virus (WNV) cells and induces humoral response in WNV infected individuals. Virol J. 2012;9:283.
  211. Mazzoni E, Corallini A, Cristaudo A, Taronna A, Tassi G, Manfrini M, Comar M, Bovenzi M, Guaschino R, Vaniglia F, Magnani C, Casali F, Rezza G, Barbanti-Brodano G, Martini F, Tognon MG. High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma. Proc Natl Acad Sci USA. 2012;109(44):18066-71.
  212. Tchidjou HK, Vescio F, Avellis L, Aquilani A, Santilli V, Mora N, Pontrelli G, Palma P, Martino AM, Bernardi S, Rossi P, Rezza G. An atypical case of multifocal infantile haemangioma in a child after Highly Active Antiretroviral Therapy (HAART) during pregnancy. Clin Neurol Neurosurg. 2012;114(8):1161-3.
  213. Marinaro M, Tempesta M, Tarsitano E, Camero M, Losurdo M, Buonavoglia C, Rezza G. Antigen-specific IFN-gamma and IL-4 production in caprine herpesvirus infected goats. Res Vet Sci. 2012;93(2):662-7.
  214. Marinaro M, Rezza G, Del Giudice G, Colao V, Tarsitano E, Camero M, Losurdo M, Buonavoglia C, Tempesta M. A Caprine Herpesvirus 1 Vaccine Adjuvanted with MF59TM Protects against Vaginal Infection and Interferes with the Establishment of Latency in Goats. PLosONE 2012; 7(4):1.
  215. Platonov A, Rossi G, Karan L, Mironov K, Busani L, Rezza G. Does the Japanese encephalitis virus (JEV) represent a threat for human health in Europe? Detection of JEV RNA sequences in birds collected in Italy. Euro Surveill. 2012;17(32):4.
  216. Rizzo C, Salcuni P, Nicoletti L, Ciufolini MG, Russo F, Masala R, Frongia O, Finarelli AC, Gramegna M, Gallo L, Pompa MG, Rezza G, Salmaso S, Declich S. Epidemiological surveillance of West Nile neuroinvasive diseases in Italy, 2008 to 2011. Euro Surveill. 2012;17(20):3.
  217. Corallini A, Mazzoni E, Taronna A, Manfrini M, Carandina G, Guerra G, Guaschino R, Vaniglia F, Magnani C, Casali F, Dolcetti R, Palmonari C, Rezza G, Martini F, Barbanti-Brodano G, Tognon MG. Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors. Hum Immunol. 2012;73(5):502-10.
  218. Madeddu G, Mancini F, Caddeo A, Ciervo A, Babudieri S, Maida I, Fiori ML, Rezza G, Mura MS. Rickettsia monacensis as cause of Mediterranean spotted fever-like illness, Italy. Emerg Infect Dis. 2012;18(4):702-4.
  219. Lo Presti A, Ciccozzi M, Cella E, Lai A, Simonetti FR, Galli M, Zehender G, Rezza G. Origin, evolution, and phylogeography of recent epidemic CHIKV strains. Infect Genet Evol. 2012;12(2):392-8.
  220. Rezza G. Aedes albopictus and the reemergence of Dengue. BMC Public Health. 2012;12:72.
  221. Ingrosso L, Rezza G, Pocchiari M, Garaci E. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità. Ann Ist Super Sanita. 2012;48(2):115-6.
  222. Balestrieri E, Arpino C, Matteucci C, Sorrentino R, Pica F, Alessandrelli R, Coniglio A, Curatolo P, Rezza G, Macciardi F, Garaci E, Gaudi S, Sinibaldi-Vallebona P. HERVs expression in Autism Spectrum Disorders. PLoS One. 2012;7(11):e48831.
  223. Marinaro M, Rezza G, Del Giudice G, Colao V, Tarsitano E, Camero M, Losurdo M, Buonavoglia C, Tempesta M. A caprine herpesvirus 1 vaccine adjuvanted with MF59™ protects against vaginal infection and interferes with the establishment of latency in goats. PLoS One. 2012;7(4):e34913.
  224.  Colucci A, Balzano R, Camoni L, Regine V, Longo B, Pezzotti P, Starace F, Cafaro L, Aloisi MS, Suligoi B, Rezza G, Girardi E. Characteristics and behaviors in a sample of patients unaware of their infection until AIDS diagnosis in Italy: a cross-sectional study. AIDS Care. 2011;23(9):1067-75.
  225.  Venturi G, Marchi A, Fiorentini C, Ramadani N, Quaglio G, Kalaveshi A, Bertinato L, Putoto G, Benedetti E, Rezza G, Ciufolini MG. Prevalence of antibodies to phleboviruses and flaviviruses in Peja, Kosovo. Clin Microbiol Infect. 2011;17(8):1180-2.
  226.  Giuliani M, Tumbarello M, Marino M, Capodiferro S, Scivetti M, Rezza G, Cauda R, Lajolo C. Dental hygienists behaviour towards HIV-positive patients in highly active antiretroviral therapy era: a pilot survey. Int J Dent Hyg. 2011;9(3):204-10.
  227. Ciccozzi M, Ciccaglione AR, Lo Presti A, Yalcinkaya T, Taskan ZP, Equestre M, Costantino A, Bruni R, Ebranati E, Salemi M, Gray R, Rezza G, Galli M, Zehender G. Reconstruction of the evolutionary dynamics of the hepatitis C virus 1b epidemic in Turkey. Infect Genet Evol. 2011;11(5):863-8.
  228. Babudieri S, Dorrucci M, Boschini A, Carbonara S, Longo B, Monarca R, Ortu F, Congedo P, Soddu A, Maida IR, Caselli F, Madeddu G, Rezza G. Targeting candidates for directly administered highly active antiretroviral therapy: benefits observed in HIV-infected injecting drug users in residential drug-rehabilitation facilities. AIDS Patient Care STDS. 2011;25(6):359-64.
  229. Mussini C, Cossarizza A, Sabin C, Babiker A, De Luca A, Bucher HC, Fisher M, Rezza G, Porter K, Dorrucci M; CASCADE Collaboration. Decline of CD4 T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals. AIDS. 2011;25(8):1041-9.
  230. Camoni L, Federico B, Capelli G, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B; SERT Study Group. Few Italian drug users undergo HIV testing. AIDS Behav. 2011;15(4):711-7.
  231. Ciccozzi M, Lo Presti A, Cenci A, Staltari O, Buttò S, Equestre M, Ciccaglione AR, Caroleo B, Rezza G, Guadagnino V. May phylogenetic analysis support epidemiological investigation in identifying the source of HIV infection? AIDS Res Hum Retroviruses. 2011;27(5):455-7.
  232. Zehender G, Ebranati E, Bernini F, Lo Presti A, Rezza G, Delogu M, Galli M, Ciccozzi M. Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin. Infect Genet Evol. 2011;11(3):646-53.
  233. Madeddu G, Rezza G, Fois AG, Naitana AG, Piredda G, Pirina P, Mura MS.Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection. Int J STD AIDS. 2011;22(4):234-5.
  234. Pezzotti P, Piovesan C, Barzon L, Cusinato R, Cattai M, Pacenti M, Piazza A, Franchin E, Pagni S, Bressan S, Martello T, Potenza R, Scipioni C, Ammendola R, Breda A, Palu G, Russo F, Rezza G. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009. Euro Surveill. 2011;16(10):3.
  235. Bassetti M, Parisini A, Calzi A, Pallavicini FM, Cassola G, Artioli S, Anselmo M, Pagano G, Rezza G, Viscoli, Ligurian H1N1 Collaborative Group. Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. Clin Microbiol Infect. 2011;17(2):247-50.
  236. Palombi L, Dorrucci M, Zimba I, Scarcella P, Mancinelli S, Buonomo E, Guidotti G, Marazzi MC, Rezza G. Immunologic response to highly active antiretroviral therapy and mortality reduction in a cohort of human immunodeficiency virus-positive persons in Mozambique. Am J Trop Med Hyg. 2010;83(5):1128-32.
  237. Zucchetto A, Suligoi B, De Paoli A, Pennazza S, Polesel J, Bruzzone S, Rezza G, De Paoli P, Dal Maso L, Serraino D. Excess mortality for non–AIDS-defining cancers among people with AIDS. Clin Infect Dis. 2010;51(9):1099-101.
  238.  Puzelli S, Facchini M, De Marco MA, Palmieri A, Spagnolo D, Boros S, Corcioli F, Trotta D, Bagnarelli P, Azzi A, Cassone A, Rezza G, Pompa MG, Oleari F, Donatelli I; Influnet Surveillance Group for Pandemic A(H1N1) 2009 Influenza Virus in Italy. Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. Euro Surveill. 2010;15(43):2.
  239.  Tchidjou HK, Vescio F, Boros S, Guemkam G, Minka E, Lobe M, Cappelli G, Colizzi V, Tietche F, Rezza G. Seasonal pattern of hospitalization from acute respiratory infections in Yaoundé, Cameroon. J Trop Pediatr. 2010;56(5):317-20.
  240.  Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Angelini P, Macini P; Chikungunya Study Group. Knowledge, attitudes and practices survey after an outbreak of chikungunya infections. Int Health. 2010;2(3):223-7.
  241.  Marinaro M, Mari V, Bellacicco AL, Tarsitano E, Elia G, Losurdo M, Rezza G, Buonavoglia C, Decaro N. Prolonged depletion of circulating CD4+ T lymphocytes and acute monocytosis after pantropic canine coronavirus infection in dogs. Virus Res. 2010;152(1-2):73-8.
  242.  Ciccaglione AR, Miceli M, Pisani G, Bruni R, Iudicone P, Costantino A, Equestre M, Tritarelli E, Marcantonio C, Tataseo P, Marazzi MC, Ceffa S, Paturzo G, Altan AM, San Lio MM, Mancinelli S, Ciccozzi M, Lo Presti A, Rezza G, Palombi L. Improving HIV-2 detection by a combination of serological and nucleic acid amplification test assays. J Clin Microbiol. 2010 Aug;48(8):2902-8.
  243. Arpino C, Sinibaldi Vallebona P, Gaudi S, Rezza G. Polyomaviruses and autism: more than simple association? J Neurovirol. 2010;16(4):330-1.
  244. Serraino D, De Paoli A, Zucchetto A, Pennazza S, Bruzzone S, Spina M, De Paoli P, Rezza G, Dal Maso L, Suligoi B. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era. Cancer Epidemiol. 2010;34(3):257-61.
  245. Puzelli S, Buonaguro FM, Facchini M, Palmieri A, Calzoletti L, De Marco MA, Arace P, de Campora E, Esposito C, Cassone A, Rezza G, Donatelli I; Surveillance Group for Pandemic H1N1 2009 Influenza Virus in Italy; Campania H1N1 Task Force. Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus. Clin Microbiol. 2010;48(6):2298-300.
  246. Serraino D, Bruzzone S, Zucchetto A, Suligoi B, De Paoli A, Pennazza S, Camoni L, Dal Maso L, De Paoli P, Rezza G. Elevated risks of death for diabetes mellitus and cardiovascular diseases in Italian AIDS cases. AIDS Res Ther. 2010;7:11.
  247. Puzelli S, Facchini M, Spagnolo D, De Marco MA, Calzoletti L, Zanetti A, Fumagalli R, Tanzi ML, Cassone A, Rezza G, Donatelli I; Surveillance Group for Pandemic A H1N1 2009 Influenza Virus in Italy. Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis. 2010;16(5):863-5.
  248. Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Spataro N, Pierro AM, Seyler T, Macini P; Chikungunya Study Group. Chikungunya virus in North-Eastern Italy: a seroprevalence survey. Am J Trop Med Hyg. 2010;82(3):508-11.
  249. Riva C, Lai A, Caramma I, Corvasce S, Violin M, Dehò L, Prati F, Rossi C, Colombo MC, Capetti A, Franzetti M, Rossini V, Tambussi G, Ciccozzi M, Suligoi B, Mussini C, Rezza G, Balotta C. Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy. AIDS Res Hum Retroviruses. 2010;26(1):41-9.
  250.  Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B; SerT Study Group. Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy. Ann Ist Super Sanita. 2010;46(1):59-65.
  251.  Rezza G. Laboratory diagnosis of HIV infection and access to HIV testing in Italy. Preface. Ann Ist Super Sanita. 2010;46(1):3.
  252.  Quaglio GL, Pattaro C, Ramadani N, Bertinato L, Elezi Y, Dentico P, Volpe A, Ciotti M, Rezza G, Putoto G. Viral hepatitis, HIV, human herpes virus and Treponema pallidum infection in haemodialysis patients from Kosovo, 2005. Euro Surveill. 2009 Dec 10;14(49): 19439.
  253. Rezza G. Swine-origin influenza virus A(H1N1)v: lessons learnt from the early phase of the epidemic. Eur J Public Health. 2009;19(6):572-3.
  254. Puzelli S, Valdarchi C, Ciotti M, Dorrucci M, Farchi F, Babakir-Mina M, Perno CF, Donatelli I, Rezza G; Italian ARI Study Group. Viral causes of influenza-like illness: Insight from a study during the winters 2004-2007. J Med Virol. 2009;81(12):2066-71.
  255. Rizzo C, Vescio F, Declich S, Finarelli AC, Macini P, Mattivi A, Rossini G, Piovesan C, Barzon L, Palù G, Gobbi F, Macchi L, Pavan A, Magurano F, Ciufolini MG, Nicoletti L, Salmaso S, Rezza G. West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill. 2009;14(40):2.
  256. Serraino D, Zucchetto A, Suligoi B, Bruzzone S, Camoni L, Boros S, De Paoli A, Dal Maso L, Franceschi S, Rezza G. Survival after AIDS diagnosis in Italy, 1999-2006: a population-based study. J Acquir Immune Defic Syndr. 2009;52(1):99-105.
  257. Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai MR, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-Ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suárez-Rincón AE, Szarka K, Tachezy R, Ueda M, van der Zee AG, von Knebel Doeberitz M, Wu MT, Yamashita T, Zehbe I, Blettner M. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 2009;10(8):772-84.
  258. Zucchetto A, Bruzzone S, De Paoli A, Regine V, Pappagallo M, Dal Maso L, Serraino D, Rezza G, Suligoi B. AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era. Epidemiol Prev. 2009;33(4-5):184-9.
  259. Zehender G, Bernini F, Delogu M, Cusi MG, Rezza G, Galli M, Ciccozzi M. Bayesian skyline plot inference of the Toscana virus epidemic: a decline in the effective number of infections over the last 30 years. Infect Genet Evol. 2009;9(4):562-6.
  260. Christova I, Di Caro A, Papa A, Castilletti C, Andonova L, Kalvatchev N, Papadimitriou E, Carletti F, Mohareb E, Capobianchi MR, Ippolito G, Rezza G. Crimean-Congo hemorrhagic fever, southwestern Bulgaria. Emerg Infect Dis. 2009;15(6):983-5.
  261. Rezza G. Chikungunya and West Nile virus outbreaks: what is happening in north-eastern Italy? Eur J Public Health. 2009;19(3):236-7.
  262. Giuliani M, Lajolo C, Sartorio A, Lacaita MG, Capodiferro S, Cauda R, Rezza G, Tumbarello M. Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Med Sci Monit. 2009;15(6):PH49-56.
  263. Arpino C, Curatolo P, Rezza G. Chikungunya and the nervous system: what we do and do not know. Rev Med Virol. 2009;19(3):121-9.
  264. Giuliani M, Montieri S, Palamara G, Latini A, Alteri C, Perno CF, Santoro MM, Rezza G, Ciccozzi M. Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy. AIDS Res Hum Retroviruses. 2009;25(2):157-64.
  265. Russo G, Pasquali P, Nenova R, Alexandrov T, Ralchev S, Vullo V, Rezza G, Kantardjiev T. Reemergence of human and animal brucellosis, Bulgaria. Emerg Infect Dis. 2009;15(2):314-6.
  266. Madeddu G, Rezza G, Mura MS. Trends in the European HIV/AIDS epidemic: a perspective from Italy. Expert Rev Anti Infect Ther. 2009;7(1):25-36.
  267. Panaiotov S, Ciccozzi M, Brankova N, Levterova V, Mitova-Tiholova M, Amicosante M, Rezza G, Kantardjiev T. An outbreak of Q fever in Bulgaria. Ann Ist Super Sanita. 2009;45(1):83-6.
  268. Vescio MF, Brookes ST, Sterne J, Moore L, Rezza G, Smith GD. Mortality at ages 50-59 and deprivation at early and late stages of the life course in Wales. J Epidemiol Community Health. 2009;63(1):56-63.
  269. Serraino D, Piselli P, Immunosuppression and Cancer Study Group. Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups. Methods Mol Biol. 2009;471:409-19.
  270. Suligoi B, Quaglio G, Regine V, Ramadani N, Bertinato L, Cami A, Dentico P, Volpe A, Figliomeni M, Camoni L, Putoto G, Rezza G. Seroprevalence of HIV, HSV-2, and Treponema pallidum in the Kosovarian population. Scand J Infect Dis. 2009;41(8):608-13.
  271. Venturi G, El-Sawaf G, Arpino C, Madeddu G, Fiorentini C, Benedetti E, Marchi A, Helaly G, El Ghazouly K, Ghazal A, Farchi F, Soddu A, Cacciatore D, El Zalabani M, Mura MS, Rezza G, Ciufolini MG. Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis. Scand J Infect Dis. 2009;41(11-12):898-9.
  272. Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B; Sert Study Group. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study. Scand J Infect Dis. 2009;41(6-7):520-3.
  273. Giuliani M, Montieri S, Palamara G, Latini A, Alteri C, Perno CF, Santoro MM, Rezza G, Ciccozzi M.  Non-B HIV Type 1 Subtypes among Men Who Have Sex with Men in Rome, Italy. AIDS Research and Human Retroviruses 2009; 25:1-8.
  274. Babakir-Mina M, Ciccozzi M, Dimonte S, Farchi F, Valdarchi C, Rezza G, Perno CF, Ciotti M. Identification of the novel KI polyomavirus in the respiratory tract of an Italian patient. J Med Virol. 2008;80(11):2012-4.
  275. Longo B, Novati S, Montieri S, Pontali E, Taglia F, Leo G, Babudieri S, Starnini G, Monarca R, Suligoi B, Rezza G, Ciccozzi M; Italian Study Group on HIV in Prison. HIV-1 diversity among inmates of Italian prisons. J Med Virol. 2008;80(10):1689-94.
  276. Santoro MM, Ciccozzi M, Alteri C, Montieri S, Alexiev I, Dimova I, Ceccherini-Silberstein F, Beshkov D, Rezza G, Perno CF. Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria. AIDS Res Hum Retroviruses. 2008;24(9):1133-8.
  277. Salemi M, Goodenow MM, Montieri S, de Oliveira T, Santoro MM, Beshkov D, Alexiev I, Elenkov I, Elenkov I, Yakimova T, Varleva T, Rezza G, Ciccozzi M. The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. AIDS Res Hum Retroviruses. 2008;24(6):771-9.
  278. Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, Pellizzer G, Berisha A, Smacchia C, Figliomeni M, Schinaia N, Rezza G, Putoto G. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol. 2008;80(5):833-40.
  279. Suligoi B, Buttò S, Galli C, Bernasconi D, Salata RA, Tavoschi L, Chiappi M, Mugyenyi P, Pimpinelli F, Kityo C, Regine V, Rezza G. Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity. J Clin Virol. 2008;41(4):288-92.
  280. Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R.Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health. 2008;62(4):305-13.
  281. Vescio MF, Piras MA, Ciccozzi M, Carai A, Farchi F, Maroli M, Mura MS, Rezza G; MSF Study Group. Socio-demographic and climatic factors as correlates of Mediterranean spotted fever (MSF) in northern Sardinia. Am J Trop Med Hyg. 2008;78(2):318-20.
  282. Salemi M, de Oliveira T, Ciccozzi M, Rezza G, Goodenow MM. High-resolution molecular epidemiology and evolutionary history of HIV-1 subtypes in Albania. PLoS One. 2008;3(1):e1390.
  283. Rezza G. Re-emergence of Chikungunya and other scourges: the role of globalization and climate change. Ann Ist Super Sanita. 2008;44(4):315-8.
  284. Nicoletti L, Ciccozzi M, Marchi A, Fiorentini C, Martucci P, D'Ancona F, Ciofi degli Atti M, Pompa MG, Rezza G, Ciufolini MG. Chikungunya and Dengue viruses in travelers. Emerg Infect Dis. 2008;14(1):177-8.
  285. Casolari S, Briganti E, Zanotti M, Zauli T, Nicoletti L, Magurano F, Fortuna C, Fiorentini C, Grazia Ciufolini M, Rezza G. A fatal case of encephalitis associated with Chikungunya virus infection. Scand J Infect Dis. 2008;40(11-12):995-6.
  286. Valdarchi C, Farchi F, Dorrucci M, De Michetti F, Paparella C, Babudieri S, Spano A, Starnini G, Rezza G. Epidemiological investigation of a varicella outbreak in an Italian prison. Scand J Infect Dis. 2008;40(11-12):943-5.
  287. Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007;43(14):2117-23.
  288. Giuliani M, Cordiali-Fei P, Castilletti C, Di Carlo A, Palamara G, Boros S, Rezza G. Incidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections. BMC Infect Dis. 2007;7:143.
  289. Montieri S, Puzelli S, Ciccozzi M, Calzoletti L, Di Martino A, Milia MG, Rossi A, Piro F, Rezza G, Donatelli I. Amino acid changes in the attachment G glycoprotein of human respiratory syncytial viruses (subgroup A) isolated in Italy over several epidemics (1997-2006). J Med Virol. 2007;79(12):1935-42.
  290. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A; CHIKV study group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007;370(9602):1840-6.
  291. Angelini R, Finarelli AC, Angelini P, Po C, Petropulacos K, Silvi G, Macini P, Fortuna C, Venturi G, Magurano F, Fiorentini C, Marchi A, Benedetti E, Bucci P, Boros S, Romi R, Majori G, Ciufolini MG, Nicoletti L, Rezza G, Cassone A. Chikungunya in north-eastern Italy: a summing up of the outbreak. Euro Surveill. 2007;12(11):E071122.2.
  292. D'Arrigo R, Ciccozzi M, Gori C, Montieri S, Aquaro S, Bellagamba R, Boumis E, Di Perri G, Pizzi D, Antinori A, Rezza G, Perno CF. gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure. AIDS Res Hum Retroviruses. 2007;23(10):1296-302.
  293. Angelini R, Finarelli AC, Angelini P, Po C, Petropulacos K, Macini P, Fiorentini C, Fortuna C, Venturi G, Romi R, Majori G, Nicoletti L, Rezza G, Cassone A. An outbreak of chikungunya fever in the province of Ravenna, Italy. Euro Surveill. 2007;12(9):E070906.1.
  294. Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S; Immunosuppression and Cancer Study Group. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer. 2007;43(14):2117-23.
  295. Venturi G, Madeddu G, Rezza G, Ciccozzi M, Pettinato ML, Cilliano M, Fiorentini C, Mura MS, Ciufolini MG. Detection of Toscana virus central nervous system infections in Sardinia Island, Italy. J Clin Virol. 2007;40(1):90-1.
  296. Rezza G. Prevention and control of emerging infections: a challenge for the 3rd millennium. New Microbiol. 2007;30(3):358-61.
  297. Ciccozzi M, Montieri S, Salemi M, De Oliveira T, Dorrucci M, Sinicco A, De Luca A, Giuliani M, Balotta C, Rezza G. An outbreak of HIV-1 subtype G among Italian injecting drug users. AIDS. 2007;21(9):1213-5.
  298. Venturi G, Ciccozzi M, Montieri S, Bartoloni A, Francisci D, Nicoletti L, Fortuna C, Marongiu L, Rezza G, Ciufolini MG. Genetic variability of the M genome segment of clinical and environmental Toscana virus strains. J Gen Virol. 2007;88(Pt 4):1288-94.
  299. Ciccozzi M, Montieri S, Facchini M, Rezza G, Donatelli I, Campitelli L. Evolutionary analysis of HA and NS1 genes of H5N1 influenza viruses in 2004-2005 epidemics. Avian Dis. 2007;51(1 Suppl):455-60.
  300. Dorrucci M, Rezza G, Porter K, Phillips A; Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration. Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. J Infect Dis. 2007;195(4):525-34.
  301. Valdarchi C, Serraino D, Cordiali Fei P, Castilletti C, Trento E, Farchi F, Rezza G; General Practitioner Study Group. Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy. Infection. 2007;35(1):22-5.
  302. Madeddu G, Calia GM, Lovigu C, Mannazzu M, Maida I, Babudieri S, Campus ML, Rezza G, Mura MS. The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women. Infection. 2007;35(1):19-21.
  303. Sarmati L, Babudieri S, Longo B, Starnini G, Carbonara S, Monarca R, Buonomini AR, Dori L, Rezza G, Andreoni M; Gruppo di Lavoro Infettivologi Penitenziari (GLIP). Human herpesvirus 8 and human herpesvirus 2 infections in prison population. J Med Virol. 2007;79(2):167-73.
  304. Spizzichino L, Pedone G, Gattari P, Luzi AM, Gallo P, Valli R, Rezza G. The female condom: knowledge, attitude,and willingness to use. The first Italian study. Ann Ist Super Sanita. 2007;43(4):419-24.
  305. Longo B, Pantosti A, Luzzi I, Tarasi A, Di Sora F, Gallo S, Placanica P, Monaco M, Dionisi AM, Volpe I, Montella F, Cassone A, Rezza G. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit. Ann Ist Super Sanita. 2007;43(1):83-8.
  306. de Oliveira T, Pybus OG, Rambaut A, Salemi M, Cassol S, Ciccozzi M, Rezza G, Gattinara GC, D'Arrigo R, Amicosante M, Perrin L, Colizzi V, Perno CF; Benghazi Study Group. Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature. 2006;444(7121):836-7.
  307. Franceschi S, Dal Maso L, Suligoi B, Rezza G. Evidence for lack of cervical cancer screening among HIV-positive women in Italy. Eur J Cancer Prev. 2006;15(6):554-6.
  308. Rezza G. The principle of precaution-based prevention: a Popperian paradox? Eur J Public Health. 2006;16(6):576-7.
  309. Nicoletti G, Schito G, Fadda G, Boros S, Nicolosi D, Marchese A, Spanu T, Pantosti A, Monaco M, Rezza G, Cassone A, Garaci E; CIGAR (Gruppo Cooperativo Infezioni Gravi ed Antibiotico Resistenza). Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting. J Chemother. 2006 Dec;18(6):589-602. Erratum in: J Chemother. 2007;19(5):602-3.
  310. Busnach G, Piselli P, Arbustini E, Baccarani U, Burra P, Carrieri MP, Citterio F, De Juli E, Bellelli S, Pradier C, Rezza G, Serraino D; Immunosuppression and Cancer Study Group. Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc. 2006;38(10):3533-5.
  311. Longo B, Pantosti A, Luzzi I, Placanica P, Gallo S, Tarasi A, Di Sora F, Monaco M, Dionisi AM, Volpe I, Montella F, Cassone A, Rezza G. An outbreak of Acinetobacter baumannii in an intensive care unit: epidemiological and molecular findings. J Hosp Infect. 2006;64(3):303-5.
  312. Naderi HR, Tagliamonte M, Tornesello ML, Ciccozzi M, Rezza G, Farid R, Buonaguro FM, Buonaguro L. Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran. Infect Agent Cancer. 2006;1:4.
  313. Boschini A, Longo B, Caselli F, Begnini M, De Maria C, Ansaldi F, Durando P, Icardi G, Rezza G. An outbreak of influenza in a residential drug-rehabilitation community. J Med Virol. 2006;78(9):1218-22.
  314. Puzelli S, Boros S, Affinito C, Calzoletti L, Facchini M, Danaya RT, Owen IL, Pozio E, Rezza G, Donatelli I. Prevalence of antibodies against A and B influenza viruses in South-Western Papua New Guinea. J Med Virol. 2006;78(6):820-4.
  315. Brown EE, Fallin D, Ruczinski I, Hutchinson A, Staats B, Vitale F, Lauria C, Serraino D, Rezza G, Mbisa G, Whitby D, Messina A, Goedert JJ, Chanock SJ. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer Epidemiol Biomarkers Prev. 2006;15(5):926-34.
  316. Campitelli L, Ciccozzi M, Salemi M, Taglia F, Boros S, Donatelli I, Rezza G. H5N1 influenza virus evolution: a comparison of different epidemics in birds and humans (1997-2004). J Gen Virol. 2006;87(Pt 4):955-60.
  317. Serraino D, Cerimele D, Piselli P, Aztori L, Farchi F, Carletti F, Navarra A, Masala MV, Rezza G. Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia. Infection. 2006;34(1):39-42.
  318. Pillay D, Bhaskaran K, Jurriaans S, Prins M, Masquelier B, Dabis F, Gifford R, Nielsen C, Pedersen C, Balotta C, Rezza G, Ortiz M, de Mendoza C, Kücherer C, Poggensee G, Gill J, Porter K, CASCADE Virology Collaboration. The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS. 2006;20(1):21-8.
  319. Starace F, Wagner TM, Luzi AM, Cafaro L, Gallo P, Rezza G. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. AIDS Care. 2006;18(1):66-72.
  320. Madeddu G, Calia GM, Lovigu C, Mannazzu M, Maida I, Babudieri S, Rezza G, Mura MS. The HIV/AIDS epidemic in the Province of Sassari in the combination antiretroviral therapy era. Ann Ist Super Sanita. 2006;42(2):197-202.
  321. Rezza G, Valdarchi C, Puzelli S, Ciotti M, Farchi F, Fabiani C, Calzoletti L, Donatelli I, Perno CF. Respiratory viruses and influenza-like illness: a survey in the area of Rome, winter 2004-2005. Euro Surveill. 2006;11(10):251-3.
  322. Serraino D, Cerimele D, Piselli P, Aztori C, Farchi F, Carletti F, Navarra A, Masala MV, Rezza G. Infection with Human Herpesvirus Type 8 and Kaposi’s Sarcoma in Sardinia. Infection 2006; 34:1-4.
  323. Serraino D, Angeletti C, Carrieri MP, Longo B, Piche M, Piselli P, Arbustini E, Burra P, Citterio F, Colombo V, Fuzibet JG, Dal Bello B, Targhetta S, Grasso M, Pozzetto U, Bellelli S, Dorrucci M, Dal Maso L, Busnach G, Pradier C, Rezza G; Immunesuppression and Cancer Study Group. Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation. 2005;80(12):1699-704.
  324. Giuliani M, Lajolo C, Rezza G, Arici C, Babudieri S, Grima P, Martinelli C, Tamburrini E, Vecchiet J, Mura MS, Cauda R, Mario T; BSAHOD study group. Dental care and HIV-infected individuals: are they equally treated? Community Dent Oral Epidemiol. 2005;33(6):447-53.
  325. Spada E, Genovese D, Tosti ME, Mariano A, Cuccuini M, Proietti L, Giuli CD, Lavagna A, Crapa GE, Morace G, Taffon S, Mele A, Rezza G, Rapicetta M. An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users. J Hepatol. 2005;43(6):958-64.
  326. Longo B, Pezzotti P, Boros S, Urciuoli R, Rezza G. Increasing proportion of late testers among AIDS cases in Italy, 1996-2002. AIDS Care. 2005;17(7):834-41.
  327. Giuliani M, Di Carlo A, Palamara G, Dorrucci M, Latini A, Prignano G, Stivali F, Rezza G. Increased HIV incidence among men who have sex with men in Rome. AIDS. 200519(13):1429-31.
  328. Ciccozzi M, Gori C, Boros S, Ruiz-Alvarez MJ, Harxhi A, Dervishi M, Qyra S, Schinaia N, D'Arrigo R, Ceccherini-Silberstein F, Bino S, Perno CF, Rezza G. Harxhi A, Pilaca A, Delia Z, Pano K, Rezza G. Crimean-Congo hemorrhagic fever: a case of nosocomial transmission. Infection. 2005 Aug;33(4):295-6. Molecular diversity of HIV in Albania. J Infect Dis. 2005;192(3):475-9.
  329. Tanzi E, Zappa A, Caramaschi F, Amendola A, Lasagna D, Gatti L, Ascoli V, Rezza G, Zanetti AR. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma. J Med Virol. 2005;76(4):571-5.
  330. Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005;76(3):311-7.
  331. Carbonara S, Babudieri S, Longo B, Starnini G, Monarca R, Brunetti B, Andreoni M, Pastore G, De Marco V, Rezza G; GLIP (Gruppo di Lavoro Infettivologi Penitenziari). Correlates of Mycobacterium tuberculosis infection in a prison population. Eur Respir J. 2005;25(6):1070-6.
  332. Rezza G, Fiorelli V, Dorrucci M, Ciccozzi M, Tripiciano A, Scoglio A, Collacchi B, Ruiz-Alvarez M, Giannetto C, Caputo A, Tomasoni L, Castelli F, Sciandra M, Sinicco A, Ensoli F, Buttò S, Ensoli B. The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters. J Infect Dis. 2005;191(8):1321-4.
  333. Starnini G, Caccamo F, Farchi F, Babudieri S, Brunetti B, Rezza G. An outbreak of Q fever in a prison in Italy. Epidemiol Infect. 2005 Apr;133(2):377-80.
  334. Dorrucci M, Ciccozzi M, Iacobelli S, Rezza G. Temporal trend in the level of 90K glycoprotein after HIV seroconversion among persons coinfected with hepatitis C virus. Infection. 2005;33(2):101-2.
  335. Brown EE, Fallin MD, Goedert JJ, Chen R, Whitby D, Foster CB, Lauria C, Alberg AJ, Messina A, Montella M, Rezza G, Vitale F, Chanock SJ; Kaposi Sarcoma Genetics Working Group. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma. Cancer Epidemiol Biomarkers Prev. 2005;14(3):633-7.
  336. Dorrucci M, Phillips AN, Longo B, Rezza G; Italian Seroconversion Study. Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002. AIDS. 2005;19(3):331-5.
  337. Serraino D, Piselli P, Angeletti C, Minetti E, Pozzetto A, Civati G, Bellelli S, Farchi F, Citterio F, Rezza G, Franceschi S, Busnach G. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer. 2005;92(3):572-5.
  338. Suligoi B, Wagner TM, Ciccozzi M, Rezza G. The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: objectives and methods of feasibility studies. Vaccine. 2005;23(12):1437-45.
  339. Dal Maso L, Polesel J, Ascoli V, Zambon P, Budroni M, Ferretti S, Tumino R, Tagliabue G, Patriarca S, Federico M, Vercelli M, Giacomin A, Vicario G, Bellù F, Falcini F, Crocetti E, De Lisi V, Vitarelli S, Piffer S, Stracci F, Serraino D, Rezza G, Franceschi S; Cancer and AIDS Registry Linkage Study. Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer. 2005;92(1):188-93.
  340. Babudieri S, Pintus A, Maida I, Starnini G, Rezza G. Does counseling increase sustained benefit of HAART among prison inmates after release to the community? Clin Infect Dis. 2005;40(2):321-2; author reply 322-3.
  341. Suligoi B, Danaya RT, Sarmati L, Owen IL, Boros S, Pozio E, Andreoni M, Rezza G. Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea. Am J Trop Med Hyg. 2005;72(1):33-6.
  342. Rezza G, Scalia Tomba G, Martucci P, Massella M, Noto R, De Risio A, Brunetti B, Ardita S, Starnini G. Prevalence of the use of old and new drugs among new entrants in Italian prisons. Ann Ist Super Sanita. 2005;41(2):239-45.
  343. Dorrucci M, Valdarchi C, Suligoi B, Zaccarelli M, Sinicco A, Giuliani M, Vlahov D, Pezzotti P, Rezza G. The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy. AIDS. 2004;18(17):2313-8.
  344. Volpi A, Sarmati L, Suligoi B, Montano M, Rezza G, Andreoni M. Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. J Med Virol. 2004;74(3):467-72.
  345. Smacchia C, Parolin A, Piselli P, Scuderi M, Serraino D, Rezza G, Boschini A, Carletti F, Zaniratti S. Infection with human herpesvirus type-8 among foreign female sex workers in Italy. Infection. 2004;32(5):303-5.
  346. Buonaguro L, Tagliamonte M, Tornesello ML, Pilotti E, Casoli C, Lazzarin A, Tambussi G, Ciccozzi M, Rezza G, Buonaguro FM; Italian Concerted Action on PHI Treatment. Screening of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy. J Acquir Immune Defic Syndr. 2004;37(2):1295-306.
  347. Rezza G. Avian influenza: a human pandemic threat? J Epidemiol Community Health. 2004;58(10):807-8.
  348. Dorrucci M, Longo B, Arpino C, Boros S, Rezza G. Combined antiretroviral therapy and the incidence of acquired immunodeficiency syndrome-related central nervous system diseases. Ann Neurol. 2004;56(2):307.
  349. Puoti M, Babudieri S, Rezza G, Viale P, Antonini MG, Maida I, Rossi S, Zanini B, Putzolu V, Fenu L, Baiguera C, Sassu S, Carosi G, Mura MS. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther. 2004;9(4):627-30.
  350. Suligoi B, Magliochetti N, Nicoletti G, Pezzotti P, Rezza G. Trends in HIV prevalence among drug-users attending public drug-treatment centres in Italy: 1990-2000. J Med Virol. 2004;73(1):1-6.
  351. Sarmati L, Carlo T, Rossella S, Montano M, Adalgisa P, Rezza G, Andreoni M. Human herpesvirus-8 infection in pregnancy and labor: lack of evidence of vertical transmission. J Med Virol. 2004;72(3):462-6.
  352. Rezza G, Marino R, Farchi F, Taranto M. SARS epidemic in the press. Emerg Infect Dis. 2004;10(2):381-2.
  353. Salemi M, Fitch WM, Ciccozzi M, Ruiz-Alvarez MJ, Rezza G, Lewis MJ. Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis. J Virol. 2004;78(3):1602-3.
  354. van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S; European and Italian Seroconverter Studies. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis. 2004;189(2):292-302.
  355. Schinaia N, Kodra Y, Sarmati L, Andreoni M, Bino S, Qyra S, Rezza G. Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV. Eur J Epidemiol. 2004;19(5):467-9.
  356. Dorrucci M, Iacobelli S, Suligoi B, Pezzotti P, Sinicco A, Angarano G, Tinari N, Rezza G. Longitudinal analysis of the 90K glycoprotein in the Italian HIV-seroconversion study: temporal trend and predictability of the maturity of HIV infection. J Biol Regul Homeost Agents. 2004;18(1):18-25.
  357. Pezzotti P, Dorrucci M, Donisi A, Cusini M, Mazzarello G, De Luca A, Salassa B, Ursitti MA, Giuliani M, Rezza G; l'Italian Seroconversion Study. Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART). Epidemiol Prev. 2003;27(6):348-55. Italian.
  358. Ticconi C, Mapfumo M, Dorrucci M, Naha N, Tarira E, Pietropolli A, Rezza G. Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr. 2003;34(3):289-94.
  359. Buttò S, Fiorelli V, Tripiciano A, Ruiz-Alvarez MJ, Scoglio A, Ensoli F, Ciccozzi M, Collacchi B, Sabbatucci M, Cafaro A, Guzmán CA, Borsetti A, Caputo A, Vardas E, Colvin M, Lukwiya M, Rezza G, Ensoli B; Tat Multicentric Study Group. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans. J Infect Dis. 2003;188(8):1171-80.
  360. Pezzotti P, Piovesan C, Michieletto F, Zanella F, Rezza G, Gallo G. Estimating the cumulative number of human immunodeficiency virus diagnoses by cross-linking from four different sources. Int J Epidemiol. 2003;32(5):778-83.
  361. Rezza G. Identification and control are the priority. J Epidemiol Community Health. 2003;57(10):772.
  362. Franceschi S, Dal Maso L, Pezzotti P, Polesel J, Braga C, Piselli P, Serraino D, Tagliabue G, Federico M, Ferretti S, De Lisi V, La Rosa F, Conti E, Budroni M, Vicario G, Piffer S, Pannelli F, Giacomin A, Bellù F, Tumino R, Fusco M, Rezza G; Cancer and AIDS Registry Linkage Study. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr. 2003;34(1):84-90.
  363. Rezza G. Severe acute respiratory syndrome. J Epidemiol Community Health. 2003;57(9):643.
  364. Dukers NH, Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS. 2003;17(12):1717-30.
  365. Dal Maso L, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E, Falcini F, Guzzinati S, Zanetti R, Vercelli M, Rezza G; Cancer and AIDS Registy Linkage Study. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer. 2003;89(1):94-100.
  366. Sarmati L, Ticconi C, Santangelo R, Montano M, Rezza G, Andreoni M. Does the risk of abortion increase in women with high human herpesvirus-8 antibody titers? J Infect Dis. 2003;188(1):173-4.
  367. Sarmati L, Andreoni M, Suligoi B, Bugarini R, Uccella I, Pozio E, Rezza G. Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia. Am J Trop Med Hyg. 2003;68(4):501-2.
  368. Suligoi B, Massi M, Galli C, Sciandra M, Di Sora F, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr. 2003;32(4):424-8.
  369. Dorrucci M, Serraino D, Rezza G. The effect of aging on the incidence of Kaposi's sarcoma among HIV-positive individuals with known dates of seroconversion. Int J Cancer. 2003;104(2):251-4.
  370. Suligoi B, Pavoni N, Borghi V, Branz F, Coppola N, Gallo G, Perucci CA, Piovesan C, Porta D, Rossetti G, Rezza G. Epidemiology of HIV infection in Italy. Epidemiol Prev. 2003;27(2):73-9.
  371. Suligoi B, Rezza G. HIV infection: incidence estimate and surveillance systems. Epidemiol Prev. 2003;27(2):67-9.
  372. Dorrucci M, Suligoi B, Pezzotti P, Rezza G. Does coinfection with Human Herpesvirus 6 have a protective effect for HIV-1 progression? Infez Med. 2003;11(1):46-8.
  373. Montella M, Crispo A, Serraino D, Rezza G, Franceschi S. Is the spread of HCV in Southern Italy attributable to iatrogenic transmission through unsterile injections? Eur J Cancer Prev. 2003;12(1):85-6.
  374. Suligoi B, Dorrucci M, Uccella I, Andreoni M, Rezza G; Italian Seroconversion Study. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters. J Med Virol. 2003;69(2):182-7.
  375. Babudieri S, Starnini G, Brunetti B, Carbonara S, D'Offizi GP, Monarca R, Mazzarello G, Novati S, Casti A, Florenzano G, Quercia G, Iovinella E, Sardu C, Romano A, Dierna M, Vullo S, Pintus A, Maida I, Dori L, Ardita S, Mura MS, Andreoni M, Rezza G. HIV and related infections in Italian penal institutions: epidemiological and health organization note. Ann Ist Super Sanita. 2003;39(2):251-7.
  376. Serraino D, Corona RM, Giuliani M, Farchi F, Sarmati L, Uccella I, Andreoni M, Rezza G. Infection with human herpesvirus type 8 and kaposi's sarcoma in a central Italian area formerly endemic for malaria. Infection. 2003;31(1):47-50.
  377. Suligoi B, Pezzotti P, Boros S, Urciuoli R, Rezza G; HIV Study Group. Epidemiological changes in AIDS and HIV infection in Italy. Scand J Infect Dis Suppl. 2003;106:12-6.
  378. Suligoi B, Dorrucci M, Volpi A, Andreoni M, Rezza G; Italian Seroconversion Study. No protective effect of acyclovir on HIV disease progression in a cohort of HSV-2-HIV-infected individuals. Antivir Ther. 2002;7(4):289-91.
  379. Goedert JJ, Vitale F, Lauria C, Serraino D, Tamburini M, Montella M, Messina A, Brown EE, Rezza G, Gafà L, Romano N; Classical Kaposi's Sarcoma Working Group. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst. 2002;94(22):1712-8.
  380. Fernandez L, Serraino D, Rezza G, Lence J, Ortiz RM, Cruz T, Vaccarella S, Sarmati L, Andreoni M, Franceschi S. Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba. Br J Cancer. 2002;87(11):1253-6.
  381. Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol. 2002;40(11):4015-20.
  382. Suligoi B, Dorrucci M, Volpi A, Andreoni M, Zerboni R, Rezza G; Italian Seroconversion Study Group. Prevalence and determinants of herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy. Sex Transm Dis. 2002;29(11):665-7.
  383. Sirianni MC, Vincenzi L, Topino S, Giovannetti A, Mazzetta F, Libi F, Scaramuzzi D, Andreoni M, Pinter E, Baccarini S, Rezza G, Monini P, Ensoli B. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. Eur J Immunol. 2002;32(10):2711-20.
  384. Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O, Brettle R, del Romero J, Prins M, van Benthem B, Kirk O, Pederson C, Hernández Aguado I, Pérez-Hoyos S, Eskild A, Bruun JN, Sannes M, Sabin C, Lee C, Johnson AM, Phillips AN, Francioli P, Vanhems P, Egger M, Rickenbach M, Cooper D, Kaldor J, Ashton L, Vizzard J, Muga R, Day NE, De Angelis D; CASCADE Collaboration. Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol. 2002;31(5):951-8.
  385. Giuliani M, Mastroianni A, Di Carlo A, Donati P, Miceli M, Monini P, Rezza G. Onset of non-AIDS Kaposi sarcoma during therapy with interferon alfa-2a in an 82-year-old man with concomitant cutaneous T-cell lymphoma. Arch Dermatol. 2002;138(4):535-7.
  386. Andreoni M, Sarmati L, Nicastri E, El Sawaf G, El Zalabani M, Uccella I, Bugarini R, Parisi SG, Rezza G. Primary human herpesvirus 8 infection in immunocompetent children. JAMA. 2002;287(10):1295-300.
  387. Parisi SG, Sarmati L, Pappagallo M, Mazzi R, Carolo G, Farchi F, Nicastri E, Concia E, Rezza G, Andreoni M. Prevalence trend and correlates of HHV-8 infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;29(3):295-9.
  388. Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S, Palladino C, Leone P, Bugarini R, Malavasi L, Cafaro A, Falchi M, Valdembri D, Rezza G, Bussolino F, Monini P, Ensoli B. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med. 2002;8(3):225-32.
  389. Rezza G. Infections and other causes of mortality correlated with drug addiction. Ann Ist Super Sanita. 2002;38(3):297-303.
  390. Conti S, Masocco M, Pezzotti P, Toccaceli V, Vichi M, Crialesi R, Frova L, Rezza G. Excess mortality from liver disease and other non-AIDS-related diseases among HIV-infected individuals in Italy. J Acquir Immune Defic Syndr. 2002;29(1):105-7.
  391. Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P, Lo Caputo S, Narciso P, Pauluzzi S, Carosi G, Nappa S, Piano P, Izzo CM, Lichtner M, Rezza G, Monforte A, Ippolito G, d'Arminio Moroni M, Wu AW, Antinori A; AdICONA Study Group. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001 Dec 15;28(5):445-9.
  392. Suligoi B, Tchamgmena O, Sarmati L, Bugarini R, Toma L, Bakary DK, Glikoutou M, Rezza G. Prevalence and risk factors for herpes simplex virus type 2 infection among adolescents and adults in northern Cameroon. Sex Transm Dis. 2001;28(12):690-3.
  393. Monini P, Sirianni MC, Franco M, Vincenzi L, Topino S, Goletti D, Leone P, Leone P, Chiozzini C, Nicastri E, Andreoni M, Borduagni O, Sgadari C, Rezza G, Stürzl M, Ensoli B. Clearance of human herpesvirus 8 from blood and regression of leukopenia-associated aggressive classic Kaposi's sarcoma during interferon-alpha therapy: a case report. Clin Infect Dis. 2001;33(10):1782-5.
  394. Calcaterra S, Zaniratti MS, Serraino D, Peroni M, Abbate I, Cappiello G, Piselli P, Pavia C, Rezza G, Ippolito G, Capobianchi MR. Cervicovaginal shedding of TT virus in HIV-infected women. J Hum Virol. 2001;4(6):343-5.
  395. Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, Angelico M, Leone P, Citterio F, Ensoli B, Rezza G. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect. 2001;43(3):195-9.
  396. Rezza G, Danaya RT, Wagner TM, Sarmati L, Owen IL, Monini P, Andreoni M, Suligoi B, Ensoli B, Pozio E. Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerg Infect Dis. 2001;7(5):893-5.
  397. Rezza G, Capobianchi M, Serraino D, Peroni M, Piselli P, Calcaterra S, Pavia C, Zaniratti S, Ippolito G. HHV-8 shedding among HIV-infected women. J Acquir Immune Defic Syndr. 2001;28(1):103-4.
  398. Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Buttò S, Lukwiya M, Bogner JR, Yaguboglu S, Sheldon J, Sarmati L, Goebel FD, Hintermaier R, Enders G, Regamey N, Wernli M, Stürzl M, Rezza G, Ensoli B. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol. 2001;65(1):123-32.
  399. Balotta C, Facchi G, Violin M, Van Dooren S, Cozzi-Lepri A, Forbici F, Bertoli A, Riva C, Senese D, Caramello P, Carnevale G, Rizzardini G, Cremonini L, Monno L, Rezza G, Perno CF, Ippolito G, d'Arminio-Monforte A, Vandamme AM, Moroni M; ICONA Study Group. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr. 2001;27(5):499-505.
  400. Dal Maso L, Rezza G, Zambon P, Tagliabue G, Crocetti E, Vercelli M, Zanetti R, Falcini F, Tonini G, Mangone L, De Lisi V, Ferretti S, Tumino R, Stanta G, Vitarelli S, Serraino D, Franceschi S; Cancer and AIDS Registry Linkage Study. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy. Int J Cancer. 2001;93(3):430-5.
  401. Spizzichino L, Zaccarelli M, Rezza G, Ippolito G, Antinori A, Gattari P. HIV infection among foreign transsexual sex workers in Rome: prevalence, behavior patterns, and seroconversion rates. Sex Transm Dis. 2001;28(7):405-11.
  402. Rezza G, Giuliani M, Garbuglia AR, Serraino D, Cappiello G, Migliore G, Branca M, Benedetto A, Ippolito G. Lack of association between p53 codon-72 polymorphism and squamous intraepithelial lesions in women with, or at risk for, human immunodeficiency virus and/or human papillomavirus infections. Cancer Epidemiol Biomarkers Prev. 2001;10(5):565-6.
  403. Rezza G, Zaccarelli M, Giuliani M, Calcaterra S, Garbuglia AR, Catalani C, Benvenuti M, Di Carlo A, Ippolito G, Antinori A. Sexual transmission of transfusion-transmitted virus. Sex Transm Dis. 2001;28(5):298-9.
  404. Pezzotti P, Pappagallo M, Phillips AN, Boros S, Valdarchi C, Sinicco A, Zaccarelli M, Rezza G; Italian Seroconversion Study. Response to highly active antiretroviral therapy according to duration of HIV infection. J Acquir Immune Defic Syndr. 2001;26(5):473-9.
  405. Wagner TM, Pezzotti P, Valdarchi C, Rezza G. Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26(4):394-5.
  406. Dorrucci M, Suligoi B, Serraino D, Tirelli U, Rezza G; Italian HIV-Seroconversion Study. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26(4):377-80.
  407. Girardi E, Aloisi MS, Serraino D, Ferrara M, Lauria FN, Carballo M, d'Arminio Monforte A, Rezza G, Moroni M, Carosi G, Alessandrini A, Giacobbi D, Cremonini L, Ranieri S, Montroni M, Ippolito G; ICONA Study Group. Sexual behaviour of heterosexual individuals with HIV infection naive for antiretroviral therapy in Italy. Sex Transm Infect. 2001;77(2):130-4.
  408. Serraino D, Locatelli M, Songini M, Cirillo R, Bottazzo GF, Andreoni M, Franceschi S, Rezza G; Sardinia-Newborn Study Group. Human herpes virus-8 infection among pregnant women and their children: results from the Sardinia-IDDM Study 2. Int J Cancer. 2001;91(5):740-1.
  409. Op de Coul EL, Prins M, Cornelissen M, van der Schoot A, Boufassa F, Brettle RP, Hernández-Aguado L, Schiffer V, McMenamin J, Rezza G, Robertson R, Zangerle R, Goudsmit J, Coutinho RA, Lukashov VV; European and Italian Seroconverter Studies. Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997. AIDS. 2001;15(2):257-66.
  410. Suligoi B, Dorrucci M, Volpi A, Andreoni M, Pezzotti P, Rezza G; Italian Seroconversion Study. Absence of an effect of herpes simplex virus type 2 infection on HIV disease progression: data from a cohort of HIV-positive individuals with known date of seroconversion. AIDS. 2001;15(1):133-5.
  411. van Griensven F, Rezza G. AIDS 2001. Epidemiology and social issues. Overview. AIDS. 2001;15 Suppl 5:S47-8.
  412. Serraino D, Toma L, Andreoni M, Buttò S, Tchangmena O, Sarmati L, Monini P, Franceschi S, Ensoli B, Rezza G. A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol. 2001;17(9):871-6.
  413. Dal Maso L, Gava M, Pezzotti P, Torelli N, Franceschi S, Rezza G; Italian Seroconversion Study. Markov models for HIV disease progression: an unverified assumption. J Acquir Immune Defic Syndr. 2000;25(5):466-8.
  414. Conti S, Masocco M, Pezzotti P, Toccaceli V, Vichi M, Boros S, Urciuoli R, Valdarchi C, Rezza G. Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr. 200025(5):451-8.
  415. Aloisi MS, Serraino D, Girardi E, Lauria FN, D'Arminio Monforte A, Cargnel A, Bonazzi L, Petrosillo N, Abrescia N, Mazzotta F, Vullo V, Ferraro T, Suter F, Masi A, Rezza G, Ippolito G; ICONA Study Group. Italian Cohort Naive Antiretrovirals. Sexual behaviour of women living with HIV/AIDS naïve for antiretroviral therapy: the ICONA-BEHEPI Study. AIDS Care. 2000;12(6):789-95.
  416. Rezza G. Immunosuppression, timing of human herpesvirus 8 infection, and risk of Kaposi's sarcoma among human immunodeficiency virus type 1-infected persons and transplant recipients. J Infect Dis. 2000;182(6):1809-10.
  417. Branca M, Migliore G, Giuliani M, Morosini PL, Mudu P, Cappiello G, Garbuglia AR, Ippolito G, Rezza G; Early Diagnosis of Neoplasia in AIDS Cooperative Study Group. Using the number of koilocytes to predict HIV serostatus in women with HPV-associated SIL. Acta Cytol. 2000;44(6):1000-4.
  418. Rezza G, Lepri AC, d'Arminio Monforte A, Pezzotti P, Castelli F, Dianzani F, Lazzarin A, De Luca A, Arlotti M, Leoncini F, Manconi PE, Rizzardini G, Minoli L, Poggio A, Ippolito G, Phillips AN, Moroni M. Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group. J Acquir Immune Defic Syndr. 2000;25(1):56-62.
  419. Benagiano G, Rezza G, Vella S. Condom use for preventing the spread of HIV/AIDS: an ethical imperative. J R Soc Med. 2000;93(9):453-6.
  420. Rezza G, Dorrucci M, Serraino D, Andreoni M, Giuliani M, Zerboni R, Sarmati L, Colangeli V, Salassa B, Monini P, Ensoli B, Pezzotti P. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study. AIDS. 2000;14(11):1647-53.
  421. de Martino M, Tovo PA, Balducci M, Galli L, Gabiano C, Rezza G, Pezzotti P. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284(2):190-7.
  422. Dal Maso L, Zanetti R, Orengo MA, Tagliabue G, Guzzinati S, Cavallieri F, Serventi L, Mangone L, Ferretti S, Milandri C, Pannelli F, Balzi D, Tonini G, Gafà L, Rezza G, Franceschi S. Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy. Epidemiol Prev. 2000;24(3):109-16. Italian.
  423. Serraino D, Pezzotti P, Boros S, Rezza G. Antiretroviral combination therapies and AIDS-defining cancers. J Acquir Immune Defic Syndr. 2000;24(1):84-6.
  424. Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L, Ballarini P, Pezzotti P, Smacchia C, Pesce A, Ippolito G, Franceschi S, Rezza G. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS. 2000;14(5):553-9.
  425. d'Arminio Monforte A, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G, Colangeli V, De Luca A, Ippolito G, Caggese L, Soscia F, Filice G, Gritti F, Narciso P, Tirelli U, Moroni M. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS. 2000;14(5):499-507.
  426. Rezza G, Tchangmena OB, Andreoni M, Bugarini R, Toma L, Bakary DK, Glikoutou M, Sarmati L, Monini P, Pezzotti P, Ensoli B. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis. 2000;27(3):159-64.
  427. Ippolito G, Rezza G, Girardi E, Malkovsky M, Cairns JS. HIV infections: the global epidemiology and goals for vaccine research. Mol Med. 2000;6(2):69-85.
  428. Giuliani M, Rezza G, Lepri AC, Di Carlo A, Maini A, Crescimbeni E, Palamara G, Prignano G, Caprilli F. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases. Sex Transm Dis. 2000;27(2):87-92.
  429. Rezza G, Padian N. AIDS 2000. Epidemiology: overview. AIDS. 2000;14 Suppl 3:S45-6.
  430. Camoni L, Colucci A, Covre P, D'Agostini A, Frati AR, Gallo P, Geraci S, Latini O, Luzi AM, Mayer R, Morrone A, Petrosillo N, Pino D, Rezza G, Rosa E, Spizzichino L, Volpicelli S, Schinaia N; Italian National Focal Point (NFP) of the AIDS & Mobility Project. Immigration and health: the Italian National Focal Point experience. Ann Ist Super Sanita. 2000;36(4):479-90.
  431. Rezza G, Farchi F, Giuliani M. Sexually transmitted infections in the population of drug dependents. Ann Ist Super Sanita. 2000;36(1):63-8.
  432. Montella M, Serraino D, Crispo A, Rezza G, Carbone S, Tamburini M. Is volcanic soil a cofactor for classic Kaposi's sarcoma? Eur J Epidemiol. 2000;16(12):1185-6.
  433. Pezzotti P, d'Arminio Monforte A, Bugarini R, Rezza G, Arici C, Angarano G, Borderi M, Alberici F, Armignacco O, Menichetti F, Prestileo T, Sighinolfi L, Sinicco A, Resta F, Vigevani M, Ippolito G; ICONA Study Group. Italian Cohort of Naïve Antivirals. Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values? Eur J Epidemiol. 2000;16(10):919-26.
  434. Branca M, Migliore G, Giuliani MLeoncini L, Ippolito G, Cappiello G, Garbuglia AR, Schiesari A, Rezza G. Squamous intraepithelial lesions (SILs) and HPV associated changes in HIV infected women or at risk of HIV. DIANAIDS Cooperative Study Group. Eur J Gynaecol Oncol. 2000;21(2):155-9.
  435. Rezza G, Dorrucci M, Andreoni M, Arpino C, De Luca A, Monini P, Nicastri E, Alliegro MB, Pezzotti P, Ensoli B. Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study. Neurology. 1999;53(9):2032-6.
  436. Pezzotti P, Serraino D, Rezza G, Dal Maso L, Vaccher E, Lepri AC, Franceschi S. The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996. Int J Epidemiol. 1999;28(5):975-81.
  437. Lyles CM, Dorrucci M, Vlahov D, Pezzotti P, Angarano G, Sinicco A, Alberici F, Alcorn TM, Vella S, Rezza G. Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. J Infect Dis. 1999;180(4):1018-24.
  438. Fiore JR, Buccoliero G, Pezzotti P, Rezza G, Saracino A, Pastore G, Fenyo EM, Angarano G. HIV-1 disease progression in women: role of the viral phenotype of the HIV-positive steady partner. AIDS. 1999 Sep 10;13(13):1801-2.
  439. Dorrucci M, Balducci M, Pezzotti P, Sinicco A, Alberici F, Rezza G. Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment. Italian HIV Seroconversion Study (ISS). J Acquir Immune Defic Syndr. 1999;22(1):65-70.
  440. Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristerà R, Aiuti F, Ortona L, Ensoli B. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst. 1999;91(17):1468-74.
  441. Serraino D, Carrieri P, Pradier C, Bidoli E, Dorrucci M, Ghetti E, Schiesari A, Zucconi R, Pezzotti P, Dellamonica P, Franceschi S, Rezza G. Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer. 1999;82(3):334-7.
  442. Monini P, Colombini S, Stürzl M, Goletti D, Cafaro A, Sgadari C, Buttò S, Franco M, Leone P, Fais S, Leone P, Melucci-Vigo G, Chiozzini C, Carlini F, Ascherl G, Cornali E, Zietz C, Ramazzotti E, Ensoli F, Andreoni M, Pezzotti P, Rezza G, Yarchoan R, Gallo RC, Ensoli B. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood. 1999;93(12):4044-58.
  443. Monini P, Carlini F, Stürzl M, Rimessi P, Superti F, Franco M, Melucci-Vigo G, Cafaro A, Goletti D, Sgadari C, Butto' S, Leone P, Chiozzini C, Barresi C, Tinari A, Bonaccorsi A, Capobianchi MR, Giuliani M, di Carlo A, Andreoni M, Rezza G, Ensoli B. Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol. 1999;73(5):4029-41.
  444.  Pezzotti P, Dal Maso L, Serraino D, Franceschi S, Rezza G. Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments? J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20(5):515-6.
  445. Boschini A, Di Perri G, Legnani D, Fabbri P, Ballarini P, Zucconi R, Boros S, Rezza G. Consecutive epidemics of Q fever in a residential facility for drug abusers: impact on persons with human immunodeficiency virus infection. Clin Infect Dis. 1999;28(4):866-72.
  446. Dorrucci M, Rezza G, Andreoni M, Pezzotti P, Nicastri E, Ventura L, Zignani M, Alliegro MB, Tarantini G, Salassa B, Colangeli V, Mazzarello G, Ursitti MA, Barbanera M, Pristerà R, Castelli F, Ortona L. Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. Italian Seroconversion Study group. Eur J Epidemiol. 1999 Apr;15(4):317-22.
  447.  Andreoni M, El-Sawaf G, Rezza G, Ensoli B, Nicastri E, Ventura L, Ercoli L, Sarmati L, Rocchi G. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst. 1999;91(5):465-9.
  448.  Pezzotti P, Galai N, Vlahov D, Rezza G, Lyles CM, Astemborski J. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20(3):275-82.
  449.  Pezzotti P, Napoli PA, Acciai S, Boros S, Urciuoli R, Lazzeri V, Rezza G. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group. AIDS. 1999;13(2):249-55.
  450.  Camoni L, Franco M, Pugliese L, Biondi M, Rezza G. Anabolic Steroids, Use & abuse. A review. The Journal of Performance Enhancing Drugs 1999; 2:4-14.
  451.  Franceschi S, Dal Maso L, Arniani S, Crosignani P, Vercelli M, Simonato L, Falcini F, Zanetti R, Barchielli A, Serraino D, Rezza G. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer. 1998;78(7):966-70.
  452. Cozzi Lepri A, Sabin CA, Phillips AN, Lee CA, Pezzotti P, Rezza G. The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count. The Italian Seroconversion Study. Epidemiol Infect. 1998;121(2):369-76.
  453. Franceschi S, La Vecchia C, Dal Maso L, Serraino D, Rezza G. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;352(9131):906-7; author reply 907.
  454. Spizzichino L, Casella P, Zaccarelli M, Rezza G, Venezia S, Gattari P. HIV infection among foreign people involved in HIV-related risk activities and attending an HIV reference centre in Rome: the possible role of counselling in reducing risk behaviour. AIDS Care. 1998;10(4):473-80.
  455. Ciuta ST, Boros S, Napoli PA, Pezzotti P, Rezza G. Predictors of survival in children with acquired immunodeficiency syndrome in Italy, 1983 to 1995. AIDS Patient Care STDS. 1998;12(8):629-37.
  456. Rezza G, Giuliani M, Serraino D, Branca M, Benedetto A, Garbuglia A, Ippolito G, Franceschi S. Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection. DIANAIDS Collaborative Study Group. Epidemiol Infect. 1998;121(1):173-7.
  457. Cozzi Lepri A, Phillips AN, Pezzotti P, Mocroft A, Sabin CA, Porter K, Rezza G. Evaluating the effect of year of seroconversion on HIV progression in cohort studies. Italian Seroconversion Study. AIDS. 1998;12(11):1353-60.
  458. Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Buttò S, Lodi G, Di Carlo A, Levy JA, Ensoli B. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer. 1998;77(3):361-5.
  459. D'Ubaldo C, Pezzotti P, Rezza G, Branca M, Ippolito G. Association between HIV-1 infection and miscarriage: a retrospective study. DIANAIDS Collaborative Study Group. Diagnosi Iniziale Anomalie Neoplastiche AIDS. AIDS. 1998;12(9):1087-93.
  460. Franceschi S, Dal Maso L, Arniani S, Lo Re A, Barchielli A, Milandri C, Simonato L, Vercelli M, Zanetti R, Rezza G. Linkage of AIDS and cancer registries in Italy. Int J Cancer. 1998;75(6):831-4.
  461. Alliegro MB, Petrucci A, Arpino C, Dorrucci M, Pezzotti P, Rezza G, Buccoliero G, Tarantini G, Sinicco A, Canessa A. Peripheral neuropathies among patients with HIV infection. J Neurol Neurosurg Psychiatry. 1998;64(3):414-5.
  462. Napoli PA, Dorrucci M, Serraino D, Pezzotti P, Franceschi S, Vella S, Rezza G. Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy. Eur J Epidemiol. 1998;14(1):41-7.
  463. Rezza G. Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17 Suppl 1:S13-6.
  464. Alliegro MB, Dorrucci M, Phillips AN, Pezzotti P, Boros S, Zaccarelli M, Pristerà R, Rezza G. Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group. Arch Intern Med. 1997;157(22):2585-90.
  465. Rezza G, Giuliani M, Branca M, Benedetto A, Migliore G, Garbuglia AR, D'Ubaldo C, Pezzotti P, Cappiello G, Pomponi Formiconi D, Suligoi B, Schiesari A, Ippolito G, Giacomini G. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol. 1997;13(8):937-43.
  466. Rezza G, D’Egidio P, Cozzi Lepri A, Costantini D, Petrucci A, Pezzotti P. Effects of age, gender, duration of drug use and infection with viral hepatitis B and C on lymphocyte subsets in a population of HIV-negative injecting drug users in Italy. Addiction Biology 1997; 2:201-206.
  467. Pezzotti P, Piovesan C, Rezza G, Moro G, Serpelloni G, Ferraro P. Combining HIV and AIDS surveillance: an experience from an Italian region. Int J Epidemiol. 1997;26(6):1352-8.
  468. Cozzi Lepri A, Phillips AN, Pezzotti P, Rezza G. Is the clinical course of HIV infection changing? Study's censoring strategy may be source of bias. BMJ. 1997;315(7117):1237.
  469. Alcabes P, Pezzotti P, Phillips AN, Rezza G, Vlahov D. Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression. Am J Epidemiol. 1997;146(7):543-51.
  470. Brancato G, Pezzotti P, Rapiti E, Perucci CA, Abeni D, Babbalacchio A, Rezza G. Multiple imputation method for estimating incidence of HIV infection. The Multicenter Prospective HIV Study. Int J Epidemiol. 1997;26(5):1107-14.
  471. Pozio E, Rezza G, Boschini A, Pezzotti P, Tamburrini A, Rossi P, Di Fine M, Smacchia C, Schiesari A, Gattei E, Zucconi R, Ballarini P. Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J Infect Dis. 1997;176(4):969-75.
  472. Giuliani M, Caprilli F, Gentili G, Maini A, Lepri AC, Prignano G, Palamara G, Giglio A, Crescimbeni E, Rezza G. Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus type 1 testing program. Sex Transm Dis. 1997;24(9):533-7.
  473. Cappiello G, Garbuglia AR, Salvi R, Rezza G, Giuliani M, Pezzotti P, Suligoi B, Branca M, Migliore G, Formigoni Pomponi D, D'Ubaldo C, Ippolito G, Giacomini G, Benedetto A. HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. DIANAIDS Collaborative Study Group. Int J Cancer. 1997;72(6):982-6.
  474. Conti S, Masocco M, Farchi G, Rezza G, Toccaceli V.  ality in Italy during the first decade of the AIDS epidemic: 1984-1993. Int J Epidemiol. 1997;26(4):873-9.
  475. Rezza G, Galai N, Pezzotti P, Vlahov D, Graham NM, Viale P, Angarano G. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study. Antivir Ther. 1997;2(3):167-74.
  476. Serraino D, Pezzotti P, Rezza G. HIV exposure category and invasive cervical carcinoma in Italy. AIDS. 1997;11(6):821-2.
  477. Buttò S, Argentini C, Mazzella AM, Iannotti MP, Leone P, Leone P, Nicolosi A, Rezza G. Dual infection with different strains of the same HIV-1 subtype. AIDS. 1997;11(5):694-6. Cozzi Lepri A, Sabin CA, Pezzotti P, England PD, Phillips AN, Rezza G. Is there a general tendency for CD4 lymphocyte decline to speed up during human immunodeficiency virus infection? Evidence from the Italian Seroconversion Study. J Infect Dis. 1997;175(4):775-80.
  478. Dorrucci M, Pezzotti P, Phillips AN, Alliegro MB, Rezza G. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study. AIDS. 1997;11(4):461-7.
  479. Pezzotti P, Piovesan C, Rezza G, Ferraro P. HIV/AIDS surveillance in Italy: the potential misinterpretation of time trends. Am J Public Health. 1997;87(3):469-70.
  480. Sagliocca L, Rezza G, Vlahov D, Baldassarre C, Siconolfi, Nespoli M, Carrieri MP. A morphine prescription program in Italy (1980-1985): retrospective evidence of protection against HIV/AIDS. Addiction Research 1997; 5:137-4.
  481. Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer. 1997;79(5):1004-8.
  482. Montella F, Pezzotti P, Di Sora F, Recchia O, Lauria F, Rezza G. Improving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive i.v. drug users. Infection. 1997;25(2):117-20.
  483. Petrucci A, Dorrucci M, Alliegro MB, Pezzotti P, Rezza G, Sinicco A, Lazzarin A, Angarano G. How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS). J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(3):243-8.
  484. Pezzotti P, Napoli PA, Rezza G, Lazzeri V, Acciai S, Curia R, Crosera C, De Rosa MG. The effect of the 1993 European revision of the AIDS case definition in Italy: implications for modelling the HIV epidemic. AIDS. 1997;11(1):95-9.
  485. Conti S, Cozzi Lepri A, Farchi G, Napoli Pier A. Prati S, Rezza G. AIDS: a major health problem among young italian women. AIDS 1996, 10:407-411.
  486. Rezza G, Pizzuti R, De Campora E, De Masi S, Vlahov D. Tetanus and injections drug use: rediscovery of a neglected problem? Eur J Epidemiol. 1996;12(6):655-6.
  487. Chiesi A, Seeber AC, Dally LG, Floridia M, Rezza G, Vella S. AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection. J Neurol Sci. 1996;144(1-2):107-13.
  488. Perria C, Magliocchetti N, Nicoletti G, Pezzotti P, Rezza G. Trends in the prevalence and geographic distribution of HIV infection among Italian drug addicts in treatment provided by public assistance services during 1990-1994. Ann Ig. 1996;8(6):621-33.
  489. Alliegro MB, Dorrucci M, Pezzotti P, Rezza G, Sinicco A, Barbanera M, Castelli F, Tarantini G, Petrucci A. Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus. Italian HIV Seroconversion Study. Clin Infect Dis. 1996;23(5):990-5.
  490. Pezzotti P, Phillips AN, Dorrucci M, Lepri AC, Galai N, Vlahov D, Rezza G. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group. BMJ. 1996;313(7057):583-6.
  491. Serraino D, Napoli PA, Zaccarelli M, Alliegro MB, Pezzotti P, Rezza G. High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS. 1996;10(9):1041-2.
  492. Manfredi Selvaggi T, Rezza G, Scagnelli M, Rigoli R, Rassu M, De Lalla F, Pellizzer GP, Tramarin A, Bettini C, Zampieri L, Belloni M, Pozza ED, Marangon S, Marchioretto N, Togni G, Giacobbo M, Todescato A, Binkin N. Investigation of a Q-fever outbreak in northern Italy. Eur J Epidemiol. 1996;12(4):403-8.
  493. Hershow RC, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, Klein RS, Des Jarlais DC, Vitek C, Khabbaz R, Freels S, Zuckerman R, Pezzotti P, Kaplan JE. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis. 1996;174(2):309-17.
  494. Boschini A, Smacchia C, Di Fine M, Schiesari A, Ballarini P, Arlotti M, Gabrielli C, Castellani G, Genova M, Pantani P, Lepri AC, Rezza G. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis. 1996;23(1):107-13.
  495. Conti S, Lepri AC, Farchi G, Napoli PA, Prati S, Rezza G. AIDS: a major health problem among young Italian women. AIDS. 1996;10(4):407-11.
  496. Conti S, Farchi G, Galletti A, Rezza G, Prati S. AIDS as a problem of great relevance for women's health. Epidemiol Prev. 1996;20(2-3):133-5.
  497. Galai N, Lepri AC, Vlahov D, Pezzotti P, Sinicco A, Rezza G. Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. Am J Epidemiol. 1996;143(3):278-82.
  498. Sabbatani S, Ferro A, Gomez V, Garçia Lacerda L, Rezza G. AIDS--TB complex in Guinea Bissau: an epidemiological updating. Infez Med. 1996;4(3):146-8. Italian.
  499. Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis. 1996;28(1):27-9.
  500. Dorrucci M, Pezzotti P, Phillips AN, Lepri AC, Rezza G. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. J Infect Dis. 1995;172(6):1503-8.
  501. Cozzi Lepri A, Pezzotti P, Phillips AN, Petrucci A, Rezza G. Clinical staging system for AIDS patients. Lancet. 1995;346(8982):1103.
  502. Serpelloni G, Vlahov D, Mazzi M, Rezza G. Interest in HIV vaccines among Italian injection drug users. The Network Interregionale SERT. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10(2):206-7.
  503. Rezza G, Pezzotti P, Aiuti F. Acquired immunodeficiency without HIV infection: epidemiology and clinical outcome in Italy. The Italian Study Group on non-HIV AIDS. BMJ. 1995;311(7008):785-6.
  504. Serraino D, Franceschi S, Dal Maso L, Lepri AC, Tirelli U, Rezza G. The classification of AIDS cases: concordance between two AIDS surveillance systems in Italy. Am J Public Health. 1995;85(8 Pt 1):1112-4.
  505. Cantoni M, Cozzi Lepri A, Grossi P, Pezzotti P, Rezza G, Verdecchia A. Use of AIDS surveillance data to describe subepidemic dynamics. Int J Epidemiol. 1995;24(4):804-12.
  506. Franceschi S, Rezza G, Serraino D, Cozzi Lepri A, Geddes M, Cote T. Risk for Kaposi's sarcoma among Italian women with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9(3):313-4.
  507. Dorrucci M, Rezza G, Vlahov D, Pezzotti P, Sinicco A, Nicolosi A, Lazzarin A, Galai N, Gafà S, Pristerà R, et al. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. AIDS. 1995;9(6):597-604.
  508. Sabbatani S, Pipitone E, Marri E, Giorgi L, Sgnaolin P, Rezza G. Appraisal of hospital length of stay and cost of illness esteem in a cohort of positive and negative HIV drug addicts. Infez Med. 1995;3(2):81-90.
  509. Rezza G, Dorrucci M, Pezzotti P, Pristerà R, Serpelloni G. Evaluation of symptoms suggestive of HIV acute disease among injecting drug users. J Infect. 1995;30(3):263-4.
  510. Manfredi R, Rezza G, Coronado VG, Cozzi Lepri A, Coronado OV, Mastroianni A, Chiodo F. Is AIDS-related cryptococcosis more frequent among men? AIDS. 1995;9(4):397-8.
  511. Sabbatani S, Ferro A, Gomes V, Garcia Lacerda L, Pipitone E, Rezza G. Tubercolosi ed infezioni da HIV 1-2 in Guinea Bissau. Aggiornamento Epidemiologico e stima delle sopravvivenze in una Coorte di Pazienti Tubercolotici con infezione da HIV-2. Infez Med. 1995;3(1):38-44.
  512. Rezza G, Alliegro MB, De Rose A, Pezzotti P, Serafin I. Prevalence of HIV infection in Italian drug users attending drug treatment centers in the years 1990-92. Ann Ist Super Sanita. 1995;31(3):301-5.
  513. Spizzichino L, Gattari P, Zaccarelli M, Casella P, Valenzi C, Rezza G. HIV Infection Among Injecting Drug Users from North Africa and the Middle East Living in Rome. Addiction Research 1995, N. 1, 3:57-62.
  514. Cozzi Lepri A, Pezzotti P, Dorrucci M, Phillips AN, Rezza G. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study. BMJ. 1994;309(6968):1537-42.
  515. Rezza G. Methadone Maintenance Treatment: Harm Reduction or Rehabilitation? Addiction 1994; 89:809-10.
  516. Rezza G, Pezzotti P, Aiuti F, Angarano G, Barbanera M, Canessa A, Castelli F. Gafà S, Lazzarin A, Muratori S, Pristerà R, Ricchi E, Salassa B, Sinicco A, Tirelli U, Viale P, Zaccarelli M. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorths. Mulricohort Analysis Project Workshop. Part I. AIDS 1994; 8:911-921.
  517. Montella F, Rezza G, Di Sora F, Pezzotti P, Recchia O. Association between hepatitis E virus and HIV infection in homosexual men. Lancet. 1994 Nov 19;344(8934):1433.
  518. Phillips AN, Pezzotti P, Lepri AC, Rezza G. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study. AIDS. 1994;8(9):1299-305.
  519. Rezza G, Nicolosi A, Zaccarelli M, Sagliocca L, Nespoli M, Gattari P, Spizzichino L, Ippolito G, Lazzarin A. Understanding the dynamics of the HIV epidemic among Italian intravenous drug users: a cross-sectional versus a longitudinal approach. J Acquir Immune Defic Syndr. 1994;7(5):500-3.
  520. Zaccarelli M, Gattari P, Rezza G, Conti S, Spizzichino L, Vlahov D, Ippolito G, Lelli V, Valenzi C. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS. 1994;8(3):345-50.
  521. Montella F, Viola P, Recchia O, Di Sora F, Rezza G. CD4+ T-lymphocytopenia and severe infections in an HIV-negative Ethiopian man. AIDS. 1994;8(3):390-1.
  522. Serpelloni G, Carrieri MP, Rezza G, Morganti S, Gomma M, Binkin N. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. AIDS Care. 1994;6(2):215-20.
  523. Rezza G, Rota MC, Buning E, Hausser D, O'Hare P, Power R. Assessing HIV prevention among injecting drug users in European Community countries: a review. Soz Praventivmed. 1994;39 Suppl 1:S61-78.
  524. Rezza G, Salmaso S, Abeni D, Brancato G, Anemona A, Rovetto C, Verani P, Perucci CA, Carballo M, and Italian Working Group. HIV Prevalence and Frequency of Risk Behaviour in Injecting Drug Users Entering-Treatment and Out-od-Treatment: A Cross-Sectional Study in Five Italian Cities. Journal of Drug Issues 1994;  3:527-535.
  525. Lo Caputo S, Rezza G, Binkin NJ, Angarano G, Rausa A, Leone V. Investigation of a Cluster of HIV-Positive Injecting Drug Users in Rural Italy. Journal of Preventive Medicine and Hygiene 1993;34:151-155.
  526. Rezza G, De Rose A, Dorrucci M, Arpino C, Serafin I. Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990-1991. Eur J Epidemiol. 1993;9(6):663-6.
  527. Gianzi FP, Salamina G, Binkin N, Lattanzi A, Rezza G. Study on attitudes and practices of directors of drug addiction treatment centers regarding HIV infection prevention in drug addicts. Ann Ig. 1993;5(4):241-5.
  528. Gafà S, Giudici MG, Pezzotti P, Rezza G. IgA as a marker of clinical progression among HIV-seropositive intravenous drug users. J Infect. 1993;26(1):33-8.
  529. Rezza G, Dorrucci M, Filibeck U, Serafin I. Estimating the trend of the epidemic of drug use in Italy, 1985-89. Br J Addict. 1992;87(12):1643-8.
  530. Rossi R, Tommaselli AP, Panza N, Ghiggi MR, Rezza G, Giuliani M, Suligoi B, De Mercato R, Lombardi G. Hormonal and immunological pattern in a patient with acquired immunodeficiency syndrome related complex and Cushing's syndrome. J Endocrinol Invest. 1992;15(11):849-52.
  531. Zanetti AR, Zehender G, Tanzi E, Galli C, Rezza G, Cargnel A, Boschini A, Mari D, Pizzocolo G, Mazzotta F, et al. HTLV-II among Italian intravenous drug users and hemophiliacs. Eur J Epidemiol. 1992;8(5):702-7.
  532. Corona R, Gentili G, Rezza G, Mele A, Caprilli F, Ferrigno L, Prignano G, Giglio A, Titti F, Palamara G, et al. Prevalence of antibodies to human immunodeficiency virus type 1 and condom use among outpatients at a sexually transmitted disease clinic in Rome. Eur J Clin Microbiol Infect Dis. 1992;11(4):328-33.
  533. Mariotto AB, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol. 1992;135(4):428-37.
  534. Gattari P, Spizzichino L, Valenzi C, Zaccarelli M, Rezza G. Behavioural patterns and HIV infection among drug using transvestites practising prostitution in Rome. AIDS Care. 1992;4(1):83-7.
  535. Sabbatani S, Mangiarotti V, Tedei F, Rezza G, Lillo F, Varnier OE, Ferro A. HIV-1 and HIV-2 seroprevalence in tuberculosis patients in Guinea Bissau. J Acquir Immune Defic Syndr. 1992;5(5):536-7.
  536. Pezzotti P, Rezza G, Lazzarin A, Angarano G, Sinicco A, Aiuti F, Zerboni R, Salassa B, Gafà S, Pristerà R, et al. Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS. J Acquir Immune Defic Syndr. 1992;5(7):745-7.
  537. Rezza G, Titti F, Pezzotti P, Sernicola L, Lo Caputo S, Angarano G, Lazzarin A, Sinicco A, Rossi GB, Verani P. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users. J Biol Regul Homeost Agents. 1992 Jan-Mar;6(1):15-20.
  538. The Italian Seroconversion Study Group. Disease Progression and Early Predictors of AIDS in HIV-Seroconverted Injecting Drug Users. AIDS. 1992, 6:421-426.
  539. Gattari P, Rezza G, Zaccarelli M, Valenzi C, Tirelli U. HIV infection in drug using transvestites and transexuals. Eur J Epidemiol. 1991;7(6):711-2.
  540. Sasse H, Salmaso S, Conti S, Rezza G. Sexual lifestyles in injecting drug users in Italy: potential for HIV infection transmission. First Multicentre Study Group. Br J Addict. 1991;86(9):1083-9.
  541. Luzi G, Greco D, Sasse H, Rezza G, Aiuti F. The spread of HIV-1 infection in Italy: seropositivity and AIDS related syndromes. Allergol Immunopathol (Madr). 1991;19(1):19-24.
  542. Tirelli U, Vaccher E, Covre P, Corso C, Serraino D, Rezza G. Condom use among transvestites in Italy. J Acquir Immune Defic Syndr. 1991;4(3):302-3.
  543. Kourouma K, Foucault-Fretz C, Diallo MP, Sabbatani S, Rezza G, Titti F, Sernicola L, Verani P, Rossi GB. HIV-1 and HIV-2 seropositivity among AIDS cases in Guinea. AIDS. 1990;4(12):1299-300.
  544. Zaccarelli M, Rezza G, Girardi E, Puro V, Pezzotti P, Lelli V, Narciso P. Monitoring HIV trends in injecting drug users: an Italian experience. AIDS. 1990;4(10):1007-10.
  545. Mele A, Rezza G, Stazi MA, Gill ON, Pasquini P. Incidence of acute hepatitis B in injecting drug users as an indicator of continuing HIV transmission--international implications. AIDS. 1990;4(6):598-9.
  546. De Mercato R, Rezza G, Giuliani M, Perna E, Iovinella V, Bassi A, Tagliaferro R. Serum B2-microglobulin and human immunodeficiency virus infection in intravenous drug users: a cross-sectional study. Boll Ist Sieroter Milan. 1990;69(2):447-8.
  547. Rezza G, Lazzarin A, Uberti-Foppa C, Tumbarello M, Menniti-Ippolito F, Pezzotti P, Titti F, Verani P. Risk behaviour and HTLV-1 seropositivity in injecting drug users. Br J Addict. 1990;85(5):686-7.
  548. Rezza G, Lazzarin A, Angarano G, Zerboni R, Sinicco A, Salassa B, Pristerà R, Barbanera M, Ortona L, Aiuti F, et al. Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males. Eur J Epidemiol. 1990;6(1):99-101.
  549. Martin GS, Serpelloni G, Galvan U, Rizzetto A, Gomma M, Morgante S, Rezza G. Behavioural change in injecting drug users: evaluation of an HIV/AIDS education programme. AIDS Care. 1990;2(3):275-9.
  550. Monfardini S, Vaccher E, Lazzarin A, Rezza G, Alessi E, Baroni C, Bernasconi C, Carbone A, Luzi G, Mandelli F, et al. Characterization of AIDS-associated tumors in Italy: report of 435 cases of an IVDA-based series. Cancer Detect Prev. 1990;14(3):391-3.
  551. Rezza G. Regional variations in HIV seroprevalence among injecting drug users in Italy. Rev Epidemiol Sante Publique. 1990;38(3):263-4.
  552. Tirelli V, Rezza G, Giuliani M, Caprilli F, Gentili G, Lazzarin A, Saracco A, DeMercato R. HIV seroprevalence among 304 female prostitutes from four Italian towns. AIDS. 1989;3(8):547-8.
  553. Rezza G, Lazzarin A, Angarano G, Sinicco A, Pristerà R, Ortona L, Barbanera M, Salassa B, Tirelli U, Aiuti F, et al. Risk of developing AIDS in newly seropositive intravenous drug abusers. J Infect Dis. 1989;159(6):1156.
  554. Vaccher E, Tirelli U, Lazzarin A, Rezza G, Malfitano A, Raise E, Carbone A, Contu L, Alessi E, Monfardini S. Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 cases. AIDS. 1989;3(5):321.
  555. Rezza G, Titti F, Tempesta E, di Giannantonio M, Weisert A, Rossi GB, Verani P. Needle sharing and other behaviours related to HIV spread among intravenous drug users. AIDS. 1989;3(4):247-8.
  556. Mele A, Verani P, Caprilli F, Gentili G, Stazi MA, Rezza G, Sernicola L, Franco E, Prignano G, Pasquini P. High prevalence of antibodies to human immunodeficiency virus in heterosexual persons attending a sexually transmitted disease clinic in Italy. Eur J Clin Microbiol Infect Dis. 1989;8(3):238-41.
  557. Tirelli U, Andrieu JM, Vaccher E, Raphael M, Touranie JM, Rezza G, Toledano M, Lazzarin A, Gavosto F, Monfardini S. Comparison of clinical findings of 148 HIV-related non-Hodgkin's lymphomas among intravenous drug abusers and homosexual men in Italy and France. Haematologica. 1989;74(2):225-6.
  558. Rezza G, Lazzarin A, Angarano G, Sinicco A, Pristerà R, Ortona L, Barbanera M, Gafà S, Tirelli U, Salassa B, et al. The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS. 1989;3(2):87-90.
  559. Tirelli U, Vaccher E, Rezza G, Barbui T, Bernasconi C, Cajozzo A, Cargnel A, de Lalla F, Dessalvi P, Fassio PG, et al. Hodgkin's disease in association with acquired immunodeficiency syndrome (AIDS). A report on 36 patients. Gruppo Italiano Cooperativo AIDS and Tumori. Acta Oncol. 1989;28(5):637-9.
  560. Sasse H, Salmaso S, Conti S, Rezza G. Significance of HIV antibody testing as a preventive measure in intravenous drug users. AIDS. 1988;2(5):402-3.
  561. Buttò S, Verani P, Titti F, Rezza G, Sernicola L, Rossi GB. Simultaneous seropositivity to HIV-1 and HIV-2 in Italian drug abusers. AIDS. 1988;2(2):139-40.
  562. Rezza G, Titti F, Rossi GB, Verani P, Menniti-Ippolito F, Oliva C. Sex as a risk factor for HTLV-I spread among intravenous drug abusers. Lancet. 1988;1(8587):713.
  563. Tirelli U, Vaccher E, Rezza G, Broccia G, Fassio PG, Gobbi M, Gritti FM, Lambertenghi Deliliers G, Lazzarin A, Luzi G, et al. Hodgkin disease and infection with the human immunodeficiency virus (HIV) in Italy. Ann Intern Med. 1988;108(2):309-10.
  564. Tirelli U, Vaccher E, Zagonel V, Rezza G, Palmieri G, Pizzoccaro G, Parrinello AE, Carbone A, Monfardini S. Malignant tumors other than lymphoma and Kaposi's sarcoma in association with HIV infection. Cancer Detect Prev. 1988;12(1-6):267-72.
  565. Titti F, Rezza G, Verani P, Buttò S, Sernicola L, Rapicetta M, Sarrecchia B, Oliva C, Rossi GB. HIV, HTLV-1, and HBV infections in a cohort of Italian intravenous drug abusers: analysis of risk factors. J Acquir Immune Defic Syndr. 1988;1(4):405-11.
  566. Mele A, Franco E, Caprilli F, Gentili G, Capitanio B, Crescimbeni E, Di Napoli A, Zaratti L, Conti S, Corona R, Rezza G, Pana’ A, Pasquini P. Genital herpes infection in outpatients attending a sexually transmitted disease clinic in Italy. Eur. J. Epidemiol. 1988; 4:386-388.
  567. Tirelli U, Rezza G, Lazzarin A, Luzi G, Broccia G, Foà R, Gavosto F, Monfardini S. Malignant lymphoma related to HIV infection in Italy: a report of 46 cases. JAMA. 1987;258(15):2064.
  568. Rezza G, Greco D. AIDS: drug addicts, homosexual males and international travel. AIDS. 1987;1(3):191.
  569. Greco D, Pescini A, Rezza G. Pediatric acquired immunodeficiency syndrome in Italy: a health problem correlated with drug abuse. Pediatr Infect Dis J. 1987;6(9):863-5.
  570. Luzi G, Aiuti F, Rezza G, Greco D. Italian HIV infection updated. Nature. 1987 Jul 30-Aug 5;328(6129):385-6.
  571. Aceti A, Attanasio R, Pennica A, Taliani G, Sebastiani A, Rezza G, Ippolito G, Perucci CA. Campylobacter pylori infection in homosexuals. Lancet. 1987;2(8551):154-5.
  572. Aceti A, Pennica A, Ippolito G, Moretto D, Rezza G, Titti F, Perucci CA. Antiamebic antibodies in homosexual men. N Engl J Med. 1987;316(11):692.
  573. Lazzarin A, Verani P, Macchi B, Federico M, Varnier O, Rezza G, Parravicini CL, Viviani AM, Vazzola G, Rossi GB, et al. First case of transfusion-associated AIDS in Italy: a single transfusion with a 51-month latency period. Vox Sang. 1987;52(1-2):155-6.
  574. Greco D, Stazi MA, Rezza G. Length of survival of patients with AIDS. Br Med J  1986;293(6544):451-2.
  575. Rezza G, Ippolito G, Marasca G, Greco D. AIDS in Italy. Lancet. 1984;2(8403):642.
  576. Ippolito G, Rezza G, Verani P, Nicoletti L, Ciufolini MG, Rossi GB, et al. Report of a Longitudinal Prospective Study of a Healthy Homosexual male Cohort in Rome. AIDS memorandum 1984; N. 1; 6:-7.

Il titolare del presente curriculum vitae, pubblicato online sul portale www.unisr.it, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.